var title_f27_28_28096="Pneumococcal pneumonia complications";
var content_f27_28_28096=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53664&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 489px\">",
"   <div class=\"ttl\">",
"    Complications of pneumococcal pneumonia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 469px; height: 259px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEDAdUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6A+Ifjaw8CaTaX+p2l9dpdXQtI47NUL7yjvk73UYxG3f0rgx+0FoB6eHvEnHH3LX/AOP1L+0zEZvDHhuNera0v/pLc14Pc6bPCu7yyVHUjmgD3UftAaCxAHh7xJk8fctf/j9XovjVp0qbo/DHiQr64s//AJIr590+0keQEKck4UYrZll8hdsLbdo7HrQB7O3xt0xRk+GPEn5Wn/yRSD436WTgeGfEmfpaf/JFeMx6gD/rgc+o5q3bhZWJiw2eMDtQB6y3xx0pZAjeGvEgY9BttP8A5IpjfHbR1Yg+G/EgI/2bT/5IrzZY12BCoYk8mqNzFDCpZNsjLyMj/GgD1xfjfpbfd8M+JD36Wn/yRUMvx40aL/WeHPEo/wCA2n/yRXhV9eSu7AF1Xpj0rmtQupZZGIV9vRRn9aAPpFf2hfDzNhfD/iQkf9M7X/4/VhPj1orjK+HPEpH+5af/ACRXyrvkX+Fv8KtWtxNH86MyEH1xQB9TxfG/TJTiPwz4kJ+lp/8AJFWU+MFo4BXwr4kIPT/jz/8Akivn3QdVWU+VLlZlOVbI+auzsr/5Buz05NAHpk/xlsYCBL4W8SKT/wBeZ/8AbimD41accY8L+JOfaz/+SK8r1e7y68kfL3qn5/7tQGH3sjBFAHsh+MdmBz4V8Sev/Ln/APJFM/4XTp+cf8Iv4kz9LP8A+SK81SUC2QON3HXNZuo3aWsJMzbM/dA5JoA9Vm+Oekwttk8NeJAf920P/txSp8cdKddy+GvEhH+7af8AyRXz3famWc+SCg/vZyTWQLm7dt/mSD3LYoA+nD8b9LC5PhnxJj6Wn/yRUTfHjRlDE+HPEgC8n5bT/wCSK+eLPUpWIjZyB/vZGa07WVnAEuGHqaAPbR+0H4fLY/4R/wASZ/652v8A8fpE/aE8PuTt8P8AiQ4/6Z2v/wAfrxldO3vlY889T0qf+z4nw0gUyDqB/EKAPY4/j/oUjbU8O+JCf9y1/wDj9SP8d9HTG7w34kH/AAG0/wDkivGTHgFY02jHAA6VA0EnORn1oA9tk+O+jxxLI/hvxIEPQ7bT/wCSKh/4aB0H/oXvEn/fFr/8fryeNIprXyXkjztx16ehrBlNtFI8cr/OrYYbT8vPIoA90b9oTw+uc+H/ABIMf9M7X/4/XVfDD4n6P8RZtYh0az1K1k0sxLOL1I1yX3427HbP+rOenbrXytLJbHA3Hr1CV63+ylGI/EHjor0dNPYHHXi4H9KAOh1z9ovwpo+u6lpNxpXiCS4sLqW0leKGAozxuUJUmUHGRxkCqq/tMeE26aL4kP8A2xt//j1fP3jSyjm8eeLHZV3HWb7n/t5krGS02sMKfyoA+nP+GlvCn/QE8Sf9+bf/AOP0D9pTwqemieJP+/Nt/wDH6+blgdSDHCvbrVmAXKEFo1Ix02j/AAoA+jR+0b4ZYAjQvEmG6furb/4/Usf7Q3h6RtqeH/EhP/XO1/8Aj9fPsFwmMSWgJ6kjFatmltcyKI08t9wxke1AHuDftA6CvXw94k9fuWv/AMfqFf2i/DbSbF0HxIW548q27f8AbevMZNPEEPlThWyBk4z+BrGbQiEfyVX5iSx/uj0oA9ob9orw2qF20HxIFHfy7b/4/VZv2lvCi5zoniTj/pjb/wDx+vnXXWRJym4FU42isGU9MLigD6oH7S3hQjI0TxJ/35t//j9DftLeFFGToniT/vzb/wDx+vlgMnGU4HpUMyq7fLkUAfWEP7SXhaZwseh+JCx6DyrYf+16ux/H3Q5V3J4d8SEZx9y1/wDj9fIURZGznBGMYNdn4YvfPZUkJDAYbPQ+hoA+kY/jnpMhwnhrxIT/ALtp/wDJFOPxw0sHB8M+JM9Olp/8kV5Fp8CmVVlUAfwtnpUV/ZqG4k5Gevb9aAPXn+Oujpnd4b8SDHX5bT/5IpifHrRXYKvhzxIWPA+S0/8AkivD75Z0hKhS+44BU9KbpUcgmBdCMDOTxigD3p/jfpaDLeGfEg/C0/8Akiqz/HzQ0ba3h3xID/uWv/x+vHL6U7PLVyC3oelZ8loXYMVAHqe9AHtzftC+HhnPh/xJx/0ztf8A4/UEn7R3hmPO/QvEgx/0ytv/AI/Xh0tvGEbdtz2OaxtQsSFLR4I7A0Ae/wAv7T/g6L7+j+JB/wBsLf8A+PVCf2qfBAznSvEnH/TvB/8AHq+VdUt2BOBgcnmucnXaOccc0AfZn/DVfgf/AKBXiT/wHg/+PUf8NV+B/wDoFeJP/AeD/wCPV8VUUAfav/DVXgjj/iVeJOf+neD/AOPUf8NV+B/+gV4k/wDAeD/49XxXQMc5HagD9U6KKKAPKv2hVD6P4WB6f22P/SS5ry37IZMqV3Ie2RzXqvx/RpNL8Kon3jrQ/wDSO6rz6b/QLQs3L4yB9aAOam/0YbYkVXHUgcisp3Y5DVoTE4J9TVOZS3zY6DFAEFamms1uoYHDNyQfSqEUZkPPCqOauK21WkYYUEBv/rUAadzcZhXySPMx8wHas2dwI8uxLY/WsufUxFOdse456ZonvYpV+YncOCoH9aAGXzB4nDBVJHBUYNczcCRQxIPXggVs3l0TCwRBknjJrIluZDu+Vcjn/P5UAZ7MS/B+tTqN8WSfm5Hpk1C0m52HAJHSpBKVjCyqQoO4Ec0AXdPlkinRujBq76zdnjUxsWBHHNcJZqJF3Kcqe9djpDkW0aAfdG0mgCfVElk2YyRjk5qra27CSMs7bf8AeBFX70bydvcZ5qtAMAeg4oA2VXy4E844wPWuR1u5e5vJPmLRqcJjpiuouyFtDg8sgHI6VzN5Cywsw/1aDkmgDIlVACWA9az2kySA3HTipbq4Y7lVAFAPU81mjYG/iOefSgC1CHDny/bHP5109qiqisG3HHPzZFcumJdvbmtaNdqAegoA6eG6KsoJC+2KvpGroHUc57GuVF/5MIMgBXOOPpWhpmsR3bC3jUqGOfm60AXL+ZYMlNuemPesW4u7hzy5UE9F4rZuY/tClAcPwMfyrCk6Fcc5wRQBNbTNGVYNn1zzkVb1yxjmSO8tI9xk/wBZt6Z9frWagG1SO2a2tHmCIYJOFlIww7HtQBzJiGDwc+lezfsrKV1rxkD/AM8LD/0K5rh77S9zncSXHJwQBXov7NsLQeI/GCNx/o2nnr/tXVAHifiWIt448VHbkHWr/wD9KZKjjswUH7slj2rb1jJ8W+JBIv7v+29Q2sD3+1SdRVn7IwRVJ4HA5oAwUs+cFCPSrMVqPlG0n1rW+xFiTngn1rQstPd/lU5PSgDDj0+NuTEQ3tWlb6fFYW+8oftjchX52jscdj9a6aHTv7NmWTdvuV+ZY+wz6nv9BWHPDJ57ZA37s4980APspGluglwd8J+Zy3OPxo1qWOytHdGCKTwfUZp7qtpaytK3yKQHI559BXBeIddF1McxYT7q4POB60AYusSefK7Iq7iew6/nXPzedvAYuOcc1syhmGAP1qBo9+FOeeeKAM4FwBz+dNjnPmskmF9KtNaj5vm5NV7i3YkcjgYFAFlFBOG4PatvwnL5eoqHwFcFeR+VYVoxUbHGBng1v6UhWRSecGgD0W0l5TcRjOM/Si6YtuJ6Yzms5JHSOMyKBnng5qy1wGGwDtkH60AUL53VlAYg9etW7ZOu1i/y889/SsjUJN9znH3cCtCBylgz8fODigBlw484nIZ8EY64pGcsC0zlUzwelQ2ylsxr65zUl3bmVyA4AT5RxQBn3E8W/GMp6ndmoEZJwY1bc2CVGe/pVmeykVSOCPY1lXCEFW7owIoAytbtA0TFYzvXr6471xN/EqscA816feEXJLfdbGSPb1FcPq1oUO4HK9qAOUII6jFJVm5iZSR2zVagBaSiigD9VKKKKAPLvj5KsGm+FZGyQutdv+vO6ryK/u5LhiZGJJ6A9q9U/aO/5AHhn/sNL/6SXNeP5oAZLwvt3qnjE3TtV4gEYPSoljLSqqjn0oAktoT5YXIB7mqGvypFCoDtEiHkgHmtq4ZLa3JOAidT6muA8QXjXMmcnYp4HpQBVvL4sSIyUjHBA6n6mofPKkNGSCKo/vHOQp474p6kIDuYE9QBQBqw3Sz5XkP3HrVe6IU+i9D7VXSTDLwFwefWrQuv4X5weuO1AGei5mEec5OafExMhSLIYn171fgIfeVx+FPhgHngugIPfvQBNpDSpKp4AH3ycciursHXzCqdAASKwEjRITtUg5rS0MKDtkBDk54oA1ro5kGD1qS2AUDdypBNLJHEWO8E88Y7VLbwqFb92M9fWgBl9Ku0A8Dg49hXP+IHLQBORuAIFdDecoD3wecVzuoqWXDjJHXPagDmvKaTcCec9TS+WEfpnnNXZPLjRmd8Y96yrjUo1cLGec55FAGjC4BBxj2qWW8SBcOuWIyB/wDXrCe/dXZUIUDgHFVDeS7y5YE57gUAbVxcCTIkBJ/lUdqzK4MRyQfpisZ9QJbDqhUdcCp4LiFmBhkKn+656n2oA9GsbsXkShifMHGT3pmpREnzRgMB8/v71iaZcMhCyggjoRXSBjJAJFw2D1/xoAzIIwWH54rU06PEgYAEYxioPJCTgKPkP3f8KvwfIwJGBg/WgDYidZY/Ilzuz8rEZxXcfACFoPFni9GIP+iaeRj03XVefJcRomWXcT0I6ivQf2f5BJ4o8WMG3f6Hp/P/AAO7oA8xvrYP4j8RtgH/AInWo/8ApXKK1dOs/tH7k4yBkZHWmi3Mmva8duQda1H8f9MlrotJtQt1G20hQRmgDN/skxKrOU2fSteySKy07dEgN1KMq+PuCtG/tvNv02j92TnHtWdet5S5PMjfdGO3r9KAKwgYyZ4LE5JJ61BNZ7rh5AB2wP8AaI6/gKtLeTsu1369AAOtO1XbYaaxIAnZdqjrj+8aAOB8U3ABEQJEa8bR3PcmvPdULOpKDaM1v+I79Hd/KYPJkgnGQP8AE/nXGX7tIzb2LcUAItx5T4Zs4PIFSRzJLja+fTg1lMQACR14pquoPBCjGfxoA6NVbgA5NRzxBxwBu9ayrW8dQMMSB61qpdJMRkgM3HNAFeKJ1fngZx612nh+CG4tE8xBuDY3Dv8A5FYEEau5DCul8NRGI4cZBOQRQB0gt42s0V+QpLLxg+lQxWiCRiGGzHcVdmwE46beMVEi/K5UZ4xQBiz20eTgBgOc4xVmaI+SFHG0YPpmrE0e5kBQcHntn61UeR5JyvTJxhRQA+FNsbMGCID8zY5PtQWgyQM47cVKlrLNIeAADgAntVuPT+fnUfgaAMvy1dsRMCfQjFUb603ZBADDqa23skUkMrY7YoMCf8tEZgPfkfjQByE1s8cMbqRlehHesTVbRZCxUYDc49DXpUunQtGAFOPTP+eawLrSYluGVwxhfHfoe1AHk1/a7WIIAzWa2nygbiAq9uc16Tq2lpA+4QhT0PrmsG5t1yfMA2qCeaAOOkiCKcfMfXpUOOnvWrfXZWVltI1WMdCV5NZ0k0j/AH2z+FAH6n0UUUAeS/tHf8gDwz/2Gl/9JLmvH1689O9ew/tGjOgeGf8AsND/ANJLmvI40BAb9KAGbCFJI71PaRfekZfQA0uB6Cre1YLcZwRGm4/zoA5zxTclFW3jfjG5h7+9ck8W9j5gJU+vetW7YvcPNKBiRiQD9azrlgAxZtqj9fYUAY9wWV9icdsCqhkjVB50gEgyMA5NS6hcecmEGwDtnlvY1gTOBn5AM9fzoA0nvXwCm3nvj/GrC3ErrISwztyvA5NY0MhVflG/JOauqGeAkAjHH5UAWbe6uIxuD4J7YFbNhf7v9aU3DrxWLBFIyZZcc4yOlTohjjHDZJwCB/n1oA62CeKdFAkXceoHGTW3pcGJQXHzdOTXE2KuiFipJ6c11+gTGQxAjp+dAHQMi7iAAeas2sZLncCO1Vx94VftuQ5OQR29aAKF4o5A6Y/KuS1udoQwyAxz1Fdjc5YkEDHOMVxnimzdiJA2F6Ed6AOR1G7kLbFb5Mn8ay5GG8FiMjHetS6tgpKgk461WuIVwJdoYgdxmgCKRgwGDms95pFRyAd3bj3rRS4H2YhlAAHbrVOafcNoJ6YIHagCj5jCIl2+Z27/AK1dsVLMoIyAfWmtIGdAVBHoatWcManK7cgdqAOg0y5JdVlclT/EeorrtJn+by3cGNunv71wUIYHK8/TrWvp96EbafuZz15B9qAO3aFgOR8ynK89qkGe/pT7M+dFGSc575zSMu1iuOnGKAE7V6T+zt/yM3i4dhaaf/6Hd15txj3r0n9nf/kZ/F//AF6af/6HdUAYmkQxS6rrvnZA/tnUuR6/bZq6CC2EUmQDs/hbPU1l+H4/+JjrbZ+9rWpDPp/ps1dGVAQN2I5H9aACOJGjeRs5VcZz06f0rlrgm4neQk4zhewC+1dTf4h0ObqfMfy/fpzWBGgUEMBj9KAGaZbo12rSDMcYLtnpx0z+OK574i3zweXAkuJdm5/UE8/4e9dtbRiysnkYAkYcjHU9hXkviq5L3dzIW3SO5JOf5UAcLdKzSt5uVXt61lzRoc8DAHXNaWpMi5MhGc5x3NZM06uxwOfc0AU5Y0wcDODxUXkRspJG057VPI5wSoU89M1WjuEZ2GevOM96AECOjDA+UjrViM8g5wqj9aREzkqeD056VIyBvr7UAbOhymS4CTNlcjr1Ar0LQLZC4Q52sMjn2ry/T8i6Qjk9q9H0Cdtu3J28Hr09qANa5LR7I2yMfeGOntVmGJjCCqkg8mowS8wCkHPH1rbSEu5XftCLwPXFAGO1u2SSnI61US32uGVPmJz06GuhlhEUKM2NziqLIIfnwGJJAHb60AR20O2RTg9ec1ceIhiAOc8DNU4Q0kg3HAznPYVYmTjIyMj71ADjAGI3rx39qiktl8wbAWXuKdazlARy46/NVtXRgxztYfw5oAzHG1uBkZ5yKoahEpBG35T3rWvHU8Be5wax5bg72jcABuBnqDQBi6tCs1oWYDcR175H/wBauB1IbmZFztI7V6Pc2jSwSnfu2YbHf0NcbfWQEsiFjlSRmgDiJ7U/88+e9UZ4AI2baQQK6q5twrYPQ96iu7NDp1zKQAfKYgY9AaAP0gooooA8n/aLGdC8MD11of8ApJc15PivWf2iBnRPDH/YaH/pJc15SikkjuKACJS8igDqQKsamMWkpOcNinWkZ81Bj5ifyo11kjgcE4jUZY/4UAcBqpUFpGO2POM46+w9a5+8uhcyF8EAdATnArS1iZ7iQjGIxnavYen41jeSxYHop7DuPpQBTkRpCQqkn1qpNahX83Ib1ULWvJs2EINrdgPSqjhVJLttGORnn8qAKUYCFgoAB5A6U+PoRz1NRXbgnNqreYB1fp+lV4rqc5Mi4P8ACQvFAGzbI4jVSGwePrVyCNv4znB5BrK86ZREVYgdST/n1qe3v5QzF8HPquMUAdNaoCik9ckniun0OHa4fAP4VyGm3iM+G+6cA8fyrudFMZgyjKQMnrzQBoRIGbjg9ela0Crvbj9KoWqAFW6k8VqxrtJ9DQBRuYmKnaMY4rmNZh3RyZxt2nrXZXGBGfXrXG+IJWSGReOlAHnl6xWUhjjHYmsua5jVHVpFB9jzTNZuJvPlKnIBP6VjsyyO2WOWHU0Aai3tuwnAHzbcjK96yBds4ZghwMA/NQI3VFaM7mJw2OaiMTLlACC3UEUAX7e+T5EMRZx0I5rTtykmFSQDb6jFYSAJIWU7QOM1o2rfL8uenp1oA34VMfzsOO1WIU3Tb0GOOVxWRFczJtUnemOQ1a1o4chom4HUdxQB2vhS6Vrc2zZ3ZypJ/T2remjyRgdQOcdK4/QWIlEkR5UDOK7XIkVXXow/XNAFRlIXGOnevRv2d/8AkZ/F/wD16af/AOh3VeeSAnODjsQf8+1eh/s8f8jR4vx/z66f/wCh3VAFHw8CdT1oZxnWtTA+v22auoZXwwCEkjArjNPuhb3ursDjZrmolj/2+zV1X2iRxuVztPI57UALre0WVrCrA7CS2OhJrMtY98yggY6kkdAOSfyq9ffPbjAJIPWm6TF5rSsQNqgKT9aAKPiKYQacsbE+ZIxcr6A9M14p4qvUEksce4szZJHb/GvTfHGo7ppYo3G8Ng4/hX0ryDXopTckvhVI4z1oA5q5ySDnPuT1qm7blOMj+tX7iMDn8s1UdBu6cc0AVWz1B561XkU72IHHWtB415xwM9fak8pDk4zmgCtbsY2IcEhhVyHGB/EAarshDd8DvUlrvXduGOeMigDRt7djcLIrEY6KBXoGhNutguMHPNcVZKZFVk5I7A812elJJ9mVowFctnB9MUAdTpiEyoccLljWzbxk5OOtUNIt5DAHddu44OTjj2robCBCWL5wBwP8aAMy9iPmLwWAGOlQ/Z8spYgYGAOta88W+TIHA7D1qqYmHUAD1NAGfHbDeTxjtx0ptxBgcvhc5xjj6VdZkXPr7VTup42X7zZz36UAUOQoVMgnv0zT0jZTk9TyD3puQ04CkHAGAKvFA0anHOODQBTlcSLwvz9D61j3kRccYLD9a0rhXRiQTwc5HeqsmGGRwe+KAKdv84Zh6bTXOa5GDO4PyuBycda6RFMcrMOEb5SPQ1ieIY8S7wD02n60Ac49p58QVNhcc4PWq2oW7roNyGUrthfqMZwpqyzNHKrgkHGDg1NqVx5nh3UVYIxWFyDjnBUj+dAH33RRRQB5T+0L/wAgbwvkZ/4nQ/8ASS6ry6IDBOOpzXqX7Qn/ACB/C3/YaH/pJdV5tEvylvyxQBPp8WX38HDbR9axvFM28tCPX5ufvH/61dIo+z2zy941Jx7muOv18/BJ4HUnvQBxlxEd7FwcKfzqkY2YgrwR3xwBXQ6hAWfdnaijk46YrAuVNzhUHlxqeh6t7mgDMup1iJSIBpAfv8Yx7VSnyW3Hc2V61rvZMGGFLZ9ulWoLLKhXAAPt0oAwY7U4HzDBHXFSG0Vfl2AgAdFroYtJ8liwJdSOpHFTixJTKkAr1GKAOcubT9wCg6MO341BBGrADb8xzz/SvQNJtQ8WxhxnJ+XpVOXRVDE5IJPGBQBz+mxMTn8hiu70lTBCRwMgfnWZpun/AD4cnOc9K6dLYKEFAGnYR5SMtya0l5PTJ9BUOnQ/IFzz61dEeHyD+FAFG84XGO1cZ4lBa1Y4+bpXd3EYLe3tXMa5CzRSADacccUAeK3VtI0js5wNxzkdajgsoixBj3e/NbV5HiaRTuyAcn3qC1Xy51LYHzcZoAzlhSNwqxrge3pUk0MYdT5aZxxxzWrexxA+YDk45K4rJvbhUBkcY7YB/SgCFoIQADGhI9utSARx7QFVT2xVKPUI8k+W271JFXbcCXhXH1Y0APWLLZVsgCrlkWiYYJz1IqNI2BJI7DFXYYgwCnPXg+lAHR6KyjEkYwjYBA7H0rtLUhrbg8DGOenNcJozG2ZgR8ucH3967TSiQGi65XrQBYkUbjkdea9A/Z7GPFHi8D/n00//ANDuq4KRWAUn3Brvv2ff+Rq8X/8AXpp//od3QByJk/4mWtRgn/kNakT/AOBk2K63TpS+mxsTzgDNcUp2614gPrrWo9f+vyWuq0l82Kj0OKANSdibUkdD6etW9JVYLAySAbSWlbPHyqKqIplUICQzHb+dW9WZYNHYgfK37tR7DvQB5PqMpllmlmyXc7iT2zziuH1wPLIdu44OM11Wq3CwAmQbieAlcNrcrXDlmJIzgKp4xQBk3hCHBZcfXNUGkVc88DmnTfISR2qu6lwxJwRg0ASnnIDDB/SnplWUnoBzVB2+badynP0qeOQphSCy+vpQBakQFQQPlP6U0ZGfSrFqAyFsggHBFWVtxI8YDbfYigB+mB90exiozzjv3r0bwzbeZtEjBgBuxn9K4rTLfbciI5yxzkdOK9C8PD7OQ+NxbgZ7ehoA6WDjEa5HAwPSt22hAheQEKAvIPr3rF0aBjJ1zgjn1roVQLayAZ57GgCmNuGbI2jkn04rNmcue4XsKvuGdVULzUTWmSNzEHHpQBmSqevGKzrhcqTwACa25oAARuPH61l3Ft8uNxxnNAGTkpOrA8n0rYt38xEV+HA6+tZ0luwdDjP4VeVQIRzgAHNAEV2mQ4x09qyZP3TAnBHcZ6irVxqSLJsKk54DE/zqoJPtJ2FdvPX0oARkAVgTkNzk1i6shmjY5+fH5MK3QMZQ9skH+lZUoLRygdQd35UAcfKu5TjqOlQXR26NqAYDm2lHP+6a0L+Hyrh1H3c5H86zdUz/AGbfdMfZ5Pr900AfoPRRRQB5X+0EM6R4W/7DX/tndV51bLvKD3r0b4/jOleFgP8AoNf+2d1Xn9ggMwAxjtQBNqpJsdi9Wb9K5aVVeTyx/CM5rrNXXZZIMfMSc4PauUuwY3EY4Y/6zHpjgH/CgDKvoxcYCjEAwAD3PqazhYAElwu0dx3NdLFDuO7b8v8AOnvbCUfcB9qAOda2TAAULjpiiOzPzMCAvrW08KRhgwDMcYA5xVCVJCxzzz0oArpIkRZQpJIzjNBuQQSsQB6npUwhLcYGc8VJFa5lVgvueTyaAJba4GzlAGIyRgdaRcMVDKAc8+9WktlUg7AMc01oy+5iM+9AE9vGqushAOOmKuK4LqSMZGKrwocYA5NWYYn3jI4xx7UAb+kIDnjoelXpFXdkL1NM02LZGucDI6ZqxIuDg9xQBVmj+TqOBzWBrSYi5Uc8ZropCR9044FZOtJuAwMjtQB5h4mscnzkCDHBHf61yq2TNPl2G0V6VqFuZA6EAqVIwTXHPZvG8oK4IPrQBkalIlqkcYHJOOK57VoJcoX+6Rxz1ror22mmuo/l/djrurN8Q77qaLyARCvXtzQBgJEWwqYycHntV+1tWz1xjgYPU1DbWchfLp7YzW/Ywc4CDpQAlrviA3HKdxmtq1jExyuBjqDUP2csgwoP41Nbr5cnAwaANe3VSCrdP5Vv6DL+9Mb5yp4+lYMDK8O5GBIGGx61r6bxPG4OCB+lAHSXS4iUnqTXc/s/f8jT4u/689P/APQ7uuHlO+IkdCAa7j9n3/kafF3/AF56f/6Hd0AcQcf2zruef+J1qP8A6WTVv6O+YZVB6EH+lc+CP7b1/IzjWtR/9LJq29I4eQeoBoA6rTQTID3XOPqeP61S8bXSQWyBckRpgL7nnNaGiA+RM68cKoPvXHeObnztSlijfPlttI7UAeX66zeZKXbLFjya5uZ98ZAPU4NdbrdvhyWUcjArmrhBzgdRigDn7qM/MQOe9UzkAfmK2boZYehFUHAycDigCmroyfMA3bJHepUUZba3UYx71KQvcCkWMdFwtAD7bKEcgeprXtGV0CD/AFgfJP8ASs6FSCcjFaOjojOylfnByp9KAOs0K3jluCxUbs857V1drHslEZAHPBzWH4djdEcOCMHjPpXd6HCZJkJA2jnntQBtaXZNDaqzYDNzgelXiFGUI6jGaktV3xMFOCV4JJ9arSq0dxGJCBjuTQBJ5SpGRx9cVVlTktnirU8gRDtPzEZ45rKn3MSWORjgenSgCjNcR+dIjE+xxUDspyM88iopLdzOWxhc0lymFIBAoAZGNzqpGSvvUWoy9EA4HFPtSRIo7Y4q7cWi3AzFsDehOKAOJvlGeRweM5q1YAeUu7k9j7V0T6cgZgyKeMY5rMe1Nu5IUADpjnFAFO/UiPIOGXn8qqKA00T4wr/L+fFaFyRJ8wHy+9Z6JiVk4+8GX8+aAOf1mHbsOB3T8Qf/AK9YOqgf2VqGO0Eg/wDHTXXeIYuG44LZH9a5bWR/xJr89P3D/j8poA+/aKKKAPL/AI+f8gzwr/2Gv/bO6rg9LQmZACOSTXe/Hn/kH+FP+w1/7Z3VcdpiYbf1JOBQAzWjhWc9IwD9f85rlRGzysdpyxyeOlddqiFnMfUdT71mLZhDtJ+Y+lAGfBG2QijnnrUV3IIEdUO4n7xParWoS+VDsjJ5PzN/SucvNRSNtrAnnt3NAEpmUAB+B1z6GoJJoURiJVIPuKzb5JLrBPyp0wTVAQmMgEgY796ANJtSkldlihGwHGSeta2it50irJhSD2rm4pEjbjOM9xWjYy751yNhB9e1AHZyWalTyxzjgVELZVVsFsGorC+RW8pmLA+oPFae5GIHTB44oApRWeJVZScD1rQgtmZlIyfXAqaNFYZzyK0bSMbdwbPSgB9iuBswcDjJ4qw6luDx0FTQR/Nk4yeKmeIbuelAGRKhBx65GaztSQhQD3FdHNGGXOQDWPqsJCjgYoA5W5thg/Meea5DVLdlnYgEjPp6V210AZCMnB9K5nxIGijaVQfl5POMUAcnfREKUTlv5VkyWT7cBgCR3rann3xERAKTwCaxpbyaNcFFODjg0AN+xmJAxOQG4461JbLh0UH8TUgvf3axsq7u9Rs0YYA559KANWEhwd3BqORCxBH0qKCUNkAdPWrCsGOFOTQAtpL5cq8ZXkZrptKUby2flIrmlh5woO4DkVvaJLlFjPPegDqhIfIBxyOK7v8AZ/GPFfi8elpp/wD6Hd159bMGgdSenNehfAA58V+Luc/6Hp3/AKFdUAcGx/4nniBe39s6if8Ayclrb0psTHOMFawJGC674gz0/tnUQf8AwLlrTsZf3i8ZG2gD0HRiI7EE9D+8PsP8ivN9ZfdqN0xxmSQsQO3Nd68og0q7fP3Y1iH1PBrzfxFcLBPvfksAVA9qAMLWomlicD1rjNQdVzk7uADt7Gug1W7N3Ieqg/wg8Vyl8dhILcH0oAqNcHBGACPfrVWSUktleCM/rQ6kEHOc96TB2k9qAGoQxAzg+/FSoQQd3A4H+fyqBlXqR3zSqPmOCQOmO1AGjbxldw6hRnitLRYcXSMx4Ukn8qXT7MhPnPLgEY+lbltAqR7ioBOAPrQB0WmxhcKpJHHOPUV3OiqyRbu7DpXKaBanyA7YwHBrtNMQcFSDz06UAblmvA9MVX1UbZYzggAZ5q/Ah2xjpngGkvLZpSCAAFzzQBmDLjcAeeeKryxOvQH24rSjj8nIOCP0pXQrw2DQBgSxEMAATiqdzFkFTn5q6GZPU9c1UnhypxgAetAGBZRkOMHkc1b24XOeV5q3HCozuGGPpTTbEEsMHOcZoAglk8/GRhwPwNZl6N6kc9qtXalMgdQagDeepzw4HPvQBiEFH2Hpnj9KrOhE8R/utz9K07yAkZB5FRxxebGJBj+7QBja7GfLGP4ZO4+tch4gTGiX45H7iQ8/7prvtTiJizkY2BvyrifEqA6NqIH8NvIR/wB8mgD7tooooA8x+O4zYeEx/wBRr/2zuq5iyiKrEMdOorqfjoM2fhIeutf+2d1WBCMEkfwj/wCtQBA8ZaZ2z1Pf9Ko3i+WMr95ugPrWswG7A5x15qhOhnPIyc8Y4xQBzOrxkQrtUls8/SuIvQY23Fcye/QCvVpbKNgUkAJ6EkVk3XhywnJZ42C55YNxQB5obqUc5z7AVGGViTIwXPSu6n8K2OfkaZPfIJ/lVB/BtszErd3GfRlBoA46aYr8kIwPerulyNuy5+bHFdH/AMIVCXz9skPsUFWoPBZ8xXW6YL2/dj/GgDNtQRKc9OoP41urLsRS54znI7VY/wCEbddpWXOBg/KB/Wlu9InW3IUnOcY4/wAaAL2kyfaE+UjJ6CuitoQqYUENxWVoGkvBtaUn5egHf9a6WGH2xz0oAIVO/wDCpGXI56VNDEAeV+lSmMHjFAFBoiMgfWsvU4PMxuByOldBJGMfLVC8iDgZGPU0AcVfWjDccdvzrAvLITI6TZ8tuBg4ruLuEOxAGa5/VIREPu/Lnr05oA81vdN+zyPGMgdQWPUViTQFZsMDjJIx3r0PV9OF1AThlbBwwri7kSoxjuIwroAQduM+9AGEYHEmWyGyTzUxzsUlc884q1KSFfzEBIwQ2KpI7liOdo5I9KAGq0i4I7dBWhb3Cuq+Zw4GAT0rMWRWJKnBA471YQDGSefWgDoLZjIyr0YfyrWtlMMgKjC8H6GsTSpCOJgMnhXPX6VvJzgHk96AN/TmBkPdWU16H+z8MeK/F49LTT//AEO7rzXSG/hzyM4+lenfAQY8W+L/AHs9OP8A49dUAea3UmPEHiFf+o1qOf8AwLlqxYz/AOmxqvPb8zWZqMm3xL4jH/Ua1A/+TctWNEdX1OIsRgOM/TOaAPQ9ZuUg0YJK2FaXc/1x/wDqry/xDcmeYzMRnpwO3auk8baoy2MCZxuk3kfyrib2QzxHZyD1P8qAMmSUHIByTWHqR5LDk+la0qr8zDIZRzz2+lZ16ysDsVT74zQBiHLMc9D+tPRTnoSDT5VUOcHIGPapI22gDhfQEc0ASW9v5kcitGctwDnGPrSCxPQdvepFuHBCggDvgd61tPhEko8zkdSMUAW7U7YIEmBCqODWrE8c90u98EkbcD8qo3KM5WKNOccAdvetnQLAO6+bzMD930oA7/wpaoLEo5J34JrqLDS0GMl2GeM//qrP0Gy2YG3G0dK62CLaANvB9KAI47Zl2kjk+9OA++TkHrWgi4UAjp3xVOZirOFUY6fjQBRuFSLDE9jwKoNOwA8tMDoMitCdAeTzzjHpVSRFHAHbgUAUpZJG4IHftUEjPzvTOeoFXmQE8jpULod3HI7GgClGoYjHUnp3q0UGzBBxjFL5W05A5zxUxO35XwR64oAxr233qcA7jWRPC0agxkhl5Ga6i4iBGVGfcVl3VvvzgYoAxTEWXK8g8/T1qOOERFkOQpGVrRijCMUbgHnPoagu/lXcF+ZeR/hQBkagm+ENg4KMv5Vwvihduh6i3OTbSDn/AHTXot3GBagr0AZgfY15z40fGk30anjyHJ/75NAH3RRRRQB5r8cBm38ID/qNj/0juqwbdQxJJOBW78cDi28IEf8AQbH/AKR3VZFgufMPtQBQun8oMeu5sVJax8Zz1H/1qZMhe5+b7i8/jU0AClt3G3pn0oAbNb7jkN0HpWdcR7ypB4BrSmbzQVUfKOh9arG3XkgfMfyoAoi3ZmViw/CmmEKwAJz0B/Gr/ltJnK/Ke9EdoSeBkjvmgChFAeWUj05rVjtz9lVd3KkCnR2zfdKjdmrhjYREDgY65xQBnuoRFPJIPFRbTPOi9CTkn6VfeL9z87LxS2USFt+DntxxQBdgjVYyQT2qykeM57jFTW6IV4B9hUyoo/hP1NAEKAHOewzSv8zE+wNTKuKXA49qAKxGKp3UZJwDz1rU2j9OtUrpcIM/lQBgvHktz0GP1rF1SHzHCk4710M3R93UVnTpukyVGc96AOaniHlbCfu81yms6ct0EVZCrKdy5HHXvXfyLksAvb0rBvIF+benIORQB5pKNqvC3WM8kVUePHzHuAOPeuu1Wwt3VpCuJhxn19q5i4VvmGAGH5igDLmszbg4bK/r3p1qvmPtPoKulS8I39c4zSpAUAAUKKAJoSCo9Aa27O4NwgwMGP5D7isBmKAKSQatabceVcIXJ2k/P9KAO20c5IPttr074Cf8jb4u/wCvPT//AEO7rzHTcAL3zzXp3wE/5G3xf/16af8A+h3dAHj+uShfE/iUY6azqJ/8mpaPDzmSZnwBhd2PxFZXjCcp4q8SRqxyda1Dj2+1S1e8N5ZZBz8xVePrQBf8azebPLFjAjCZPtj/AOvWIk+IFBXlTVzxDOJLy8AbczkkH1I6fyrm0ugnylgPrQA+7beznuDmsWeTkgj7x4xT9TumkbKNkDvjFZm47tx5PvQBJK/JXFRrIcqcDjjrUsas4yMkEY59aRrdgdu07h1FAFrTUSabDFlIHbn2rsdHtgtq2WPI4rlLKJlQlVIUnJ71vaVcyN+5ZyFwcHoT9aANXTISRLckj0xXReFrUS3wYnAUA1gWzhbONM53NzXfeB7AYdwucsDz1xQB2ulptbJPIABrftuoz24qnFYtu3AYyAOvfFalpBJ5Y6tj3zQA6qboDIxye9aLRkqeOQOwqFk45GM0AZ7RADI7VVmiDAnJBPFasygAHvVKfYCSSBxQBmeUPU03yOAM9KsSbOcHj3pBy20EE/WgCpJF86DPNNkTJ9xkVfMbMTuBz1/WkkhG3JXnuaAMnIhDZ5B61DdRgc5OGq9dRYPTjvVFnEY2yZ2kfXFAGXeR7AWB6djVC5YPiQ5B9K07pWLfOBs6VnohLNGeR1H0oArXihbEjnCw/wAq8r8Xndpl/wD9cH/9BNepa04Fpgd1ZT9a8u8Xf8gi9/64Sf8AoJoA+7qKKKAPM/jodtn4SOcY1v8A9s7qsvS/mXJ6N/hWj8eCRYeFCOv9tf8AtndVleHmWWFCw6Ng80ADQ4lfcOdxqteSfNsTt94jvWlekxBmAwxOB9ayPL3FuuewHegB0bEuFO4enbNXorUjmTHPI+lNgtgnXIPBxV6KJgANpI/KgCt5ShMBOeMcUnklBuwFHXNaJEcWCuGcY796glLTPluvTigCqpJJKr07kUySYKCXbj0q1cxEKIU655qn9jOQSCFB5HqaAI5CJGCANk+vHFaFtDleBhc8fSq1nFuly5OScj2ragjwOR0OKAHwptHIwRxUygHjnOP1p0Khs56VKqYIx6YoAhRMgn8jSoh3cjvVhRk4pKAK7JgfyNVLtMpwOa0iAcZ7c1XnjXaBnmgDnbiPk5HXkVSmC7MhTyK2LtAdw69+veqLRAjABAoAx3iBYnGOMfjWRfwcnK9a6SaBtxKgn0qlPCsqEEc9KAOIvLMOjZXr0Nclq+nEOZEUjAJOD1FekXcXl9eccVg6hCjAqeh6nNAHnobPDjj6dKlDf3iMDoabqmYLoxOMIxyprPV2iY4H1X1oAtsd5ywO0ZxU1suJURuh71DGVLKVO4HqK0bKEOQTxngew9aAOp0qXdCo43Dj8O1eq/AM58XeMP8Ar00//wBCuq8a0qbEhjYgE8Yr2T4ADHi3xgPS004f+PXVAHz74xkz498SpnhdZv8A9bqSt7wlyrM3RGVsn6Vzfi7/AJKJ4r9tavv/AEpeuk8NlYtJuJGOFzuOfQCgDH1W6CSzEtmTzGwPQZNcrLORK27OQatX915uo3Uj43Fyf1/wrNuDhuMc9qAJZmyvGORVbOD1p6MXTaeg5FJJb5YHk0AEcrBflJANXYt5YbmLE9SKht7bJGR9RmtS2iUkoR8o6c/e96AJbfIjAwcDPGKs6WrvcqQrfezwP0qdIgsBYsVB5JPc1LZyNAQSMbjzn0oA1RhbhbdlAbPp+VeseAk/ckFQXryTTf3+rGRj87DnHTPb+teyeCohFGCe/bvQB3lsg28jgjNaFsgWPgAZNVrE4QN2FXYFwg4GSaAGyoAGPqO1UJeOg6mtKQYQ+4NZ0qsxGORQBSkDDOTxn1qvLGGP3cjHNX3jyPmGKrNgGgDIlUq4GOO+aaqEyblyD14q/NGBnGcY9OlQrFhsnp1FADl3fLu7dcUrDKkYzxSsoypyDQ2R9MdaAKdwo+bIrGuot2SoJU/pW9MqvnkZ9M1QmjHQ9u9AGCytIux8cfd96geMRfORjHU1euU2MHXjHIqnqUgCqRjbjNAGHq/NvgDOCx/SvLvF7j+yr0f9MX/9BNel6p/x7HI58pj+deVeLnH9nXecZMT8/gaAPvyiiigDy/49HGn+FP8AsNj/ANI7qsXwzlYGzjBbitn4+HGm+FD/ANRsf+kd1WR4fH7mMDoRuoAu6jiRth4HXPvUEFttbLn5sYxWgIw0rPxgnP1qysBc8AZxxQBVihZm5AqZiQSgI3dCfT6VNtydq9up9asQQfLyBuPQ0AZawsW68+1TQwjcQD+dbCWiHbkA9PxqWOyQN90bvX8aAMhoPm34BJPQ1HLaMWBDYBGcdq6AWgGcADJ9TTHtCwBXBB7elAHOQQbZcMAoHp61pRDeCMAdadf25g5YZXsAetJb7tvAAyMn2oAnjTauBzzUnltnHFIqluM05IznLDigByRlWznIpSgJH1z9aeopcHdjv0oAhaLj5c5qtcAAL6mr2B6VBcJ+vSgDEniySQcNnpjiqske1x/nNac4xnpkVUmYhwuPqPWgDPlUK2KzpI16qSPqK2LjALYwvOOlUJo8rkAe9AGFqFurgkHqPSuZ1GLyiQwBzXY3I+U+3FYWq7DwyjAFAHl/ieyKqJshlyCPUVisEdN+T154rvdXtFktJFIBQjj/AGa4YxbXWMchuPqaAGwn96Qox6/7NbcYKqrqQBgVjlPLO1ePX3q2kxRtjZwffPPrQBq6ewbUYDnHzAEY617f8ADnxb4x/wCvXT//AEK6rxHSE330asAcHn8K9s/Z9z/wlvjLPX7Lp/8A6FdUAfO3jI4+Ifizkj/idX3/AKUSVtxTC38LznvIqj82P+FYnjL/AJKH4sxwf7avs/8AgRJVvVJvK8Pwx8gsUH4hc/1oA5i6b/THYjhj/OoZVz83Oc8+xp9yCJA3qOKeMOvPQ0AQJjgk49sVbDIiK7dDVM8E1Nb/ADsAwyq/pQBagIZto4PU/Sp4rhTOBGpOzPBPpVF8yZCgggZJzRFJsBKZHG3IoA35L5ZIlRUbk9M8VZ3oxhjJYNnNYEcxLoBwB6VrQFp7qIE7nAAyaAOn0K1P25zkYUCvZ/CEWYFB+8VyDXjXhtmGrujdCeM96938Iw4tY3K4I70AdBaJJHGA3IPPWtK1bOB6Ed6WKLCkjGR1qzbpleByeaAK8/CBcYJ45qs6FWx+NaMqb16ZNV8YGcUAUJI8sDk5qvJCOv8AKr0pBbI781WlxkY47UAUZYSWAB6g9aiEOMhjz7VfxnPtTQMEn1oApeWAP0FRyD6Ec/zrRZAeT61WnQgEkeuOaAMubiTngHpVaVQ7kd+OPWrV6GCKy+uM1SmZhIoA9O9AFK7VQCCBz04rm7uUOroT9zP5V0GoS7kO0ncK5yTP2pDjgjDUAZes/LAnP3o9leSeLHzYXQ9Y2P6V6trj/wChxZJz5jE15H4pcNZXGe0bfyNAH6FUUUUAeW/H/wD5BfhX/sNj/wBI7qsfRWKxgDqE6fhWv+0D/wAgrwr/ANhsD/yUuqx9IHDt6KB+dAG/GuAhIwp61dUY4HHuO1QIT5ZPUg8VYtCcc9SM0ATQ26tzjHc1bihH8I/GnW8YOPTHJq2AAMDpQBGkQHbp0qQL6Dmnhcgc9TipCnPcg9aAIcfnSY4HYVZCAKQOhpAi5DDNAFSaGOYYkUMKrGzVSducHoK0zEMHGc03yxkAe/NAGaEC8Y5p6LubH51ckjAOGP0qMIAPwxQBGIuCc0CP94OvXPNTUUAVtnybjnP0qGYApn0q85Ixt61UlyVAPPA4oAzJVBc8ZqhKAWzuyB1Nac5x8v51SliBBAHHU0AZzAMCDWbcB14Vm+hrcWBRuDE5xiqVzEr5OScdKAMC5YheRx0OPWsTUlLRkgZ57eldXPApQ8msqezXLBSee1AHDX+TFIrDAwea46W0MWGZfmJ4PpXpmraVE0EgUsCcBhn3rktR00ooCMTg8AgcUAcjeBkw2MA/rzUBlO7cTkZxV7UQyu0DjAFZL/JIQfzoA63w1J5u2ZvvBtp/xr239n3/AJG7xn/17af/AOhXVeF+G22XSQg/K3B9jXuX7PZz4t8Z44H2bT//AEK6oA+dvGR/4uJ4t46a1ff+lElSa0f+JfZKxON5/H5BUXjPn4jeLBn/AJjV8f8AyYkqTxBxbWKD7y5b8SBQBg3mNobsOBVZJeqg5AqS6bzAUBwoPFVYfl+b1+XFAE7fM2QMD2pyOUY7ec8fWlJy20nCjimRgk8DkUAWQeCVPzHjNNRMEddp9afax5YKzYzx0q2kKMxAJxigCOCPJB53DPFXYJXEiumQ3t2oZIkRUz36c1d06y82fAB2ABic9OM0Ab3hWVp9RRyCSepHHPrX0T4b4tEAPAxyBjPvXgnhiAxX8WBwCM89ya+gdEXy4IsHPABFAHUQLleScYxU8eABt6dqr28isoIJAP61ZjPKkcmgBsgwpwfxqqwPTOKtTEbQQfTmqtAFdoyM9+1QSIDjJwc1fxzmq08a4TBPSgCkAR6+tITyPerGwAHaOcYqCgAqOVQw54A71JTWGVOeKAM65Qbfugr6Vj37BASuM46/1rWmbY7Lng881iamzBsjoefpQBiXMpWTDE7TWbcDajN/EOlXbz5nyegNZ99IRbsSPujFAHP68/8Aor88LucV5L4mbNnccjmI8fga9Q8SNi0uOePIHPucV5V4hcG2uveNh+lAH6K0UUUAeVftB/8AII8Lf9hsf+kl1WVpI/0U46nBzWp+0MSNG8L46/20Mf8AgJdVmWZ8uyZgcFUwPrigDobZvNJH8IGKvQRkMfbisnSWDKAOp6V0MQwM4xmgCzbnrVtIzwe1QoMDB7d6sRDg9vx9qAHdhtPH9KUe/wCfrSjpRQAUU7jJ4/WlOOPlz070AMI/WilIJKlcY5znvTiOny4696AGYHpUMyjqPyqfBzjvSEZFAFbYaQjBqyFGMUm1c57/AFoArVBOPmz2xVt0we2D3qGVdw96AMxos5YjOPWq1xtjUseByeBWi2ApJ9KzLsqy4GMn1oAzppt7cDC9Me1ZFzI284JA/pWk5AYhfyzmsi8mG7AGF788UAEkxQj3pko3kMvGe1Vp5VCDDbfTPNCzhYizHCjrQBV1GPceMA965++hBOMDd3rUlvElkLDIwMdaguI967lGeKAOS1GwjliOUUnHUiuPu9OeG4MhI2KePY9q9JniO88AjvWZdWatFgoGU9c96AOS0hgl3CQxGHA/Xmvef2ev+Rt8af8AXtp//oV1XhqWzW2pKpGVHQ+vv/n0r3H9nc58VeMT/wBOunfzuqAPnjxcpb4k+Kxnj+3L3/0oeovFs2I4x/FwAfw5qfxVx8TPFp9NZv8A/wBKHFZPiWXzbtwDkR7VAz6DBoAzgcgH1qJAfNCgZycAVLZo07COFSz11ej6E0ZV3QGQ9yKAKGlaDcXagu6rk4I610UXhuEKrNGrHPfP+NdDp1mI8YRQCfTFbKWTuu4KNuMYoA5iDQYEHyxRAkdcVqWuk2wyfKi4HPy1rJYMMb0G71q9bWhQ4I5oAwG0eFnKLFFlep21ettHCMm9EAI5A71tfYC6HKAHpWjY2rgoUGT3HqKAMvR9JUXWNqMQOO3NeraHGz2Ue8/Op5J9KwNHsPNucoijjv8AyrtbWDy0wQN3pQBIqjoKsW/Tr700R4YHsKliGGG0cD0oAbIpKdOtV8H+VXG+4o79aj2jIPpQBXCkjPaopV+XPtV3HXPNQumCPpzQBQYYqq/3j9a0pEByT1xVGWM5Zv0oArO2PXrg1C8hAPJIFPm6jgj8arythTz7UAQ3J3Eqq/Njr6VhXLqEKnnHNaNySd2D05HNZUgDZJ4PcnjNAGRdKVTnn3rnbqXfK0Qzzz9K6DVWxCB/Eelcq7FJN7HnOMn1oAx/FUmLVupLpj8BXlOuuPIuAeMxscfhXpXit8Qj2hKn65ry7X2Agm9dpFAH6SUUUUAeV/tBjdpPhQeuuKP/ACUuaxrR99vGARh8k/Stv4+jdp3hIf8AUdX/ANJLmsDSwWW2U/3D/M0AdFoyFVViMHoK6OLGF3ZxWFYLg4/unFbUTblwe1AF9QTxyfrVmMYUdeearr94Y61ZUYABoAXFPUD+IYGPT3oHyg/gak2EggnrQBHgbsc4z2qTAKrkdME8UCP5i2cHmlUEqDuOT7UAMVQOoJ4PShkwevr/ACqQKQMbjSP0ySe4oAhJJOcimjHenlQuc9vSm4APNACHg0Yp2M89zmkIwSPSgBjruwD0zUDDH5A1YbtzioGPv2FAGfeKVjYjisC7cox9CPyror0FkK+x61yl+54z1NAGdPKynKtg1iXNwxUnqOnStK/chcA+5rKlXco28AnnNADJWBhBY9BnHpTWmJgCDHPXimTggsmenH1pAuULgnjjFAGbMoViV4B4xVu0LOnP4VBMvBGelaWnwZiznkUAUbiAY+73OcVlzr8pXA5+7W/coADycHmsO6AzkdjjFAGLf2iuDIqYK8Z74r039nLP/CTeMN3X7Jp387quClG6NgfSu/8A2dv+Rq8Y/wDXrp387qgD598UYPxL8Wg451q9H/ky9czfsZZZ2GWZmJGPrXReKWx8TfF+en9t3n/pRJWNpNt9tu9rNgDk/nQBseENK2uHlTLNzk+tegQWiqo+XkYNY2hWoTy+T24rq4EV8AcEjk/5+lABaQbiPlOO2K6Gxtg2AV444FULCLoM8A4rodOiAOcnPGKAIjYZG4KfSrEVkOfkOcela8FurAAE9M1bis0z1OeuaAMZLM7clD1xz6VahsyrZUEcdRWqtqu3qetSRwAfKTnsKALWjW+3lfvetdJHgjIHfqetZWkQgA7TxjvWsihQQKAJdvHP51JCoAz3qIMxGM8YqQNtCAe1ADZ+MdgBVSRyW+UnFWZSWAB9Kp9j7UAPJPzfMcdqZk5zk08qcHB4zj8hUdADJHUcHPPHSq74Zj6GpJydwBqtI5Vhj0oArzKNvAz6Vn3GE+9nHPWtI5OPas+7UsCPbNAGZM2Ac9SMVi6hMqA7fyrSun2A55wM8VgX7lufagCleyeauRy3QCuZ1ciFSc8KNx+tbfmEyn+6Oce9c54gkJtZcd+KAOe8UyD7ISeu1c/jzXlmvSblcZPQ5r0vxW4+wk47xj9K8t1xzuYdyKAP02ooooA8v+Pf/IO8J/8AYbH/AKR3Vc5oXLJn+GMfrk12Pxn0bVtY0rQToenS6jNZ6oLmWGKWONvL+zzx5BkdVPzSLxnPNchp2neKbXYH8F6wQEwdt1Y9f/AigDqYT5fToSB9K1LXgD6VzKt4jDgnwTrhweP9JsP/AJJq/Dfa+n3vBGvnjH/Hxp//AMk0AdfF97oDVhQTgCuXh1nW0HPgbxD0xxcaf/8AJVSrr2tA/wDIi+Iun/Pxp/8A8lUAdKAS3HGMVMR1xjPrXLjxBrOefAviLoP+W+nf/JVP/wCEi1n/AKEXxJ/3/wBO/wDkqgDpsD0pqghRwc/Wub/4SLWP+hF8R/8Af/T/AP5KpF8RayBg+BfEh+s+n/8AyVQB049hQRkcgVzP/CR6z/0IviP/AL/6f/8AJVH/AAkes/8AQi+I/wDv/p//AMlUAdKyg9h1/OolUk9eSM/rXP8A/CRaxnP/AAgviT/v/p//AMlUg8Raz38C+I+n/PfT/wD5KoA6A9SCPXH50wjBwawm8Q6w3XwL4j4/6b6f/wDJVRf27rOf+RF8R4z/AM/Gn9P/AAKoA6HuKjmHP4Vhf27rX/Qi+Iv/AAI0/wD+Sqa2ua2engbxH/4Eaf8A/JVAGhdr8nvzXNXcJZ88EdqvzatrUgI/4QXxCfrcaf8A/JVZ8txrrMSvgfXx3H+k6f8A/JNAGBfR4cn0NZkQKyP83GDkVt3dp4jmYkeCdbyfW5sP/kmsttG8V8lfBmsAn/p7sf8A5IoAyeT5gb6frUkK4iyOSGyfetFdD8UEgv4L1jPtd2P/AMkU06J4s/h8GasB/wBfVj/8kUAZLrvcgdsZragjCW64+pqpH4c8ViXe/g3V/wALux/+SK0TpnirbgeDNZz3/wBKsf8A5IoAyb0D5vxrDvDz078munn0PxbJnHgzVuTnm6sf/kis6Twt4xZsjwdqf/gXZf8AyRQBzjthSPXJFd9+zr/yNXjPP/Ptp387muYk8G+Njjb4Q1H8buy/+P133wN8M69oet+J7zXdIm02K8hs44BLNDIXMZn3f6t2xjevXHWgD5h8WZ/4WX4wx1/tu9x/3/kqXwnahYvmC72OSa7TxN8JPHs/jrxHqFr4alns7vVbm5hlS8thvjeZ2U4aUEZBBwQDVrS/hr47tBiTwjeEf7N5Z/8Ax6gCnbr5e5VHzHkewrpdMQEcnOO1Rw+BfGqy738IaiSev+mWX/x+tix8M+L7f7/g3VD9Lux/+SKAJ7aHEik4Of51t2MWAvAqrHpfihQAfBWscf8AT1Y//JFadrD4hi27/BGuEj/p5sP/AJJoA2bKFnUcAj3rSW2AA4HSsmG816Mc+Btf49LjT/8A5JqdNT10Ek+BvEB44/0jT/8A5KoA0xCO5H0xUgtMjKkDNZg1bXO/gXxBn/rvp/8A8lVKus6yDz4F8RH/ALeNP/8AkqgDes4DEgHtmrqpz6A5xXMprusrwfAviLGO0+n/APyVUv8AwkWs4/5EXxH/AN/9O/8AkqgDpAuOcZPb8qUDpwK5r/hI9Z/6EXxH/wB/9P8A/kqj/hI9Z/6EXxH/AN/9P/8AkqgDelCg+xFQhPm4AGKxX8Qaw2P+KF8R8f8ATfT/AP5Kpn9vaznjwN4jx/18af8A/JVAG+y5GMVAykdRisYa7rPfwL4j/C40/wD+SqRtc1k4/wCKE8RH/tvp/wD8lUAaky5XOenOKpSoSciqTaxrZ6eBvEOP+vjT/wD5KqB9S11mP/FDeIMH1uNP/wDkqgCzKpDbvWq06lgPQdarSXevsCB4H172zcWH/wAk1VkfxGxG3wTroGeR9psP/kmgCvqabwduAen/ANaubvsk4Xr0610VxF4kkzt8E63z63Nh/wDJNZF3o/iqXJTwXq4J9bqx/wDkigDmb75EwOD1yPWufv3E5UgZB659K66/8K+MrjPl+DtTH1u7L/4/WYvgXxuC4PhDUCp+7/pllwf+/wDQB5n4qbdYqR3IOPoSK8z1fO9x+Fe9a18LfH99GFh8J3S4H8V7Zjndn/ntXI33wI+JlwzFfC7D0zf2v/x2gD7wooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Radiographic images of the complications of pneumococcal pneumonia.",
"    <br/>",
"    (Left panel) Lung abscess with an air-fluid level in the right lung. Abscess cavity material is nearly always culture positive, and patients commonly defervesce within 48 hours of interventional drainage.",
"    <br/>",
"    (Right panel) Radiograph of necrotizing pneumonia in the left lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28096=[""].join("\n");
var outline_f27_28_28096=null;
var title_f27_28_28097="Tertiary syphilis";
var content_f27_28_28097=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51169&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Tertiary syphilis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Noduloulcerative lesions in a ring-like distribution on the posterior thigh, known as lues maligna, in a patient with tertiary syphilis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David H Martin and Tomasz F Mroczkowski. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28097=[""].join("\n");
var outline_f27_28_28097=null;
var title_f27_28_28098="MPM 73yr man";
var content_f27_28_28098=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74187&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Epithelial diffuse peritoneal malignant mesothelioma in a 73-year-old man who had a long history of asbestos exposure and complained of weight loss",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 520px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Intravenous contrast-enhanced CT scan shows sheetlike thickening of the anterior peritoneum (arrows), encasement of the small bowel, and pleating of the small bowel mesentery (arrowheads). (Panel B) Image from a barium examination shows separation of small bowel segments and irregular fold thickening of small bowel segments in the left lower abdomen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. RadioGraphics 2008; 28:583. Copyright &copy;2008 Radiological Society of North America.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28098=[""].join("\n");
var outline_f27_28_28098=null;
var title_f27_28_28099="Thenar space abscess";
var content_f27_28_28099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F56271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F56271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Thenar space abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 357px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A thenar space abscess is characterized by a widely abducted thumb and fullness on the dorsum of the first web space as shown in the photograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28099=[""].join("\n");
var outline_f27_28_28099=null;
var title_f27_28_28100="Cetirizine: Patient drug information";
var content_f27_28_28100=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cetirizine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36390?source=see_link\">",
"     see \"Cetirizine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/7/18549?source=see_link\">",
"     see \"Cetirizine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F148795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      All Day Allergy [OTC];",
"     </li>",
"     <li>",
"      ZyrTEC&reg; Allergy [OTC];",
"     </li>",
"     <li>",
"      ZyrTEC&reg; Children's Allergy [OTC];",
"     </li>",
"     <li>",
"      ZyrTEC&reg; Children's Hives Relief [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F148796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aller-Relief [OTC];",
"     </li>",
"     <li>",
"      Apo-Cetirizine&reg; [OTC];",
"     </li>",
"     <li>",
"      Extra Strength Allergy Relief [OTC];",
"     </li>",
"     <li>",
"      PMS-Cetirizine;",
"     </li>",
"     <li>",
"      Reactine [OTC];",
"     </li>",
"     <li>",
"      Reactine&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019614\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hives.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019613\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701757",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cetirizine, hydroxyzine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019618\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019621\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is most useful if started before contact with the allergen. Take at least 1 to 3 hours before.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694356",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (syrup) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chewable tablet: Chew or crush well. Mix crushed tablet with food. Do not swallow it whole.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699494",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (syrup) at room temperature or in a refrigerator.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11954 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-382E3F64B8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28100=[""].join("\n");
var outline_f27_28_28100=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148795\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148796\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019614\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019613\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019618\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019619\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019621\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019616\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019617\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019622\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019623\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/34/36390?source=related_link\">",
"      Cetirizine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/7/18549?source=related_link\">",
"      Cetirizine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_28_28101="Biomarkers of cardiac injury other than troponins and creatine kinase";
var content_f27_28_28101=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Biomarkers of cardiac injury other than troponins and creatine kinase",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Allan S Jaffe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28101/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/28/28101/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac injury can be defined as the disruption of normal cardiac myocyte membrane integrity resulting in the loss into the extracellular space (including blood) of intracellular constituents including detectable levels of a variety of biologically active cytosolic and structural proteins such as troponin, creatine kinase, myoglobin, heart-type fatty acid binding protein, and lactate dehydrogenase. Injury is usually is considered irreversible (cell death), but definitive proof that cell death is an inevitable consequence of the process is not available.",
"   </p>",
"   <p>",
"    Causes of cardiac injury include trauma, toxins, and viral infection, but ischemia or infarction consequent to an imbalance between the supply and demand of oxygen (and nutrients) is the most common cause.",
"   </p>",
"   <p>",
"    When a sufficient number of myocytes have died (myocyte necrosis) or lost function, acute clinical disease is apparent; examples included myocardial infarction (MI) or myocarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25209?source=see_link\">",
"     \"Criteria for the diagnosis of acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The biochemical characteristics and utility of myoglobin, fatty acid binding protein, and lactate dehydrogenase for the diagnosis of and prognosis after acute MI will be reviewed here. Troponins and creatine kinase, which are the preferred biomarkers for diagnosis and prognosis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MYOGLOBIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myoglobin is a ubiquitous heme protein that is rapidly released from damaged tissue because of its small size [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/1\">",
"     1",
"    </a>",
"    ]. Its half-life in plasma is in the range of nine minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Use as a marker of early injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to its early appearance in the serum, myoglobin was postulated to be a useful adjunct to either troponin or creatine kinase MB (CK-MB) for the early diagnosis of MI [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"     \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With contemporary, highly sensitive troponin assays and the use of the 99th percentile or 10 percent coefficient of variation cut off, troponin is elevated prior to elevations in myoglobin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Thus, there is little advantage for the use of myoglobin as a marker of early injury unless an insensitive troponin assay is being employed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition there are several limitations to the use of serum myoglobin for the diagnosis of acute MI. First, the rapid release and metabolism of myoglobin can result in an undulating or \"staccato\" pattern characterized by increases and decreases in serum myoglobin concentration that can lead to clinical confusion (",
"    <a class=\"graphic graphic_figure graphicRef74748 \" href=\"UTD.htm?22/38/23150\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/7\">",
"     7",
"    </a>",
"    ]. Another problem is that myoglobin lacks specificity for the heart. Serum concentrations are elevated after injury to a variety of tissues (particularly skeletal muscle), after recent cocaine use, and in patients with impaired renal function due to decreased clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of these limitations and absence of any advantage over troponins, myoglobin should",
"    <strong>",
"     not",
"    </strong>",
"    be routinely measured in patients with suspected MI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Use in predicting reperfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serial measurements of serum myoglobin have been used in the past to predict reperfusion in patients with an ST elevation MI after fibrinolytic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. The observation that coronary reperfusion increases the washout of myoglobin led to a variety of attempts to utilize this change to predict coronary patency. The best criteria appeared to be a rate of change over the first hour of more than 2.6",
"    <span class=\"nowrap\">",
"     ng/min",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/15\">",
"     15",
"    </a>",
"    ] or a 4.6 fold rise over two hours. However, these changes do not distinguish between TIMI grade 2 and TIMI grade 3 (normal) flow [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. This is an important issue since reperfusion in patients with an ST elevation MI improves clinical outcomes only in patients who attain TIMI grade 3 flow. Thus, the clinical use of myoglobin as with other analytes has never become relied on clinically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7786?source=see_link&amp;anchor=H3#H3\">",
"     \"Fibrinolytic (thrombolytic) agents in acute ST elevation myocardial infarction: Markers of efficacy\", section on 'TIMI flow grade'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some failures of recanalization represent transient opening and closing. Thus, release of myoglobin during the transient opening may fulfill the criteria for persistent coronary patency. This is a particular problem in patients who are treated late after the onset of symptoms when myoglobin is already elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Use in predicting prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myoglobin elevations may have prognostic value in patients with acute coronary syndromes. An analysis from the TIMI 11B and TACTICS-TIMI 18 trials of patients with a non-ST elevation acute coronary syndrome found that a baseline myoglobin concentration above 110",
"    <span class=\"nowrap\">",
"     &micro;g/L",
"    </span>",
"    was associated with an increase in six month mortality (adjusted odds ratio 3.0) but not nonfatal MI [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/16\">",
"     16",
"    </a>",
"    ]. This effect was independent of other prognostic variables such as electrocardiographic changes and CK-MB and troponin I. However, these trials used a relatively insensitive troponin assay. It is unlikely that similar results would be obtained with contemporary assays and the sensitive cut off values now recommended (99th percentile or 10 percent coefficient of variation).",
"   </p>",
"   <p>",
"    It has been suggested that the use of myoglobin with other cardiac markers may have additive prognostic value [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/3,16,17\">",
"     3,16,17",
"    </a>",
"    ]. In the above review, for example, a myoglobin elevations produced a similar proportionate increase in six-month mortality in those who also had elevated troponin I but the absolute values were higher (9.4 versus 3.4 percent with normal myoglobin) compared to those who had a normal troponin I (4.9 versus 1.6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/16\">",
"     16",
"    </a>",
"    ]. Unfortunately, these studies tended to use high cutoff values for troponin, did not take into account the utility of serial values,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    used insensitive troponin assays. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=see_link&amp;anchor=H15#H15\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\", section on 'Serum biomarkers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     HEART-TYPE FATTY ACID BINDING PROTEIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart-type fatty acid binding protein (H-FABP) is a low molecular weight protein that behaves similarly to myoglobin in its kinetics and release. However, in contrast to myoglobin, there is more fatty acid binding protein in heart compared to skeletal muscle, making this a potentially more specific test [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The possible efficacy of H-FABP for the early diagnosis of acute MI was illustrated in a study of 371 patients with acute chest pain and suspected MI [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/19\">",
"     19",
"    </a>",
"    ]. There were 68 patients who presented within two hours of symptoms, 37 of whom had a final diagnosis of MI. The sensitivity for MI at two hour measurement was significantly higher with serum H-FABP compared to cardiac troponin T or myoglobin (89 versus 22 and 38 percent, respectively). However, cardiac troponin T had a significantly higher specificity (94 versus 52 percent). In a more recent study, H-FABP performed much better with respect to detection of ACS, but an insensitive troponin assay was used as the comparator [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to a possible role in diagnosis, H-FABP has been touted to help predict prognosis in patients with an acute coronary syndrome. However, its benefit appears often to be in patients without troponin elevations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/21\">",
"     21",
"    </a>",
"    ]. Thus, it may signal the presence of non cardiovascular co-morbidities that exist in specific patient subsets [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/22\">",
"     22",
"    </a>",
"    ]. In these same studies, prognosis is worse with higher peak values even in those with elevated troponin values but this effect may be due to differences in the extent of the injury which might also be evaluated easily by peak troponin values had they been obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=see_link&amp;anchor=H21#H21\">",
"     \"Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction\", section on 'Heart-type fatty acid binding protein'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Numerous studies have compared H-FABP to troponin for diagnosis or prognosis. However, they used high cut off values for troponin or insensitive assays. Good comparison studies using contemporary troponin assays that are sensitive, with the recommended cut off values are needed to confirm these claims.",
"   </p>",
"   <p>",
"    Measurement of H-FABP has not been widely evaluated or adopted as a biomarker of cardiac injury and is not approved for clinical use in the United States.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LACTATE DEHYDROGENASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactate dehydrogenase (LD, formerly abbreviated LDH) was commonly used in the past in combination with aspartate aminotransferase (AST or SGOT) and CK-MB to diagnose an acute MI.",
"   </p>",
"   <p>",
"    LD consists of M (muscle) and H (heart) subunits that give rise to five isoenzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/23\">",
"     23",
"    </a>",
"    ]. The heart primarily contains LD1 and some LD2. Red cells, kidney, stomach, and pancreas are other important sources of LD1. In contrast, LD5 predominates in skeletal muscle and liver [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LD activity rises to abnormal levels approximately 10 hours after the onset of MI, peaks at 24 to 48 hours, and remains elevated for six to eight days [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/21\">",
"     21",
"    </a>",
"    ]. However, since troponins are more specific than LD and remain elevated for five to ten days, current recommendations suggest that LD no longer has a role in the diagnosis of MI [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28101/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While there are theoretical advantages of other cardiac biomarkers, such as myoglobin, heart-type fatty acid binding protein, and lactate dehydrogenase, all available data suggest that cardiac troponin outperforms each of them in almost every specific way. Their use is not encouraged. &nbsp;",
"   </p>",
"   <p>",
"    We recommend using cardiac troponins in preference to CK-MB for diagnostic and prognostic purposes. It is unnecessary to obtain both values. Cardiac troponins I and T are equally useful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Kagen LJ. Myoglobin: Biochemical, Physiological and Clinical Aspects, Columbia University Press, New York 1973.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/2\">",
"      Klocke FJ, Copley DP, Krawczyk JA, Reichlin M. Rapid renal clearance of immunoreactive canine plasma myoglobin. Circulation 1982; 65:1522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/3\">",
"      McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 2001; 104:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/4\">",
"      Eggers KM, Oldgren J, Nordenskj&ouml;ld A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004; 148:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/5\">",
"      Ilva T, Eriksson S, Lund J, et al. Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept. Eur J Clin Invest 2005; 35:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/6\">",
"      Kavsak PA, MacRae AR, Newman AM, et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chim Acta 2007; 380:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/7\">",
"      Kagen L, Scheidt S, Butt A. Serum myoglobin in myocardial infarction: the \"staccato phenomenon.\" Is acute myocardial infarction in man an intermittent event? Am J Med 1977; 62:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/8\">",
"      Roberts R. Myoglobinemia as index to myocardial infarction. Ann Intern Med 1977; 87:788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/9\">",
"      Hollander JE, Levitt MA, Young GP, et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J 1998; 135:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/10\">",
"      Christenson RH, Ohman EM, Topol EJ, et al. Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7. Circulation 1997; 96:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/11\">",
"      Stewart JT, French JK, Th&eacute;roux P, et al. Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998; 31:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/12\">",
"      Tanasijevic MJ, Cannon CP, Wybenga DR, et al. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. Am Heart J 1997; 134:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/13\">",
"      Laperche T, Steg PG, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. Circulation 1995; 92:2079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/14\">",
"      Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996; 105:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/15\">",
"      Abendschein, DR, Ellis, AK, Eisenberg, PR, et al. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma. Coron Artery Dis 1991; 2:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/16\">",
"      de Lemos JA, Morrow DA, Gibson CM, et al. The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol 2002; 40:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/17\">",
"      Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 2001; 103:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/18\">",
"      Van Nieuwenhoven FA, Kleine AH, Wodzig WH, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 92:2848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/19\">",
"      Seino Y, Ogata K, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003; 115:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/20\">",
"      O'Donoghue M, de Lemos JA, Morrow DA, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/21\">",
"      Kilcullen N, Viswanathan K, Das R, et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 2007; 50:2061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/22\">",
"      de Lemos JA, O'Donoghue M. The skinny on fatty acid-binding protein. J Am Coll Cardiol 2007; 50:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/23\">",
"      Marshall T, Williams J, Williams KM. Electrophoresis of serum isoenzymes and proteins following acute myocardial infarction. J Chromatogr 1991; 569:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/24\">",
"      Smit MJ, Duursma AM, Bouma JM, Gruber M. Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase. J Biol Chem 1987; 262:13020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28101/abstract/25\">",
"      Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28:2525.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 97 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-5CA193EFE4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28101=[""].join("\n");
var outline_f27_28_28101=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MYOGLOBIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Use as a marker of early injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Use in predicting reperfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Use in predicting prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      HEART-TYPE FATTY ACID BINDING PROTEIN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LACTATE DEHYDROGENASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/97\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/97|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/38/23150\" title=\"figure 1\">",
"      Staccato pattern of myoglobin",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25209?source=related_link\">",
"      Criteria for the diagnosis of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7786?source=related_link\">",
"      Fibrinolytic (thrombolytic) agents in acute ST elevation myocardial infarction: Markers of efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25754?source=related_link\">",
"      Risk factors for adverse outcomes after unstable angina or non-ST elevation myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_28_28102="Thoracic positron emission tomography";
var content_f27_28_28102=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thoracic positron emission tomography",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28102/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/28/28102/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron emission tomography (PET) allows in vivo imaging of metabolic, physiologic, and pathologic processes. It has been used as a research tool for many years, and has evolved into a clinically indispensable imaging examination. The increased clinical use is a consequence of regional commercial radiopharmacies being more able to supply hospitals throughout the country with radiopharmaceuticals, while the equipment has become more robust and financially more affordable. Traditional PET scanners with an array of several thousand ring detectors cost about $1.8 million; however, they can be replaced by traditional two-headed single photon emission computed tomography (SPECT) gamma cameras that have been retrofitted with coincidence detectors to allow 18-fluoro-2-deoxyglucose (FDG)-PET imaging. Many PET scanners are being replaced by integrated whole-body PET and computed tomography scanners",
"    <span class=\"nowrap\">",
"     (PET/CT",
"    </span>",
"    scanners), while integrated, hybrid PET and magnetic resonance",
"    <span class=\"nowrap\">",
"     (PET/MR)",
"    </span>",
"    scanners are being developed [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Technical issues (ie, radionuclides, technique, sources of error) and the indications for thoracic PET imaging are reviewed here. The use of PET scanning in the evaluation of solitary pulmonary nodules or lung cancer staging is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=see_link\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"     \"Role of imaging in the staging of non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TECHNICAL ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Radionuclides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Positron-emitting radionuclides are produced in a cyclotron (eg, oxygen-15, nitrogen-13, carbon-11, and fluorine-18) or by a generator (eg, rubidium-82, copper-62). Fluorine-18 is one such radionuclide that is produced by proton bombardment of oxygen-18 in a cyclotron. When it is bound to a D-glucose analog, it forms 18-fluoro-2-deoxyglucose (FDG), which is the most commonly used radionuclide in thoracic PET.",
"   </p>",
"   <p>",
"    FDG is transported into cells where it is phosphorylated by hexokinase to form FDG-6-phosphate, which remains trapped temporarily because it is not further metabolized by the enzyme glucose-6-phosphatase, nor is it easily extruded from the cell. The fluorine-18 emits positrons as it decays, which travel a short distance before they are annihilated by electrons, resulting in the emission of two 0.511 MeV photons oriented at 180 degrees to each other. These events are registered when the photons collide with the sodium iodide or bismuth germanate contained within the scintillation detectors that surround the patient (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59100 graphicRef70885 \" href=\"UTD.htm?2/36/2627\">",
"     image 1A-B",
"    </a>",
"    ), thereby triggering an electronic pulse within the scintillation crystal. Three-dimensional localization of the decay is possible because of the coincidence circuitry that detects the annihilation radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/2\">",
"     2",
"    </a>",
"    ]. The end result is measurement of the distribution of FDG throughout the body. The FDG is eventually extruded from the cell, filtered by the glomerulus without being resorbed in the proximal convoluted tubule, and excreted in the urine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;During a PET scan, the patient lies within a scanner that consists of a moving table and gantry, reminiscent of the equipment used for computed tomography (CT). Before the administration of FDG, scans are obtained using a rotating germanium-68 pinpoint source. This process is called attenuation correction and its purpose is to adjust for the decrement of positron-related radiation caused by soft tissues of varying electron densities (",
"    <a class=\"graphic graphic_figure graphicRef66420 \" href=\"UTD.htm?36/38/37485\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/3\">",
"     3",
"    </a>",
"    ]. FDG is injected intravenously using a dose of 10 to 20 mCi (370 to 740 MBq) and then multiple (ie, 30 to 45) axial (ie, cross-sectional) images are obtained. A cross-sectional, axial field of view of 16 to 20 cm and a spatial resolution of 5 mm are achieved at full width half maximum. Finally, axial, coronal, and sagittal projections are viewed on a workstation and whole body images can be generated.",
"   </p>",
"   <p>",
"    PET images and CT images obtained from separate studies are sometimes combined, in an effort to incorporate the detailed anatomical information generated by CT scans with the metabolic localization of PET scans. However, the results are often difficult to interpret due to respiratory variability and variations in the patient&rsquo;s position. Integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scanners avoid these pitfalls by fusing images obtained in tandem from PET and CT (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81038 \" href=\"UTD.htm?13/37/13905\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70273 \" href=\"UTD.htm?20/1/20496\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    During the acquisition of an integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scan, the CT is performed first. FDG is then injected intravenously and the PET is performed 40 to 60 minutes later [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. A major advantage of integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    is that it reduces the examination time by 30 percent compared to the time that it takes to acquire each study separately (whole body integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    images can be obtained within 30 minutes) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/6\">",
"     6",
"    </a>",
"    ]. This time savings is achieved because integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    eliminates the need for the separate attenuation correction step with the germanium-68 pinpoint source, described above, since the attenuation maps created using CT scan data can be used for this purpose. Integrated or hybrid whole-body",
"    <span class=\"nowrap\">",
"     MR/PET",
"    </span>",
"    scanners are also feasible and provide diagnostic image quality in the assessment of pulmonary masses [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6684631\">",
"    <span class=\"h2\">",
"     Clinical role",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical role of thoracic PET is related to the fact that aerobic glycolysis is amplified in tumor cells (ie, the Warburg effect) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/7\">",
"     7",
"    </a>",
"    ]. To facilitate aerobic glycolysis, more glucose transporters (eg, Gluc-1) are expressed on the surface of tumor cells, leading to increased transport of FDG into the tumor cells. In addition, an increased concentration of hexokinase is expressed within the cell, leading to enhanced intracellular trapping of the FDG [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The result is magnified uptake and accumulation of FDG within tumor cells, creating discrete, selected foci of FDG uptake that can be visualized on the PET scan. Quantification of the amount of radioactivity in a voxel is obtained by calculating the standardized uptake value (SUV). The SUV equals the mean region of interest",
"    <span class=\"nowrap\">",
"     (mCi/mL)",
"    </span>",
"    divided by the administered activity (mCi per body weight). An SUV exceeding 2.5 raises the possibility of malignant disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Additional parameters, like metabolic tumor volume (MTV) and total lesion glycolysis (TLG), can be utilized and may have prognostic value in the assessment of non-small cell lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/12\">",
"     12",
"    </a>",
"    ]. TLG is the product of MTV and maximal SUV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Sources of error",
"    </span>",
"    &nbsp;&mdash;&nbsp;The likelihood of an abnormal integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scan in a patient with malignancy (ie, the sensitivity) is close to 90 percent, while the likelihood of a normal integrated",
"    <span class=\"nowrap\">",
"     PET/CT",
"    </span>",
"    scan in a patient without malignancy (ie, the specificity) is approximately 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/13\">",
"     13",
"    </a>",
"    ]. As a consequence, false positive results (ie, 1-specificity) are more common than false negative results (ie, 1-sensitivity). The specificity is lower than the sensitivity because inflammatory and granulomatous lesions can yield a positive FDG-PET scan.",
"   </p>",
"   <p>",
"    False positive results are generally due to metabolically active infectious or inflammatory lesions, which can produce substantial FDG accumulation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/14\">",
"     14",
"    </a>",
"    ]. Examples include rheumatoid nodules, tuberculous granulomata, fungal granulomata, pneumonia, empyema, drug toxicity, and sarcoidosis. Radiation pneumonitis may also lead to increased FDG accumulation; therefore, FDG-PET should not be performed until three months after the completion of radiation therapy, to reduce the likelihood of false positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/15\">",
"     15",
"    </a>",
"    ]. All of these conditions recruit inflammatory cells (eg, histiocytes, plasma cells, and lymphocytes), which have a high metabolic rate and yield an increased uptake of FDG [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/16\">",
"     16",
"    </a>",
"    ]. In geographic regions where infections with tuberculosis or fungi (eg, histoplasmosis, coccidioidomycosis, and blastomycosis) are endemic, FDG-PET may have a lower specificity for the diagnosis of malignant solitary pulmonary nodules.",
"   </p>",
"   <p>",
"    False positive lesions are not limited to infectious or inflammatory lesions. Brown adipose tissue that is located at the base of the neck, in the supraclavicular region, in the superior mediastinum, and in the upper abdomen of adult humans can exhibit strong uptake of FDG and cause false positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. Brown fat is metabolically active and uses glucose to uncouple the electron transport chain for thermogenesis. Atrial natriuretic peptides and B-type natriuretic peptide stimulate the synthesis and activity of brown fat [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/20\">",
"     20",
"    </a>",
"    ]. Treatment with benzodiazepines prior to FDG-PET reduces the sympathetic tone, which keeps the patient warm, reduces the metabolism of brown fat, and decreases the likelihood of false positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/5,16\">",
"     5,16",
"    </a>",
"    ]. Normal or hyperplastic thymic tissue can also be glucose avid, which can lead to high uptake of FDG in the anterior mediastinum [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/21\">",
"     21",
"    </a>",
"    ]. Other regions of physiological FDG uptake in the chest that can lead to false positive results include the heart and breast tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    False negative results are less frequent, but generally occur in three clinical settings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tumors with slow growth and with low metabolism &ndash; Tumors with relatively low metabolic activities may fail to concentrate enough FDG to be detected, as has been reported with selected cases of bronchioloalveolar cell carcinomas, well differentiated adenocarcinomas, and carcinoid tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/22-25\">",
"       22-25",
"      </a>",
"      ]. Rarely, metastatic lesions from renal cell, prostate, or testicular cancers may be devoid of detectable amounts of FDG.",
"     </li>",
"     <li>",
"      Small tumors &ndash; Small tumors (&lt;7 mm in diameter) may not be detected because the amount of FDG uptake by the lesions is below the resolution threshold of FDG-PET scanners [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/26\">",
"       26",
"      </a>",
"      ]. PET scanners that use single photon emission computed tomography (SPECT) cameras have a lower sensitivity than dedicated FDG-PET scanners and are not state of the art anymore.",
"     </li>",
"     <li>",
"      Hyperglycemia &ndash; An elevated serum glucose level decreases intracellular FDG uptake because the FDG and glucose compete for the same cell surface receptor [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/27\">",
"       27",
"      </a>",
"      ]. This competition is more pronounced in the presence of acute hyperglycemia. A reasonable (albeit unstudied) approach that may minimize this confounding factor is for patients to follow a low carbohydrate diet beginning 24 hours prior to PET scanning and to adhere to a four-hour fasting period (except water) immediately prior to the study. The management of oral hypoglycemic agents and insulin in fasting patients is discussed separately. (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29688?source=see_link&amp;anchor=H9#H9\">",
"       \"Perioperative management of diabetes mellitus\", section on 'Type 2 diabetes treated with oral hypoglycemic agents'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29688?source=see_link&amp;anchor=H10#H10\">",
"       \"Perioperative management of diabetes mellitus\", section on 'Type 1 or insulin treated type 2 diabetes'",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of thoracic 18-fluoro-2-deoxyglucose (FDG)-PET and integrated",
"    <span class=\"nowrap\">",
"     PET/computed",
"    </span>",
"    tomography",
"    <span class=\"nowrap\">",
"     (PET/CT)",
"    </span>",
"    has been best studied and most widely accepted in four clinical settings [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Solitary pulmonary nodules &ndash; FDG-PET or integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      may help distinguish benign from malignant pulmonary nodules (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75774 graphicRef55811 graphicRef69851 graphicRef58095 graphicRef82372 graphicRef59657 graphicRef73552 \" href=\"UTD.htm?25/41/26266\">",
"       image 4A-G",
"      </a>",
"      ). The role of FDG-PET and integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      in the evaluation of solitary pulmonary nodules is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=see_link\">",
"       \"Diagnostic evaluation and management of the solitary pulmonary nodule\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=see_link\">",
"       \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lung cancer staging &ndash; FDG-PET or integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      may help identify tumor tissue that has metastasized beyond the primary lesion, thus facilitating clinical-radiological staging (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef59658 graphicRef79073 graphicRef72484 graphicRef68761 graphicRef57052 graphicRef78739 graphicRef61004 \" href=\"UTD.htm?32/35/33338\">",
"       image 5A-G",
"      </a>",
"      ). The role of FDG-PET and integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      in the staging of non-small cell lung cancer is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"       \"Role of imaging in the staging of non-small cell lung cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"       \"Diagnosis and staging of non-small cell lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surveillance for lung cancer recurrence &ndash; FDG-PET or integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      can be helpful in the follow-up of patients after initial therapy in order to detect or exclude recurrent tumor. It may assist in the differentiation of recurrent or persistent malignant disease from changes caused by radiation therapy or surgery. FDG-PET and integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      have greater sensitivity and specificity for detecting recurrence of tumor in a previously irradiated part of the body than either CT or MRI alone [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/31-34\">",
"       31-34",
"      </a>",
"      ]. Increased uptake of FDG beyond eight weeks after the completion of radiation therapy suggests recurrent or persistent tumor, rather than an effect of radiation therapy.",
"     </li>",
"     <li>",
"      Evaluation for metastatic esophageal cancer &ndash; Integrated",
"      <span class=\"nowrap\">",
"       PET/CT",
"      </span>",
"      may identify metastatic disease that has eluded other imaging modalities [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28102/abstract/5,35\">",
"       5,35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positron emission tomography (PET) plays an integral role in the detection of malignant disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6684631\">",
"       'Clinical role'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During a traditional PET scan, the patient lies within a scanner that consists of a moving table and gantry. 18-fluoro-2-deoxyglucose (FDG) is injected intravenously and multiple sequential images are obtained. Axial, coronal, sagittal, and whole body images can then be viewed on a workstation. In contrast, integrated PET and computed tomography",
"      <span class=\"nowrap\">",
"       (PET/CT)",
"      </span>",
"      scanners fuse images obtained from PET and CT performed in tandem, combining the detailed anatomical information generated by CT scans with the metabolic localization of PET scans. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Radionuclides'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Technique'",
"      </a>",
"      above.) Early experience with hybrid",
"      <span class=\"nowrap\">",
"       PET/MR",
"      </span>",
"      scanners is being accrued.",
"     </li>",
"     <li>",
"      The clinical role of thoracic PET is based upon the enhanced uptake and accumulation of FDG within tumor cells, creating discrete foci of FDG-induced radioactivity that can be visualized on the PET scan. Quantification of the amount of radioactivity in a voxel is obtained by calculating the standardized uptake value (SUV). An SUV exceeding 2.5 raises the possibility of malignant disease. (See",
"      <a class=\"local\" href=\"#H6684631\">",
"       'Clinical role'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      False positive results are generally due to metabolically active infectious or inflammatory lesions, but they may also be due to metabolically active brown fat or thymic tissue. False negative results are typically a consequence of a tumor with low metabolic activity, a small tumor, or hyperglycemia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Sources of error'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indications for PET include distinguishing benign from malignant solitary pulmonary nodules, staging lung cancer, surveying for recurrent lung cancer, and evaluating for metastatic esophageal cancer. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/1\">",
"      Schwenzer NF, Schraml C, M&uuml;ller M, et al. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. Radiology 2012; 264:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/2\">",
"      DeGrado TR, Turkington TG, Williams JJ, et al. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/3\">",
"      Lowe VJ, Naunheim KS. Positron emission tomography in lung cancer. Ann Thorac Surg 1998; 65:1821.",
"     </a>",
"    </li>",
"    <li>",
"     Mettler FA Jr, Guiberteau MJ. Essentials of Nuclear Medicine Imaging, 5th ed, Saunders, Philadelphia 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/5\">",
"      O'Donnell JS, Rini J, Chusid J, Shah R. Abnormal Uptake on PET/CT: Imitators of Malignancy in Thoracic Imaging. Contemporary Diagnostic Radiology 2011; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/6\">",
"      von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/7\">",
"      Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004; 4:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/8\">",
"      Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60:2682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/9\">",
"      Wahl RL, Hutchins GD, Buchsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer 1991; 67:1544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/10\">",
"      Hatanaka M. Transport of sugars in tumor cell membranes. Biochim Biophys Acta 1974; 355:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/11\">",
"      Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/12\">",
"      Chen HH, Chiu NT, Su WC, et al. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology 2012; 264:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/13\">",
"      Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/14\">",
"      Roberts PF, Follette DM, von Haag D, et al. Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg 2000; 70:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/15\">",
"      Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 2004; 24:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/16\">",
"      Asad S, Aquino SL, Piyavisetpat N, Fischman AJ. False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. AJR Am J Roentgenol 2004; 182:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/17\">",
"      Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009; 360:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/18\">",
"      Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009; 360:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/19\">",
"      Cronin CG, Prakash P, Daniels GH, et al. Brown fat at PET/CT: correlation with patient characteristics. Radiology 2012; 263:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/20\">",
"      Wang TJ. The natriuretic peptides and fat metabolism. N Engl J Med 2012; 367:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/21\">",
"      Ferdinand B, Gupta P, Kramer EL. Spectrum of thymic uptake at 18F-FDG PET. Radiographics 2004; 24:1611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/22\">",
"      Erasmus JJ, McAdams HP, Patz EF Jr, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 1998; 170:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/23\">",
"      Higashi K, Ueda Y, Seki H, et al. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998; 39:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/24\">",
"      Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998; 170:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/25\">",
"      Jadvar H, Segall GM. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med 1997; 38:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/26\">",
"      Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/27\">",
"      Torizuka T, Clavo AC, Wahl RL. Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. J Nucl Med 1997; 38:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/28\">",
"      Erasmus JJ, McAdams HP, Patz EF Jr, et al. Thoracic FDG PET: state of the art. Radiographics 1998; 18:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/29\">",
"      Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/30\">",
"      Patz EF Jr, Goodman PC. Positron emission tomography imaging of the thorax. Radiol Clin North Am 1994; 32:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/31\">",
"      Mac Manus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001; 92:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/32\">",
"      Mac Manus MP, Hicks RJ, Matthews JP, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2003; 21:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/33\">",
"      Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999; 14:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/34\">",
"      Keidar Z, Haim N, Guralnik L, et al. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. J Nucl Med 2004; 45:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28102/abstract/35\">",
"      Bruzzi JF, Munden RF, Truong MT, et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics 2007; 27:1635.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6975 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-B6FAD70B64-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28102=[""].join("\n");
var outline_f27_28_28102=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H7\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TECHNICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Radionuclides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6684631\">",
"      Clinical role",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Sources of error",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6975\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6975|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/20/40256\" title=\"diagnostic image 1A\">",
"      RLL BAC CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/12/10446\" title=\"diagnostic image 1B\">",
"      RLL BAC PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/37/13905\" title=\"diagnostic image 2\">",
"      FDG PET CT lung",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/1/20496\" title=\"diagnostic image 3\">",
"      FDG PET CT axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/11/29887\" title=\"diagnostic image 4A\">",
"      RUL SPN PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/20/1344\" title=\"diagnostic image 4B\">",
"      RUL SPN PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/56/18304\" title=\"diagnostic image 4C\">",
"      Benign granuloma PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/20/38223\" title=\"diagnostic image 4D\">",
"      Benign granuloma CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/11/37053\" title=\"diagnostic image 4E\">",
"      Benign granuloma PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/53/43870\" title=\"diagnostic image 4F\">",
"      RLL nodule CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/54/17263\" title=\"diagnostic image 4G\">",
"      RLL nodule PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/55/28528\" title=\"diagnostic image 5A\">",
"      Superior sulcus PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/45/7903\" title=\"diagnostic image 5B\">",
"      Superior sulcus CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/46/25326\" title=\"diagnostic image 5C\">",
"      Superior sulcus PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/15/14576\" title=\"diagnostic image 5D\">",
"      Central lung tumor PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/52/34639\" title=\"diagnostic image 5E\">",
"      Central lung tumor CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/28/9665\" title=\"diagnostic image 5F\">",
"      Central lung tumor PET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/36/43598\" title=\"diagnostic image 5G\">",
"      Right lung tumor FDG scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6975|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/38/37485\" title=\"figure 1\">",
"      Attenuation of PET emission",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=related_link\">",
"      Computed tomographic and positron emission tomographic scanning of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=related_link\">",
"      Diagnostic evaluation and management of the solitary pulmonary nodule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/63/29688?source=related_link\">",
"      Perioperative management of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=related_link\">",
"      Role of imaging in the staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_28_28103="Assess LV asynchrony";
var content_f27_28_28103=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 626px\">",
"   <div class=\"ttl\">",
"    Assessment of LV synchrony",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 606px; height: 363px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Regional volume time curves (left) obtained in a patient with LV asynchrony without (left) and with (right) biventricular pacing. Note the changes in asynchrony index with pacing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Victor Mor-Avi, PhD and Roberto M Lang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28103=[""].join("\n");
var outline_f27_28_28103=null;
var title_f27_28_28104="Sarcoidosis resembling lichen nitidus";
var content_f27_28_28104=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73271%7EDERM%2F69405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73271%7EDERM%2F69405&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cutaneous sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 293px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flat-topped, round or polygonal papules are present on the neck. In addition, there are multiple 1 to 3 mm round, shiny, skin colored papules in groups at the base of the neck, resembling lichen nitidus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Papular sarcoidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple small papules are present on the nose and cheeks of this patient with cutaneous sarcoidosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc. Original photo provided by NYU (Tisch) Department of Dermatology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28104=[""].join("\n");
var outline_f27_28_28104=null;
var title_f27_28_28105="Pathology and pathogenesis of necrotizing enterocolitis in newborns";
var content_f27_28_28105=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathology and pathogenesis of necrotizing enterocolitis in newborns",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Richard J Schanler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28105/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/28/28105/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrotizing enterocolitis (NEC), the most common gastrointestinal emergency in the newborn infant, is a disorder manifested by ischemic necrosis of the intestinal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/1\">",
"     1",
"    </a>",
"    ]. It is associated with inflammation, invasion of enteric gas forming organisms, and dissection of gas into the muscularis and portal venous system.",
"   </p>",
"   <p>",
"    NEC occurs in 1 to 3 per 1000 live births and is seen predominately in premature infants with an incidence of about 6 to 7 percent in very low birth weight (VLBW) infants (birth weight &lt;1500 g). Although early recognition and aggressive treatment of this disorder has improved clinical outcomes, NEC accounts for substantial long-term morbidity in survivors of neonatal intensive care, particularly in VLBW infants.",
"   </p>",
"   <p>",
"    First described in 1965, the etiology of NEC remains uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The pathology and the current understanding of the pathogenesis of NEC are reviewed here. The clinical features, management, and prevention of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link\">",
"     \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35928?source=see_link\">",
"     \"Management of necrotizing enterocolitis in newborns\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7207?source=see_link\">",
"     \"Prevention of necrotizing enterocolitis in newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathology of necrotizing enterocolitis (NEC) is primarily due to changes from intestinal infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/5\">",
"     5",
"    </a>",
"    ]. The specific findings vary and depend upon the progression of the disease and the presence of underlying pathogenic factors. The terminal ileum and colon are involved in the majority of cases, although the entire gastrointestinal tract is affected in severe cases.",
"   </p>",
"   <p>",
"    On gross examination, the bowel appears distended and hemorrhagic. Subserosal collections of gas occasionally are present along the mesenteric border. Gangrenous necrosis occurs on the antimesenteric border, and perforation may be present. As the gut heals, thickening of the bowel wall, fibrinous adhesions, and areas of stenosis appear.",
"   </p>",
"   <p>",
"    The major histologic findings in NEC are mucosal edema, hemorrhage, and transmural bland necrosis. Other findings include acute inflammation, secondary bacterial infiltration, and collections of gas. Vascular thrombi are rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of necrotizing enterocolitis (NEC) remains unknown, but it is probably a heterogeneous disease resulting from multiple factors that result in mucosal injury in a susceptible host. The following factors have been implicated in the pathogenesis of NEC (",
"    <a class=\"graphic graphic_figure graphicRef74897 \" href=\"UTD.htm?29/5/29776\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prematurity",
"     </li>",
"     <li>",
"      Microbial bowel overgrowth",
"     </li>",
"     <li>",
"      Milk feeding",
"     </li>",
"     <li>",
"      Impaired mucosal defense",
"     </li>",
"     <li>",
"      Circulatory instability of the intestinal tract",
"     </li>",
"     <li>",
"      Medications that cause intestinal mucosal injury or enhance microbial overgrowth",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Currently, epidemiologic studies have identified prematurity and milk feeding as consistent risk factors for NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/4,6\">",
"     4,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 90 percent of NEC cases occur in premature infants born who have been fed enterally. The following factors due to immaturity of the gastrointestinal tract and immune system are thought to predispose the preterm infant to NEC (",
"    <a class=\"graphic graphic_figure graphicRef68015 \" href=\"UTD.htm?14/50/15138\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immature mucosal barrier with increased permeability and bacterial penetration into the intestinal wall (translocation) compared to term infants (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Impaired mucosal defense'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Immature local host defenses with diminished concentrations of secretory IgA, mucosal enzymes (eg, pepsin and proteases), and other protective agents (eg, lactoferrin), and increased gastric pH, which promotes bacterial overgrowth.",
"     </li>",
"     <li>",
"      Immature bowel motility and function. Premature infants have decreased small bowel motility, resulting in delayed transit time, which increases bacterial proliferation and overgrowth [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bacterial overgrowth and increased intestinal permeability are factors that contribute to greater bacterial translocation from the intestinal lumen into the intestinal tissue leading to an inflammatory response with activation of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Inflammation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Exposure to glucocorticoids matures intestinal barrier function, and antenatal treatment has been proposed to reduce the incidence of NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=see_link&amp;anchor=H5#H5\">",
"     \"Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery\", section on 'Reduction of IVH, NEC, NNM, infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Term infants",
"    </span>",
"    &nbsp;&mdash;&nbsp;NEC in term infants is generally associated with predisposing or underlying conditions, such as congenital heart disease, perinatal asphyxia, polycythemia, sepsis, and respiratory disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Milk feeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 90 percent of infants who develop NEC have received milk feeding, although NEC also occurs in infants who have never been fed [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/12\">",
"     12",
"    </a>",
"    ]. Enteral feeding may contribute to the pathogenesis of NEC because human milk and commercial formulas serve as substrates for bacterial proliferation in the gut.",
"   </p>",
"   <p>",
"    Newborns, especially premature infants, have not developed the ability to completely digest and absorb nutrients. As a result, bacterial fermentation products of incompletely digested carbohydrates and lipids (eg, reducing substances, organic acids, short chain fatty acids, carbon dioxide, and hydrogen gas) in the intestine of premature infants may cause mucosal injury. Delayed transient time due to impaired motility in the premature infant exacerbates this process. Supportive data was provided by a study using an animal model that demonstrated a mixture of casein, organic acids, and low pH led to mucosal injury with infiltration of cellular elements and vasoactive compounds [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although NEC is associated with enteral feeds, it remains uncertain whether feeding-related factors are important in the development of NEC:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rate of advancement &ndash; In a 2011 systematic review, available data demonstrated that slow advancement of feeds was",
"      <strong>",
"       not",
"      </strong>",
"      associated with a reduced risk of NEC and was associated with a delay in regaining birth weight and establishing full enteral feeds compared with faster rates of advancement [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Timing of initial feeding &ndash; In a 2011 meta-analysis, available data demonstrated that a delay in the introduction of enteral feeds (after four days of age) was",
"      <strong>",
"       not",
"      </strong>",
"      associated with a reduced risk of NEC and that the delay is associated with a longer time to establish full enteral feeds [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Providing minimal enteral or trophic feeding does not increase the incidence of NEC [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/16-18\">",
"       16-18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Human milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human milk, compared to formula, is more protective against NEC in premature infants. Factors present in human milk may play a role in this protection by reducing inflammation or the introduction of foreign antigens in the gastrointestinal tract. Human milk feeding is associated with a lower intestinal pH to facilitate the growth of non-pathogenic bacteria, which counteract pathogenic bacteria. The mucus coat of the intestine is less affected by human milk and growth factors within human milk (such as epidermal growth factors) repair disruptions in this layer. Human milk improves intestinal motility, which avoids milk stasis and decreases intestinal permeability. Human milk also stimulates the mucosal defense system so that local immune activation is thwarted. Protective factors within human milk include platelet activating factor acetylhydrolase, secretory Immunoglobulin A, cytokines (IL-10, IL-11), epidermal growth factor [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/19\">",
"     19",
"    </a>",
"    ], nucleotides, glutamine, and antioxidants such as vitamin E, carotene, and glutathione. The benefits of human milk compared to formula in reducing the risk of NEC in premature infants are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link&amp;anchor=H3#H3\">",
"     \"Infant benefits of breastfeeding\", section on 'Gastrointestinal function'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Microbial colonization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial colonization is believed to play a pivotal role in the development of NEC because NEC does not occur in utero when the gut is sterile. After delivery, rapid colonization of the intestinal tract by commensal bacteria from the maternal rectovaginal flora occurs. These bacteria play a symbiotic role with the intestine through toll-like receptors by regulating the expression of genes involved in intestinal physiology, postnatal maturation, and function (eg, barrier, digestion, angiogenesis, and production of IgA), and protection against more pathologic organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8,20-22\">",
"     8,20-22",
"    </a>",
"    ]. Pathologic host-bacterial interactions may induce pro-inflammatory and pro-apoptotic responses in the intestinal host cells mediated by signaling pathways, such as the NF-kappa B pathway [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8,21,23\">",
"     8,21,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although, there are limited data regarding these roles of bacteria in prenatal and postnatal intestinal development, intestinal noncommensal bacterial overgrowth, especially with coagulase negative staphylococci, appears to be associated with NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/24\">",
"     24",
"    </a>",
"    ]. Overgrowth of noncommensal bacteria may cause mucosal injury by affecting intestinal maturation, increasing inflammation and apoptosis, and releasing endotoxin release. This appears to occur in the absence of a primary infection, particularly in most sporadic cases of NEC in which infectious agents play a secondary role in the disease process [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most very preterm infants (gestational age less than 28 weeks) are colonized by Staphylococci species and very few by Bifidobacterium, commensal intestinal bacterium [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/25\">",
"     25",
"    </a>",
"    ]. Approximately 20 to 30 percent of infants with NEC have associated bacteremia, which is often caused by coagulase-negative staphylococci and is most likely seeded by intestinal bacteria translocated through the damaged intestinal mucosa [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/4\">",
"     4",
"    </a>",
"    ]. In some cases, especially in outbreaks of NEC, primary infection by pathogenic bacteria may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of probiotic therapy has been proposed to reduce bacterial overgrowth of more invasive bacteria and promote commensal intestinal bacteria, which inhibit inflammatory pathways, thereby decreasing the risk of NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8,21\">",
"     8,21",
"    </a>",
"    ]. However, the current use of probiotics should be limited to clinical trials until there is unequivocal evidence that confirms the efficacy and safety of probiotic therapy compared to other preventive modalities, and establishes the most effective regimen for premature infants (ie, bacterial strain, dosing, and timing and duration of therapy). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7207?source=see_link&amp;anchor=H4#H4\">",
"     \"Prevention of necrotizing enterocolitis in newborns\", section on 'Probiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, prolonged initial empiric antibiotic therapy greater than five days duration is associated with an increased risk of NEC or death, most likely due to a change in the bacterial colonization of the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/8,26\">",
"     8,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Primary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;NEC may be due to primary invasions of the gut by pathogenic enteric bacteria. Bacterial organisms usually found in the distal gastrointestinal tract have been recovered from the blood and peritoneal cavities of patients with NEC. These organisms include Escherichia coli, Klebsiella pneumoniae, Pseudomonas, and Clostridium difficile [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. In particular, Clostridium species, toxin-producing bacteria that are associated with pseudomembrane formation, submucosal and subserosal gas blebs, and intestinal gangrene, has been associated with more severe NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to these bacteria, viral and fungal pathogens have been isolated in some sporadic cases of NEC and in epidemic outbreaks [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Virus particles have been isolated from the stools of infants with NEC and their caregivers, including their mothers, the midwives, and the nursery nursing staff. Injury caused by infectious agents may be aggravated by inflammatory mediators. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Inflammation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The use of molecular techniques may prove to be a useful tool in evaluating the role of infection in the pathogenesis of NEC. In a small prospective study, stool samples from 12 infants less than 34 weeks gestation who were admitted to the neonatal intensive care unit were analyzed using PCR and gel electrophoresis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/34\">",
"     34",
"    </a>",
"    ]. Clostridium perfringens was recognized during the first two weeks of life in the three infants who later developed NEC but not in the nine infants who did not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Impaired mucosal defense",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants are susceptible to the development of NEC because immunologic and gastrointestinal immaturity results in altered host resistance. The impairment of the mucosal barrier allows bacteria to gain access to deeper tissues resulting in inflammation. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Inflammation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Mucosal defense in the gut is mediated by several interrelated components, some of which provide a physical barrier and others a biochemical and immunologic barrier [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Factors that contribute to innate resistance include luminal pH, enzymes, mucins, epithelial barriers, and gut motility, as well as nonspecific antimicrobial factors, such as lactoferrin and lysozyme.",
"   </p>",
"   <p>",
"    Premature infants have lower concentrations or more immature function of contributing mucosal defense factors than do term infants and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The intestinal mucin barrier, which hampers bacterial epithelial binding and enhances bacterial removal, is not fully developed in very premature infants. An immature mucin layer increases bacterial intestinal penetration and adherence, which may result in injury or cause inflammation. As a result, premature infants are more susceptible to enteric infections or mucosal inflammation [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/1,21\">",
"       1,21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Secretory IgA, the major gastrointestinal immunoprotective antibody, is absent from the human intestinal mucosa at birth.",
"     </li>",
"     <li>",
"      Paneth cells are secretory enterocytes located at the base of the small intestinal crypts that release lysozyme, phospholipase A2, and antimicrobial peptides (defensins and cathelicidins) that help regulate the intestinal bacterial populations. Animal and human studies suggest that the expression of defensins and number of Paneth cells are lower in premature infants and fetuses than in term infants and adults [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/21,37\">",
"       21,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tight junctions between epithelial cells maintain the semipermeable property of the intestinal tract. In premature infants, there is increased permeability most likely due to immaturity of the composition and function of the tight junctions [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/37\">",
"       37",
"      </a>",
"      ]. Further disruption of these tight junctions occurs because of alterations in host-bacterial interactions, which may induce inflammation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Microbial colonization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Inflammation'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Growth factors, such as epidermal growth factor (EGF), are important in intestinal development and preservation of gut barrier function [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/38\">",
"       38",
"      </a>",
"      ]. Animal models and studies in humans suggest a predictive or protective role for EGF in the pathogenesis of NEC. In one study, an EGF receptor mice knockout model demonstrated hemorrhagic necrosis, a pathologic finding similar to that seen in infants with NEC [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/39\">",
"       39",
"      </a>",
"      ]. Another animal study showed EGF supplementation reduced the incidence of NEC in a neonatal rat model of NEC [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/40-43\">",
"       40-43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of human neonates with gestational ages &le;32 weeks gestation, infants who developed NEC had lower salivary epidermal growth factor (sEGF) levels at one week of age when compared to infants without NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/44\">",
"     44",
"    </a>",
"    ]. In infants with NEC compared to those without NEC, there was also a greater increase in sEGF levels from week one to week two of life.",
"   </p>",
"   <p>",
"    Further investigations on the role of EGF in the pathogenesis of NEC are required to determine whether there is a role for EGF in either predicting or preventing NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Circulatory instability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic insult to the gastrointestinal tract has been proposed as a major contributor to NEC, although most infants with NEC have not had an obvious perinatal hypoxic-ischemic event [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/27,45,46\">",
"     27,45,46",
"    </a>",
"    ]. Circulatory events that have been implicated in the development of NEC include perinatal asphyxia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/47\">",
"     47",
"    </a>",
"    ], recurrent apnea, hypoxia from severe respiratory distress syndrome, hypotension, congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/48\">",
"     48",
"    </a>",
"    ], patent ductus arteriosus, heart failure, umbilical arterial catheterization, anemia, polycythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/49,50\">",
"     49,50",
"    </a>",
"    ], and red blood cell [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/51-53\">",
"     51-53",
"    </a>",
"    ] and exchange transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/54\">",
"     54",
"    </a>",
"    ]. A diminished blood supply to the gut may contribute to the pathogenesis of NEC in infants exposed to cocaine [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many of these observations have occurred in term infants. In premature infants with NEC, the predisposing role of circulatory instability remains unproven in premature infants with NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/27,46\">",
"     27,46",
"    </a>",
"    ]. In case-controlled studies, episodes of hypoxia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypotension occur with the same frequency in premature infants with or without NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/56\">",
"     56",
"    </a>",
"    ]. In addition, other manifestations of hypoxic-ischemic injury (eg, acute tubular necrosis and intraventricular hemorrhage) do not correlate with the development of NEC.",
"   </p>",
"   <p>",
"    These findings have led to the hypothesis that a subtle reduction in blood flow and subsequent reperfusion occurring in response to hypoxia may contribute to bowel injury. Although the regulation of mesenteric blood flow in the newborn is poorly understood, one small prospective trial reported that high vascular resistance of the superior mesenteric artery determined by Doppler flow velocity on the first day of life was associated with an increased risk of NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/57\">",
"     57",
"    </a>",
"    ]. In a prospective case-controlled study of term infants with congenital heart disease, persistent diastolic flow reversal in the abdominal aorta was associated with increased risk of NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31669350\">",
"    <span class=\"h3\">",
"     RBC transfusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Red blood cell (RBC) transfusions given after the first weeks of life are associated with an increased risk of NEC. However, it is unclear whether RBC transfusions play a pathogenetic role in the development of NEC or whether it is an epiphenomenal marker of imminent NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several retrospective studies and a systematic review have reported an association between RBC transfusions and NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/51-53,58-61\">",
"     51-53,58-61",
"    </a>",
"    ]. In the systematic review of 11 case-control studies and one cohort study, the following findings were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/61\">",
"     61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There was a temporal relationship between recent RBC transfusions and episodes of NEC.",
"     </li>",
"     <li>",
"      Infants with transfusion-associated NEC were more premature (mean difference in gestational age, -1.5 weeks, 95% CI -0.9 to -2.1 weeks), had lower birth weight (mean difference -528 g, 95% CI -496 to -560), and were more likely to have a patent ductus arteriosus (odds ratio [OR] 2.68, 95% CI 1.81-2.97) or receive ventilatory support (OR 3.16, 95% CI 1.6-6.22) than infants with NEC not associated with RBC transfusion. &nbsp;",
"     </li>",
"     <li>",
"      Infants with transfusion-associated NEC had a higher risk of mortality but this analysis was not adjusted for confounding factors.",
"     </li>",
"     <li>",
"      In six of the studies, transfusion-associated NEC was delayed occurring at an older postnatal age than NEC not associated with transfusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the authors caution that these results do not establish a cause-effect relationship between RBC transfusions and NEC as the included studies were retrospective in nature and did not adjust for confounding risk factors (ie, prematurity, birth weight, ventilatory status, and the presence of a patent ductus arteriosus). In addition, the rationale for the blood transfusion is infrequently mentioned so it furthers the confusion of this association.",
"   </p>",
"   <p>",
"    Similar results were reported in a large Canadian case-control study of 927 preterm infants with NEC and 2781 control patients without NEC matched by gestational age (GA) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/62\">",
"     62",
"    </a>",
"    ]. In this study, exposure to transfusion in the previous two days was higher in NEC cases compared with controls (15.5 versus 7.7 percent, adjusted odds ratio 2.44, 95% CI 1.87-3.18). The definition of exposure in NEC cases was defined as receiving a transfusion within two calendar days before the diagnosis of NEC and in the control cases as receiving an RBC transfusion within two calendar days before the median age of diagnosis among NEC cases with the same GA. In this cohort, infants with NEC were more likely to be small for gestational age and were sicker based on higher initial illness severity scores compared with controls. In addition, infants with NEC that was associated with transfusion exposure were also of lower birth weight and GA and had higher illness severity scores than those with NEC that was not associated with transfusion. &nbsp;",
"   </p>",
"   <p>",
"    Proponents of a causal relationship between RBC transfusion and NEC have proposed the following pathologic mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      RBC transfusion results in immunologic injury to the intestine similar to what is seen in transfusion-related acute lung injury.",
"     </li>",
"     <li>",
"      Components of stored RBCs may cause intestinal injury due to impaired blood flow due to vasoconstriction and thrombus formation. Known abnormalities associated with stored RBCs include reduced RBC deformability, increased RBC adhesion and aggregation, prothrombotic effects, and decreased nitric oxide stores.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, others suggest RBC transfusion is a marker for clinically significant anemia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a clinically unstable infant with incipient NEC who also is anemic. The degree of anemia requiring transfusion is postulated to result in further intestinal injury due to impaired oxygen delivery.",
"   </p>",
"   <p>",
"    Further research is required including prospective clinical trials to test the hypothesis of a relationship between RBC transfusion and NEC. These studies need to carefully document indications for RBC transfusion and see whether they correlate with the onset of symptoms associated with NEC. Data from such studies would be helpful in determining whether or not RBC transfusions or anemia contribute to the pathogenesis of NEC. Until more definitive data are available, we have not changed our practice regarding transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The administration of hyperosmolar medications",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    formulas can cause mucosal injury and may result in NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/63\">",
"     63",
"    </a>",
"    ]. Oral medications such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/49/24344?source=see_link\">",
"     theophylline",
"    </a>",
"    , multivitamins, or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/63/29689?source=see_link\">",
"     phenobarbital",
"    </a>",
"    contain hypertonic additives that might irritate the intestinal mucosa. Instillation of hyperosmolar contrast agents into the bowel for diagnostic radiographic studies also can cause mucosal injury because of fluid shifts, bowel distention, and ischemia. Isotonic contrast agents should be used to avoid this complication. Hyperosmolar formulas, such as those concentrated above recommended strengths or containing multiple additives, should be avoided in the first few weeks after birth.",
"   </p>",
"   <p>",
"    Histamine type 2 receptor (H2) antagonists, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/58/43943?source=see_link\">",
"     cimetidine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/1/33815?source=see_link\">",
"     ranitidine",
"    </a>",
"    , and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/61/29655?source=see_link\">",
"     famotidine",
"    </a>",
"    , are associated with higher rates of NEC. This was illustrated in a report from the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/64\">",
"     64",
"    </a>",
"    ]. In this study of 11,072 premature infants (birth weight 401 to 1500 g) from 1998 to 2001, the incidence of NEC was 7.1 percent. Infants with NEC compared to matched controls were more likely to have received H2-antagonists (OR 1.71, 95% CI 1.34 to 2.19). A possible explanation for this finding is that gastric acidity, which may reduce the risk of NEC by inhibiting bacterial growth [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/65\">",
"     65",
"    </a>",
"    ], was lowered by the use of H2-antagonists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory mediators induced by ischemia, infectious agents, or mucosal irritants may further aggravate mucosal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/21,66\">",
"     21,66",
"    </a>",
"    ]. These soluble inflammatory cytokines, including tumor necrosis factor (TNF), interleukins (IL-1, IL-6, IL-8, IL10, IL12, and IL-18), and platelet activating factor (PAF), increase vascular permeability and attract inflammatory cells. Levels of these cytokines are increased in premature infants with NEC and correlate with the severity of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/21,67-70\">",
"     21,67-70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This cascade of cellular events may be mediated at least in part by PAF, which is synthesized by many cell types, including macrophages, neutrophils, eosinophils, and endothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/71\">",
"     71",
"    </a>",
"    ]. In animals, administration of PAF causes intestinal necrosis as well as systemic hypotension, capillary leakage, pulmonary hypertension, neutropenia, and thrombocytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations may be applicable to humans. Plasma concentrations of PAF are higher in infants taking milk feedings, although the acetylhydrolase present in human milk breaks down PAF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/71\">",
"     71",
"    </a>",
"    ]. Plasma acetylhydrolase activity is lower in infants with NEC compared to controls and may contribute to the increased concentrations of PAF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medications or conditions that affect cytokines or oxygen free radicals can contribute to the development of NEC [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/71\">",
"     71",
"    </a>",
"    ]. For example, a deficiency of magnesium or copper can increase the synthesis or activity of cytokines and oxygen-free radicals, leading to intestinal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/72\">",
"     72",
"    </a>",
"    ]. In addition, in a trial of vitamin E administration to prevent retinopathy of prematurity, NEC occurred more often in treated infants with high levels of serum tocopherol (greater than 3.5",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/73\">",
"     73",
"    </a>",
"    ]. The mechanism may be due to a reduction of antimicrobial defenses by excessive scavenging of oxygen free radicals. On the other hand, treatment with vitamin E is not associated with NEC in infants with lower serum tocopherol concentrations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633847325\">",
"    <span class=\"h3\">",
"     Chorioamnionitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chorioamnionitis is an antenatal proinflammatory process involving the placenta and fetal membrane, which may play a contributing role in the pathogenesis of NEC. However, data are inconclusive whether it is a significant clinical risk factor as illustrated by a systematic review of the literature [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/74\">",
"     74",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meta-analysis of studies examining the relationship between NEC and chorioamnionitis confirmed by histology found no significant association between histologic-confirmed chorioamnionitis (HC) and NEC. However, a subgroup analysis demonstrated an association between NEC and HC that included fetal involvement.",
"     </li>",
"     <li>",
"      In another meta-analysis, clinically diagnosed chorioamnionitis was associated with an increased risk of NEC.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there are several methodological issues that affect the interpretation of these findings causing heterogeneity of results. These include not controlling for confounding factors such as gestational age (incidence of chorioamnionitis and NEC is inversely related to gestational age) and a lower rate of breastfeeding in mothers with chorioamnionitis (human milk is protective against NEC), and differences among studies in inclusion and exclusion criteria, and criteria for the clinical diagnosis of chorioamnionitis.",
"   </p>",
"   <p>",
"    Further investigation is needed to determine whether there is a significant clinical role of chorioamnionitis in the pathogenesis of NEC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Intestinal vascular resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mucosal injury and inflammation may alter the balance of endogenous vasoactive agents, which may contribute to the development of NEC with changes in the intestinal vascular resistance and microcirculation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/36,75-77\">",
"     36,75-77",
"    </a>",
"    ]. Data are limited on the roles of nitric oxide, the primary vasodilator, and endothelin-1, a potent vasoconstrictor, in the pathogenesis of NEC.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endothelin -1 (ET-1) &ndash; In a pathologic study of resected intestinal specimens from infants with suspected NEC, there were increased levels of ET-1 in areas that demonstrated histological findings consistent with NEC as compared to nonaffected tissue from the same specimen [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/77\">",
"       77",
"      </a>",
"      ]. In addition, arterioles showed increased vasoconstriction in affected compared to nonaffected tissue that was reversed by an endothelin receptor antagonist.",
"     </li>",
"     <li>",
"      Nitric oxide (NO) &ndash; The limited data available on the role of NO are conflicting. In one report, inducible NO synthase (iNOS) gene and protein expression were detected more often in apical enterocytes in infants undergoing surgical resection for NEC than for intestinal atresia or other noninflammatory conditions [",
"      <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/76\">",
"       76",
"      </a>",
"      ]. These results would suggest that increased NO may contribute to failure of gut barrier function, bacterial translocation, and direct intestinal damage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, another study reported that although endothelial NO synthase (eNOS) was present in specimens from infants undergoing surgical resection for NEC and control patients with intestinal atresia, eNOS function was impaired, resulting in decreased NO production in arterioles from NEC specimens compared to controls [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28105/abstract/40\">",
"     40",
"    </a>",
"    ]. Arterioles from patients with NEC failed to normally dilate in response to acetylcholine stimulation or increased arteriolar.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/29/18897?source=see_link\">",
"       \"Patient information: Newborn necrotizing enterocolitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Necrotizing enterocolitis (NEC), the most common gastrointestinal emergency in the newborn infant, is a disorder manifested by ischemic necrosis of the intestinal mucosa associated with inflammation, invasion of enteric gas forming organisms, and dissection of gas into the muscularis and portal venous system.",
"   </p>",
"   <p>",
"    The pathologic findings of NEC vary depending upon the progression of the disease. In general, the bowel appears distended and hemorrhagic on gross examination. The major histologic findings include mucosal edema, hemorrhage, and transmural bland necrosis. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although the pathogenesis of NEC remains unknown, it is probably caused by multiple factors in a susceptible host. Prematurity and milk feeding are established risk factors for NEC, with 90 percent of cases occurring in enterally fed premature infants. Immaturity of the gastrointestinal tract appears to predispose premature infants to NEC because it results in impaired mucosal defense, and intestinal motility and function. These factors result in microbial overgrowth and an increased likelihood of mucosal injury leading to inflammation, ischemia, and necrosis, and the development of NEC. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Pathogenesis'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/1\">",
"      Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996; 43:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/2\">",
"      MIZRAHI A, BARLOW O, BERDON W, et al. NECROTIZING ENTEROCOLITIS IN PREMATURE INFANTS. J Pediatr 1965; 66:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/3\">",
"      S&aacute;ntulli TV, Schullinger JN, Heird WC, et al. Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 1975; 55:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/4\">",
"      Kliegman RM, Walker WA, Yolken RH. Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr Res 1993; 34:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/5\">",
"      Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: a ten-year experience. J Pediatr 1990; 117:S6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/6\">",
"      Holman RC, Stoll BJ, Clarke MJ, Glass RI. The epidemiology of necrotizing enterocolitis infant mortality in the United States. Am J Public Health 1997; 87:2026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/7\">",
"      Neu J, Weiss MD. Necrotizing enterocolitis: pathophysiology and prevention. JPEN J Parenter Enteral Nutr 1999; 23:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/8\">",
"      Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008; 63:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/9\">",
"      Morriss FH Jr, Moore M, Gibson T, West MS. Motility of the small intestine in preterm infants who later have necrotizing enterocolitis. J Pediatr 1990; 117:S20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/10\">",
"      Bauer CR, Morrison JC, Poole WK, et al. A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 1984; 73:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/11\">",
"      Halac E, Halac J, B&eacute;gu&eacute; EF, et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. J Pediatr 1990; 117:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/12\">",
"      Berseth CL. Feeding strategies and necrotizing enterocolitis. Curr Opin Pediatr 2005; 17:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/13\">",
"      Clark DA, Miller MJ. Intraluminal pathogenesis of necrotizing enterocolitis. J Pediatr 1990; 117:S64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/14\">",
"      Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2011; :CD001241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/15\">",
"      Morgan J, Young L, McGuire W. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2011; :CD001970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/16\">",
"      La Gamma EF, Browne LE. Feeding practices for infants weighing less than 1500 G at birth and the pathogenesis of necrotizing enterocolitis. Clin Perinatol 1994; 21:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/17\">",
"      Schanler RJ, Shulman RJ, Lau C, et al. Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics 1999; 103:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/18\">",
"      Bombell S, McGuire W. Early trophic feeding for very low birth weight infants. Cochrane Database Syst Rev 2009; :CD000504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/19\">",
"      Caplan M. Is EGF the Holy Grail for NEC? J Pediatr 2007; 150:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/20\">",
"      Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/21\">",
"      Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/22\">",
"      Morowitz MJ, Poroyko V, Caplan M, et al. Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis. Pediatrics 2010; 125:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/23\">",
"      Okogbule-Wonodi AC, Gross GW, Sun CC, et al. Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infants. Pediatr Res 2011; 69:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/24\">",
"      Stewart CJ, Marrs EC, Magorrian S, et al. The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection. Acta Paediatr 2012; 101:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/25\">",
"      Jacquot A, Neveu D, Aujoulat F, et al. Dynamics and clinical evolution of bacterial gut microflora in extremely premature patients. J Pediatr 2011; 158:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/26\">",
"      Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/27\">",
"      Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/28\">",
"      Uauy RD, Fanaroff AA, Korones SB, et al. Necrotizing enterocolitis in very low birth weight infants: biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1991; 119:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/29\">",
"      Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev 1988; 9:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/30\">",
"      Brook I. Microbiology and management of neonatal necrotizing enterocolitis. Am J Perinatol 2008; 25:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/31\">",
"      Scheifele DW. Role of bacterial toxins in neonatal necrotizing enterocolitis. J Pediatr 1990; 117:S44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/32\">",
"      Dittmar E, Beyer P, Fischer D, et al. Necrotizing enterocolitis of the neonate with Clostridium perfringens: diagnosis, clinical course, and role of alpha toxin. Eur J Pediatr 2008; 167:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/33\">",
"      Stuart RL, Tan K, Mahar JE, et al. An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr Infect Dis J 2010; 29:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/34\">",
"      Turcios-Ruiz RM, Axelrod P, St John K, et al. Outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit. J Pediatr 2008; 153:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/35\">",
"      de la Cochetiere MF, Piloquet H, des Robert C, et al. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 2004; 56:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/36\">",
"      Udall JN Jr. Gastrointestinal host defense and necrotizing enterocolitis. J Pediatr 1990; 117:S33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/37\">",
"      Ford HR. Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 2006; 41:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/38\">",
"      Warner BW, Warner BB. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis. Semin Pediatr Surg 2005; 14:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/39\">",
"      Miettinen PJ, Berger JE, Meneses J, et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 1995; 376:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/40\">",
"      Dvorak B, Fituch CC, Williams CS, et al. Increased epidermal growth factor levels in human milk of mothers with extremely premature infants. Pediatr Res 2003; 54:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/41\">",
"      Dvorak B, Halpern MD, Holubec H, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002; 282:G156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/42\">",
"      Clark JA, Lane RH, Maclennan NK, et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 288:G755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/43\">",
"      Clark JA, Doelle SM, Halpern MD, et al. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 2006; 291:G938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/44\">",
"      Warner BB, Ryan AL, Seeger K, et al. Ontogeny of salivary epidermal growth factor and necrotizing enterocolitis. J Pediatr 2007; 150:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/45\">",
"      Nowicki P. Intestinal ischemia and necrotizing enterocolitis. J Pediatr 1990; 117:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/46\">",
"      Davey AM, Wagner CL, Cox C, Kendig JW. Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial. J Pediatr 1994; 124:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/47\">",
"      Kamoji VM, Dorling JS, Manktelow B, et al. Antenatal umbilical Doppler abnormalities: an independent risk factor for early onset neonatal necrotizing enterocolitis in premature infants. Acta Paediatr 2008; 97:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/48\">",
"      Carlo WF, Kimball TR, Michelfelder EC, Border WL. Persistent diastolic flow reversal in abdominal aortic Doppler-flow profiles is associated with an increased risk of necrotizing enterocolitis in term infants with congenital heart disease. Pediatrics 2007; 119:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/49\">",
"      Hakanson DO, Oh W. Necrotizing enterocolitis and hyperviscosity in the newborn infant. J Pediatr 1977; 90:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/50\">",
"      Nowicki PT, Oh W, Yao A, et al. Effect of polycythemia on gastrointestinal blood flow and oxygenation in piglets. Am J Physiol 1984; 247:G220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/51\">",
"      Christensen RD, Lambert DK, Henry E, et al. Is \"transfusion-associated necrotizing enterocolitis\" an authentic pathogenic entity? Transfusion 2010; 50:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/52\">",
"      Josephson CD, Wesolowski A, Bao G, et al. Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr 2010; 157:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/53\">",
"      Blau J, Calo JM, Dozor D, et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011; 158:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/54\">",
"      Touloukian RJ, Kadar A, Spencer RP. The gastrointestinal complications of neonatal umbilical venous exchange transfusion: a clinical and experimental study. Pediatrics 1973; 51:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/55\">",
"      Farrar HC, Kearns GL. Cocaine: clinical pharmacology and toxicology. J Pediatr 1989; 115:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/56\">",
"      Wilson R, del Portillo M, Schmidt E, et al. Risk factors for necrotizing enterocolitis in infants weighing more than 2,000 grams at birth: a case-control study. Pediatrics 1983; 71:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/57\">",
"      Murdoch EM, Sinha AK, Shanmugalingam ST, et al. Doppler flow velocimetry in the superior mesenteric artery on the first day of life in preterm infants and the risk of neonatal necrotizing enterocolitis. Pediatrics 2006; 118:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/58\">",
"      Christensen RD. Association between red blood cell transfusions and necrotizing enterocolitis. J Pediatr 2011; 158:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/59\">",
"      Singh R, Visintainer PF, Frantz ID 3rd, et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011; 31:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/60\">",
"      Paul DA, Mackley A, Novitsky A, et al. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011; 127:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/61\">",
"      Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: a meta-analysis of observational data. Pediatrics 2012; 129:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/62\">",
"      Stritzke AI, Smyth J, Synnes A, et al. Transfusion-associated necrotising enterocolitis in neonates. Arch Dis Child Fetal Neonatal Ed 2013; 98:F10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/63\">",
"      Book LS, Herbst JJ, Atherton SO, Jung AL. Necrotizing enterocolitis in low-birth-weight infants fed an elemental formula. J Pediatr 1975; 87:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/64\">",
"      Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117:e137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/65\">",
"      Carrion V, Egan EA. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 1990; 11:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/66\">",
"      Caplan MS, Hsueh W. Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor. J Pediatr 1990; 117:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/67\">",
"      Caplan MS, Sun XM, Hseuh W, Hageman JR. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 1990; 116:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/68\">",
"      Harris MC, Costarino AT Jr, Sullivan JS, et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/69\">",
"      Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/70\">",
"      Sharma R, Tepas JJ 3rd, Hudak ML, et al. Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg 2007; 42:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/71\">",
"      Caplan MS, MacKendrick W. Inflammatory mediators and intestinal injury. Clin Perinatol 1994; 21:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/72\">",
"      Caddell JL. A review of evidence for a role of magnesium and possibly copper deficiency in necrotizing enterocolitis. Magnes Res 1996; 9:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/73\">",
"      Johnson L, Quinn GE, Abbasi S, et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr 1989; 114:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/74\">",
"      Been JV, Lievense S, Zimmermann LJ, et al. Chorioamnionitis as a risk factor for necrotizing enterocolitis: a&nbsp;systematic review and meta-analysis. J Pediatr 2013; 162:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/75\">",
"      MacKendrick W, Caplan M, Hsueh W. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/76\">",
"      Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28105/abstract/77\">",
"      Nowicki PT, Dunaway DJ, Nankervis CA, et al. Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr 2005; 146:805.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4991 Version 19.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28105=[""].join("\n");
var outline_f27_28_28105=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prematurity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Term infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Milk feeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Human milk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Microbial colonization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Primary infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Impaired mucosal defense",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Circulatory instability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31669350\">",
"      - RBC transfusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H633847325\">",
"      - Chorioamnionitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Intestinal vascular resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4991\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4991|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/5/29776\" title=\"figure 1\">",
"      Pathogenesis of NEC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/50/15138\" title=\"figure 2\">",
"      NEC prematurity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/55/31610?source=related_link\">",
"      Antenatal corticosteroid therapy for reduction of neonatal morbidity and mortality from preterm delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=related_link\">",
"      Human milk feeding and fortification of human milk for premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35928?source=related_link\">",
"      Management of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/29/18897?source=related_link\">",
"      Patient information: Newborn necrotizing enterocolitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7207?source=related_link\">",
"      Prevention of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_28_28106="Epidemiology, pathogenesis, and clinical features of epidermolysis bullosa";
var content_f27_28_28106=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, pathogenesis, and clinical features of epidermolysis bullosa",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Martin Laimer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Johann Bauer, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Dedee F Murrell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Susan J Bayliss, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/28/28106/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/28/28106/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H2900679\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermolysis bullosa (EB) comprises a clinically and genetically heterogeneous group of rare inherited disorders characterized by marked mechanical fragility of epithelial tissues with blistering and erosions following minor trauma.",
"   </p>",
"   <p>",
"    EB is caused by mutations involving at least 17 genes encoding structural proteins that form the dermoepidermal anchoring complex within the basement membrane zone (BMZ) of the skin and mucosae (",
"    <a class=\"graphic graphic_figure graphicRef52111 \" href=\"UTD.htm?7/20/7493\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1\">",
"     1",
"    </a>",
"    ]. The integrity of the BMZ, which is a highly specialized interface between epithelial cells and the underlying matrix, is crucial for cell adhesion, proliferation, and differentiation; tissue repair; and barrier function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, and clinical features of EB are discussed in this topic. The diagnosis and management of EB are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39255?source=see_link\">",
"     \"Diagnosis of epidermolysis bullosa\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/63/3066?source=see_link\">",
"     \"Overview of the management of epidermolysis bullosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4215666\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most reliable figures on prevalence and incidence of epidermolysis bullosa (EB) are derived from the National EB Registry (NEBR), which collected cross-sectional and longitudinal data on about 3300 EB patients in the United States from 1986 through 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Over a five-year period (1986 through 1990), the prevalence of EB was estimated to be approximately 8 per million and the incidence 19 per million live births. Over the same period, the incidence rates of EB by subtype were approximately 11 per million live births for EB simplex; 2 per million live births for junctional EB; 3 per million live births for dominant dystrophic EB; and 2 per million live births for recessive dystrophic EB. Data from the Australasian EB Registry provided a prevalence estimate of 10 cases per million live births [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/5\">",
"     5",
"    </a>",
"    ]. Prevalence rates ranging from 15 to 32 cases per million have been estimated in the UK [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900693\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF EB",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most recent classification of epidermolysis bullosa (EB) recognizes four major types according to the ultrastructural level of blister formation within the epidermal basal membrane zone (BMZ) (",
"    <a class=\"graphic graphic_figure graphicRef52111 \" href=\"UTD.htm?7/20/7493\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidermolytic (EB simplex) &ndash; cleavage plane within the basal keratinocytes (basilar EB simplex) or above the level of basal keratinocytes (suprabasal EB simplex) (",
"      <a class=\"graphic graphic_table graphicRef77709 \" href=\"UTD.htm?6/16/6415\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lamina lucidolytic (junctional EB) &ndash; cleavage plane within the lamina lucida of the dermoepidermal junction (",
"      <a class=\"graphic graphic_table graphicRef67202 \" href=\"UTD.htm?9/28/9678\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Dermolytic (dystrophic EB) &ndash; cleavage plane within the upper papillary dermis at level of anchoring fibrils (sublamina densa) (",
"      <a class=\"graphic graphic_table graphicRef55262 \" href=\"UTD.htm?21/9/21662\">",
"       table 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Mixed type EB (Kindler syndrome) &ndash; multiple cleavage planes (intraepidermal, intra-lamina lucida, or sublamina densa) (",
"      <a class=\"graphic graphic_table graphicRef81536 \" href=\"UTD.htm?14/53/15195\">",
"       table 4",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These four major types are further divided into more than 30 subtypes, based upon phenotype, mode of inheritance, and genotype.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900707\">",
"    <span class=\"h1\">",
"     EPIDERMOLYSIS BULLOSA SIMPLEX",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900714\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidermolysis bullosa simplex (EBS) is the most common type of EB, accounting for 75 to 85 percent of all cases of EB in western countries [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/9\">",
"     9",
"    </a>",
"    ]. In the vast majority of cases, EBS is caused by mutations in the keratin genes, resulting in the formation of a cleavage plane at the level of the basal keratinocytes. Rare variants are associated with mutations in genes encoding other structural proteins of the basal membrane zone, including desmoplakin, plakophilin-1, plakoglobin, integrins A3, A4, and B4, type XVII collagen, plectin, and dystonin (",
"    <a class=\"graphic graphic_figure graphicRef52111 \" href=\"UTD.htm?7/20/7493\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/10\">",
"     10",
"    </a>",
"    ]. EBS is inherited in an autosomal dominant fashion, but rare autosomal recessive forms have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/9,11-14\">",
"     9,11-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EBS is characterized by trauma- or friction-induced skin blistering with localized or disseminated anatomic distribution. The most common subtypes of EBS are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      EBS, localized (formerly known as Weber-Cockayne EBS)",
"     </li>",
"     <li>",
"      EBS, Dowling-Meara",
"     </li>",
"     <li>",
"      EBS, other generalized, including the type formerly known as Koebner EBS",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rare variants include recessive EBS, EBS associated with pyloric atresia, EBS with mottled pigmentation, EBS associated with muscular dystrophy, and EBS of Ogna. The pattern of inheritance, gene mutations, and clinical features of EBS variants are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef77709 \" href=\"UTD.htm?6/16/6415\">",
"     table 1",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5626143\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, EBS is caused by dominant negative missense mutations in",
"    <em>",
"     KRT5",
"    </em>",
"    and",
"    <em>",
"     KRT14",
"    </em>",
"    genes (",
"    <a class=\"graphic graphic_table graphicRef77709 \" href=\"UTD.htm?6/16/6415\">",
"     table 1",
"    </a>",
"    ), encoding keratins that are mostly expressed in the basal epidermal layer [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/15\">",
"     15",
"    </a>",
"    ]. Genotype-phenotype analyses revealed that mutations affecting conserved areas at the beginning (N-terminal end-domain) or end (C-terminal end-domain) of the central alpha-helical rod segment of keratin molecules inhibit the end-to-end aggregation of keratin filaments [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/2,16-19\">",
"     2,16-19",
"    </a>",
"    ] and are associated with a severe disruption of the cytoskeleton, epidermal fragility to friction forces, and phenotype.",
"   </p>",
"   <p>",
"    Mutations affecting less conserved areas, such as the head or tail domain, result in an impaired but still possible partial filament formation and are associated with a milder phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/9,11\">",
"     9,11",
"    </a>",
"    ]. Some keratin mutations may affect cytoskeletal dynamics or interfere with normal post-translational keratin modifications [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/20\">",
"     20",
"    </a>",
"    ]. The disease severity is also influenced by homozygosity (severe phenotype) or heterozygosity (milder phenotype) of the genetic defect and by the type of point mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations in the",
"    <em>",
"     PLEC1",
"    </em>",
"    gene that encodes plectin (a hemidesmosomal protein expressed in various tissues, including gastrointestinal epithelia and striated muscle) are associated with EBS with muscular dystrophy and EBS with pyloric atresia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Many plectin mutations cluster in exon 31 that encodes the rod domain. Plectin mutations are also associated with the autosomal dominant EBS of Ogna and with a variant of autosomal recessive lethal acantholytic EBS (LAEB) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LAEB also may be associated with loss-of-function mutations in the",
"    <em>",
"     DSP",
"    </em>",
"    gene, encoding the desmosomal protein desmoplakin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/27\">",
"     27",
"    </a>",
"    ].",
"    <em>",
"     DSP",
"    </em>",
"    mutations lead to the truncation of the keratin-binding tail domain of desmoplakin, resulting in impaired attachment or connection between the keratin intermediate filaments and the desmosomal inner dense plaque in all layers of the epidermis.",
"   </p>",
"   <p>",
"    Ectodermal dysplasia-skin fragility syndrome is caused by loss-of-function mutations on both alleles of the",
"    <em>",
"     PKP1",
"    </em>",
"    gene encoding plakophilin1, a component of the desmosomal plaque [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"    <em>",
"     PKP1",
"    </em>",
"    is expressed throughout the epidermis and particularly in suprabasal cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H68965254\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576858238\">",
"    <span class=\"h3\">",
"     EBS, localized",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized epidermolysis bullosa simplex (EBS), formerly known as Weber-Cockayne EBS, is the mildest and most common form of EB. Localized EBS presents between infancy and the third decade with trauma- or friction-induced blistering limited to the palms and soles (",
"    <a class=\"graphic graphic_picture graphicRef86390 graphicRef86391 graphicRef86392 graphicRef86393 \" href=\"UTD.htm?32/50/33578\">",
"     picture 1A-D",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/32\">",
"     32",
"    </a>",
"    ]. An associated palmoplantar hyperidrosis is common. Blistering or ulceration of the oral mucosa may develop in infants, sometimes triggered by trauma from bottle feeding, and usually resolves with increasing age. Hair and teeth are normal; nail dystrophy is rare and generally mild. Blisters heal without scarring or milia. Discrete or punctate calluses are common, especially in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576858308\">",
"    <span class=\"h3\">",
"     EBS, Dowling-Meara",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized EBS of Dowling-Meara (EBS-DM) is the most severe form of EBS. EBS-DM presents at birth with disseminated trauma or friction-induced blistering. Grouped blisters with an arcuate, &ldquo;herpetiform&rdquo; arrangement may appear spontaneously on the trunk, upper limbs, or neck (",
"    <a class=\"graphic graphic_picture graphicRef86392 graphicRef86393 \" href=\"UTD.htm?15/29/15832\">",
"     picture 1C-D",
"    </a>",
"    ). Involvement of the oral mucosa is common. Hyperkeratosis of the palms and soles appears during infancy and can progress over time to confluent keratoderma. Additional clinical features include nail dystrophy, nail shedding, and alopecia.",
"   </p>",
"   <p>",
"    Erosions usually heal without scarring, but postinflammatory hypo- or hyperpigmentation are common; milia and atrophy may occur. EBS-DM tends to improve with age. High ambient temperatures or sweating (eg, during summer) are exacerbating factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576858354\">",
"    <span class=\"h3\">",
"     EBS, other generalized",
"    </span>",
"    &nbsp;&mdash;&nbsp;EBS, other generalized (formerly known as Koebner EBS) includes all forms of generalized EBS other than the Dowling-Meara subtype [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1\">",
"     1",
"    </a>",
"    ]. Blistering starts at birth or during early infancy, is generally mild, and particularly involves the hands, feet, and extremities. Development of hair, teeth and nails is normal. Lesions often heal with postinflammatory dyspigmentation; atrophy and milia may occur, although less frequently than in the Dowling-Meara form.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H576858380\">",
"    <span class=\"h3\">",
"     Unusual variants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unusual variants of EBS, including suprabasal subtypes, EBS with mottled pigmentation, EBS with muscular dystrophy, EBS with pyloric atresia, autosomal recessive EBS, and EBS Ogna, are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef77709 \" href=\"UTD.htm?6/16/6415\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900721\">",
"    <span class=\"h1\">",
"     JUNCTIONAL EPIDERMOLYSIS BULLOSA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H381880\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Junctional epidermolysis bullosa (JEB) comprises a group of autosomal recessive disorders characterized by blistering of the skin and mucosae that heal with scarring. In most cases, JEB is caused by autosomal recessive mutations in the laminin-332 genes, which result in a structural defect of the anchoring filaments located in the lamina lucida and superior lamina densa of the basal membrane zone. Rare variants of JEB are associated with mutations in the genes encoding the hemidesmosomal proteins collagen XVII, integrin alpha-6, and integrin beta-4.",
"   </p>",
"   <p>",
"    Genotypic and phenotypic variants of JEB include (",
"    <a class=\"graphic graphic_table graphicRef67202 \" href=\"UTD.htm?9/28/9678\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      JEB, Herlitz type or lethalis (JEB-H)",
"     </li>",
"     <li>",
"      JEB, non-Herlitz, generalized (JEB-nH)",
"     </li>",
"     <li>",
"      JEB, non-Herlitz, localized",
"     </li>",
"     <li>",
"      JEB with pyloric atresia (JEB-PA)",
"     </li>",
"     <li>",
"      JEB, laryngo-onycho-cutaneous syndrome (JEB-LOC)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5626455\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of JEB Herlitz (JEB-H) and several of JEB non-Herlitz (JEB-nH) are caused by autosomal recessive mutations in the",
"    <em>",
"     LAMA3",
"    </em>",
"    ,",
"    <em>",
"     LAMB3",
"    </em>",
"    , and",
"    <em>",
"     LAMC2",
"    </em>",
"    genes encoding the alpha-3, beta-3, and gamma-2 subunits of laminin-332 (",
"    <a class=\"graphic graphic_table graphicRef67202 \" href=\"UTD.htm?9/28/9678\">",
"     table 2",
"    </a>",
"    ). The absence of any of the three laminin subunits prevents the assembly and secretion of functional trimeric laminin-332. Laminin-332 is expressed in embryonal and adult tissues, including amnion; embryonic cartilage; enamel forming matrix; cornea; dermoepidermal junction; and the basement membrane zone of kidney (glomeruli and tubuli), lung (alveoli, bronchioli, and bronchi), and small intestine epithelium [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/33-36\">",
"     33-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 80 percent of mutations occur in the",
"    <em>",
"     LAMB3",
"    </em>",
"    gene, which harbors a number of recurrent mutations, such as R635X [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/37\">",
"     37",
"    </a>",
"    ]. In JEB-H, homozygous null mutations within the",
"    <em>",
"     LAM",
"    </em>",
"    genes generate premature termination codons that lead to accelerated nonsense mediated mRNA decay or truncated, unstable, nonfunctional proteins sensitive to proteolytic degradation. Any of these pathways results in biallelic complete loss of laminin-332 and a severe phenotype.",
"   </p>",
"   <p>",
"    The majority of JEB-nH is caused by missense mutations or in-frame deletions in the",
"    <em>",
"     LAM",
"    </em>",
"    genes leading to a reduced expression of aberrant laminin-332, due to defective triple helix formation, decreased thermal stability, and intracellular accumulation. The abnormal laminin-332 retains a residual biological activity which results in mild or moderate non-Herlitz phenotypes.",
"   </p>",
"   <p>",
"    The remaining JEB-nH cases are caused by mutations in the",
"    <em>",
"     COL17A1",
"    </em>",
"    gene, encoding the hemidesmosomal protein collagen XVII, also known as bullous pemphigoid antigen 180 (BP180) or BPAG2 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1,37,38\">",
"     1,37,38",
"    </a>",
"    ]. Most mutations are nonsense and",
"    <span class=\"nowrap\">",
"     insertion/deletion",
"    </span>",
"    mutations causing premature chain termination. Since collagen XVII is only expressed in hemidesmosomes, the clinical manifestations are limited to the skin, hair, and mucous membranes and do not involve other organs as in other forms of JEB.",
"   </p>",
"   <p>",
"    Approximately 30 percent of patients with JEB-nH due to mutations in",
"    <em>",
"     COL17A1",
"    </em>",
"    or",
"    <em>",
"     LAMB3",
"    </em>",
"    present with the &ldquo;revertant mosaicism&rdquo; phenomenon, also called &ldquo;natural gene therapy&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. This phenomenon occurs when a causative germline mutation is corrected by a spontaneous genetic event in a somatic cell, including intragenic crossover, second-site mutation, mitotic gene conversion, or true back mutation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Revertant mosaicism may be the cause of milder than expected phenotypes in some patients with JEB-nH. These patients present at birth with skin areas that are typically darker than affected areas and do not blister.",
"   </p>",
"   <p>",
"    The JEB variant with pyloric atresia (JEB-PA) is caused by mutations in the genes",
"    <em>",
"     ITGB4",
"    </em>",
"    and",
"    <em>",
"     ITGA6",
"    </em>",
"    encoding the hemidesmosomal protein alpha-6 beta-4 integrin. The level of tissue separation in JEB-PA is just above the plasma membrane. A total lack of functional alpha-6 beta-4 integrin, due to mutations generating premature termination codons in both alleles, is associated with severe skin fragility and early mortality. However, more subtle missense mutations have been identified in association with milder disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Homozygous mutations in the",
"    <em>",
"     ITGA3",
"    </em>",
"    gene encoding the transmembrane integrin receptor subunit integrin alpha-3 have been reported in three patients with a new form of epidermolysis bullosa characterized by mild skin fragility but fatal multiorgan involvement with congenital nephritic syndrome and interstitial lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/10\">",
"     10",
"    </a>",
"    ]. The structural abnormalities detected in these patients (eg, subepidermal multi-layer blistering with lamina densa located in the blister floor with intact hemidesmosomes and cell fragments) are similar to those described in integrin alpha-3 knockout mice [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/44\">",
"     44",
"    </a>",
"    ]. These observations indicate that integrin alpha-3 is indispensable for epidermal cell adhesion and basement-membrane organization.",
"   </p>",
"   <p>",
"    Mutations of the",
"    <em>",
"     LAMA3A",
"    </em>",
"    gene, encoding the laminin alpha-3a polypeptide, a component of the laminin-332 heterotrimer, are associated with the laryngo-onycho-cutaneous (LOC) syndrome, a distinct variant of JEB (JEB-LOC), seen in families from the Punjabi region of Pakistan and India. The affected individuals are generally homozygous for the recessive frameshift mutation 151insG in",
"    <em>",
"     LAMA3A",
"    </em>",
"    on chromosome 18q11.2. However, the LOC syndrome can be caused by other mutations in exon 39 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/45,46\">",
"     45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mutations causing JEB are generally inherited in an autosomal recessive pattern. However, unusual inheritance patterns have been described in some JEB patients, including uniparental isodisomy (inheritance of two identical copies of one parental chromosome) of chromosome 1 with reduction to homozygosity or compound heterozygosity (two different pathogenic mutations in the same gene that together are sufficient to manifest a recessive phenotype) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/47-50\">",
"     47-50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=see_link\">",
"     \"Glossary of genetic terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H382308\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900729\">",
"    <span class=\"h3\">",
"     JEB, Herlitz",
"    </span>",
"    &nbsp;&mdash;&nbsp;JEB-H presents with generalized, extensive mucocutaneous blistering at birth (",
"    <a class=\"graphic graphic_picture graphicRef86264 graphicRef86267 graphicRef86269 graphicRef86270 graphicRef86271 \" href=\"UTD.htm?39/28/40394\">",
"     picture 2A-E",
"    </a>",
"    ) and is associated with early lethality despite aggressive therapeutic interventions. Secondary lesions following repeated tissue traumatization include atrophic scarring, webbing (scar formation between fingers or toes), contractures (typically in the axillary vaults), and milia. Pigmentary abnormalities include hypo- or mottled pigmentation and, rarely, EB nevi. (See",
"    <a class=\"local\" href=\"#H61550620\">",
"     'Epidermolysis bullosa nevi'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Exuberant granulation tissue presenting as moist, red, friable plaques (",
"    <a class=\"graphic graphic_picture graphicRef87697 \" href=\"UTD.htm?26/7/26738\">",
"     picture 3",
"    </a>",
"    ) around the mouth, central face, or nose is pathognomonic of JEB-H [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/51\">",
"     51",
"    </a>",
"    ]. Other areas involved include the upper back, axillary vaults, and nail folds. Periorificial vegetations can cause luminal occlusion and may mimic squamous cell carcinoma clinically.",
"   </p>",
"   <p>",
"    Onychodystrophy with onychogryphosis (thickened, yellowish, longitudinally grooved, markedly curved nail plates), or absence of nails (anonychia) due to atrophy and scarring of the nail bed and matrix are common findings in JEB-H (",
"    <a class=\"graphic graphic_picture graphicRef86271 \" href=\"UTD.htm?33/40/34432\">",
"     picture 2E",
"    </a>",
"    ). Uncommon cutaneous features include localized or diffuse scarring alopecia, palmoplantar keratoderma, and areas of congenital absence of the skin (aplasia cutis congenita) presenting as smooth, red, well-demarcated, depressed patches on hands, feet, wrists, or ankles.",
"   </p>",
"   <p>",
"    Blisters and erosions may occur in all stratified squamous epithelial tissues, including the conjunctival, oral, gastrointestinal, respiratory, and genitourinary mucosae. Strictures and obstructions resulting from healing of mucosal lesions are associated with significant morbidity and mortality (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H55888270\">",
"     'Extracutaneous manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Enamel hypoplasia is a characteristic feature of intraoral disease in all JEB subtypes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/52\">",
"     52",
"    </a>",
"    ]. Excessive pitting and furrowing of the tooth surfaces create areas that are difficult to clean and are ideal for microbial growth and substrate retention, which cause dental caries. In addition, the thin enamel provides decreased resistance to the development and progression of caries.",
"   </p>",
"   <p>",
"    Upper airway injury may occur spontaneously or follow episodes of coughing, crying, or upper respiratory tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/53\">",
"     53",
"    </a>",
"    ]. Symptoms associated with laryngotracheal stenosis, such as chronic hoarseness, weak cry, or inspiratory stridor, are seen in up to 50 percent of patients with JEB-H and are ominous signs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/54\">",
"     54",
"    </a>",
"    ]. Partial or complete occlusion of the upper airways may occur in the generalized subtypes of JEB within the first year of life [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/53\">",
"     53",
"    </a>",
"    ]. The risk of upper airway obstruction decreases in later childhood, probably because of the age-related increase in the luminal diameter of airways.",
"   </p>",
"   <p>",
"    Urologic complications may occur in patients with JEB-H [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/55\">",
"     55",
"    </a>",
"    ]. Urethral meatal stenosis and urinary retention have been reported in approximately 10 percent of patients; less frequent complications include hydronephrosis and bladder hypertrophy.",
"   </p>",
"   <p>",
"    The risk of death among JEB-H children is estimated to be approximately 45 percent by age 1 and 60 percent by age 15. These estimates are based upon data from the United States national epidermolysis bullosa registry (NEBR), which included cases diagnosed by nonmolecular tests from 1986 through 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. In contrast, mortality rates of up to 100 percent, with most deaths occurring in the first two years of life, have been reported among children with JEB-H in whom the diagnosis was based upon the complete absence of functional laminin-332 in immunofluorescence antigen mapping and DNA analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/5,58\">",
"     5,58",
"    </a>",
"    ]. Sepsis, failure to thrive, and respiratory failure are the major causes of death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900736\">",
"    <span class=\"h3\">",
"     JEB, non-Herlitz",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-Herlitz JEB (JEB-nH) comprises a group of rare, less severe forms of JEB, initially described in patients presenting with a JEB-H phenotype who survived to adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. The disease was formerly termed &ldquo;generalized atrophic benign epidermolysis bullosa&rdquo; (GABEB) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. Several variants of JEB-nH have been recognized (",
"    <a class=\"graphic graphic_table graphicRef67202 \" href=\"UTD.htm?9/28/9678\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1\">",
"     1",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    In infants and children, JEB-nH is clinically indistinguishable from other forms of generalized EB (",
"    <a class=\"graphic graphic_picture graphicRef86399 \" href=\"UTD.htm?30/37/31313\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/61\">",
"     61",
"    </a>",
"    ]. In adults, generalized JEB-nH is characterized by serous or hemorrhagic blisters predominantly located in sites exposed to friction, trauma, or heat (",
"    <a class=\"graphic graphic_picture graphicRef86400 graphicRef86401 \" href=\"UTD.htm?0/39/630\">",
"     picture 5A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/63\">",
"     63",
"    </a>",
"    ]. Lesions may progress to form superficial or deep ulcers, crusted lesions, and fissures. Recurrent blistering and healing results in skin atrophy with poikilodermatous appearance, pigmentary disturbances, and faint stellate scars [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1,61,62\">",
"     1,61,62",
"    </a>",
"    ]. Sometimes, a mild disease early in life may evolve to a severe phenotype in adults or vice versa.",
"   </p>",
"   <p>",
"    Additional clinical features include a permanent, diffuse, but incomplete alopecia that becomes apparent by the end of the first or second decade, dystrophic or absent nails (",
"    <a class=\"graphic graphic_picture graphicRef86402 \" href=\"UTD.htm?16/58/17314\">",
"     picture 6",
"    </a>",
"    ), dental enamel hypoplasia and caries, and EB nevi. Involvement of mucous membranes may occur in infancy and early childhood and, in contrast to JEB-H, is usually moderate and without scarring. However, tracheolaryngeal stenosis, esophageal webs and strictures, and urogenital complications have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with generalized JEB-nH, there is a substantial risk of death during infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900750\">",
"    <span class=\"h1\">",
"     DYSTROPHIC EPIDERMOLYSIS BULLOSA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H382238\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dystrophic epidermolysis bullosa (DEB) is characterized by blistering of the skin and mucosal membranes that heal with scarring. DEB is caused by mutations in the",
"    <em>",
"     COL7A1",
"    </em>",
"    gene encoding the alpha-1 chain of type VII collagen. Collagen VII is the main constituent of the anchoring fibrils located below the lamina densa of the epidermal basement membrane zone. DEB can be inherited in an autosomal dominant or recessive fashion. (See",
"    <a class=\"local\" href=\"#H381977\">",
"     'Pathogenesis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The 2008 consensus classification recognizes one major dominant and two major recessive subtypes of DEB and several rare dominant or recessive subtypes (",
"    <a class=\"graphic graphic_table graphicRef55262 \" href=\"UTD.htm?21/9/21662\">",
"     table 3",
"    </a>",
"    ). The phenotypic spectrum of DEB ranges from the mildest &ldquo;nail-only&rdquo; dominant DEB phenotype, in which patients have only dystrophic toe nails, to the &ldquo;severe generalized&rdquo; recessive DEB phenotype, in which there is generalized blistering and scarring leading to fusion of fingers and toes (pseudosyndactyly or &ldquo;mitten&rdquo; deformity).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H381977\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;All DEB subtypes are caused by mutations in the",
"    <em>",
"     COL7A1",
"    </em>",
"    gene on chromosome 3p21.31, coding for the alpha-1 chain of type VII collagen. Collagen VII is the main constituent of the anchoring fibrils, which are located below the basal lamina at the dermoepidermal basement membrane zone and anchor the epidermal basement membrane to the dermis.",
"   </p>",
"   <p>",
"    More than 600 distinct mutations in the",
"    <em>",
"     COL7A1",
"    </em>",
"    gene have been identified in DEB [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/66-71\">",
"     66-71",
"    </a>",
"    ]. Although a few mutations are recurrent in some populations due to founder effect, most families carry unique mutations (&ldquo;private mutations&rdquo;).",
"   </p>",
"   <p>",
"    In autosomal dominant DEB (DDEB), the predominant type of mutation is a missense mutation resulting in a glycine substitution within the triple helical domain of the pro-&alpha;-chain of type VII collagen [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/66\">",
"     66",
"    </a>",
"    ]. Less frequently, deletions and splice-junction mutations have been identified. Both the mutated and the wild-type allele are expressed in DDEB, so some anchoring fibrils are functionally intact, accounting for the relatively mild phenotype. In rare cases, the skin symptoms may be transient with improvement in the first years of life.",
"   </p>",
"   <p>",
"    In severe recessive DEB (RDEB [formerly called Hallopeau-Siemens]) nonsense mutations, deletions, insertions, or splice site mutations with frame shift of translation typically result in premature termination codons [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/72\">",
"     72",
"    </a>",
"    ]. Homozygosity or compound heterozygosity for premature termination codon mutations in",
"    <em>",
"     COL7A1",
"    </em>",
"    result in null alleles and complete absence of anchoring fibrils, as visualized by transmission electron microscopy and by entirely negative immunofluorescence for type VII collagen epitopes. Complete absence of anchoring fibrils is associated with extreme skin fragility, extensive scarring, joint contractures and mutilations, severe mucosal involvement, malnutrition, and growth retardation.",
"   </p>",
"   <p>",
"    In milder forms of RDEB, different types of mutations (eg, missense or splice site mutations) and allelic combinations (eg, a premature termination codon mutation on one allele and a missense mutation or in-frame deletion on the other) result in defective collagen VII synthesis and structurally abnormal anchoring fibrils [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/73\">",
"     73",
"    </a>",
"    ]. In these patients, electron microscopy reveals anchoring fibrils morphologically altered or reduced in number and immunofluorescence for collagen VII is positive but attenuated. &nbsp;",
"   </p>",
"   <p>",
"    Genotype-phenotype correlation studies have helped in the understanding of the phenotype diversity in recessive dystrophic EBS. As an example, specific recessive arginine and glycine substitutions in the triple helix domain of type VII collagen were demonstrated to cause the inversa type of recessive DEB that predominantly involves the intertriginous areas [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H382171\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical hallmarks of DEB are skin fragility, blistering, scarring, nail changes, and milia formation (",
"    <a class=\"graphic graphic_picture graphicRef86594 graphicRef86595 graphicRef86596 graphicRef86597 graphicRef87097 \" href=\"UTD.htm?41/54/42858\">",
"     picture 7A-E",
"    </a>",
"    ). Since collagen VII is expressed also in noncutaneous stratified epithelia, blistering also occurs in the mucous membranes and upper third of the esophagus.",
"   </p>",
"   <p>",
"    The phenotypic spectrum of DEB ranges from the mildest &ldquo;nail-only&rdquo; DDEB, in which patients have only dystrophic toe nails, to the most severe RDEB, in which there is generalized blistering and scarring leading to fusion of fingers and toes (ie, pseudosyndactyly or &ldquo;mitten&rdquo; deformation). The three major clinical subtypes of DEB are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dominant DEB, generalized",
"     </li>",
"     <li>",
"      Recessive DEB, severe generalized (formerly named RDEB, Hallopeau&ndash;Siemens type)",
"     </li>",
"     <li>",
"      Recessive DEB, other",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Uncommon variants of dominant and recessive DEB are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef55262 \" href=\"UTD.htm?21/9/21662\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476057\">",
"    <span class=\"h3\">",
"     Dominant DEB, generalized",
"    </span>",
"    &nbsp;&mdash;&nbsp;In generalized dominant DEB, blistering starts at birth or soon after, predominantly in the skin overlying bony prominences, such as the knees, ankles, and dorsa of the hands and feet. Mucosal involvement is rare and teeth are normal. Blisters heal with scarring and milia. Nail dystrophy is probably the most important diagnostic feature, especially in adults, because most patients have only limited scarring that becomes less noticeable with age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476064\">",
"    <span class=\"h3\">",
"     Recessive DEB, severe generalized",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe generalized recessive DEB, formerly known as Hallopeau-Siemens type, is the most severe form of DEB. Blistering starts at birth, spontaneously or after the mildest trauma, particularly in skin areas exposed to repeated friction or mechanical trauma (eg, knees, elbows, hands, feet, back of the neck, shoulders, and over the spine). Occasionally, there is extensive denudation of a body area due to congenital absence of the skin. Healing occurs with scarring and milia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pseudosyndactyly due to repeated blistering and scarring on hands and feet is a clinical hallmark of recessive dystrophic EB. Pseudosyndactyly initially presents as partial fusion of the interdigital spaces due to proximal webbing and synechiae and is followed by progressive bridging and complete fusion of all of the individual digits in a cocoon-like, scarred mass (&ldquo;mitten&rdquo; deformity) (",
"    <a class=\"graphic graphic_picture graphicRef86598 \" href=\"UTD.htm?13/15/13554\">",
"     picture 8",
"    </a>",
"    ). Contractures of hands and feet begin to develop as early as in the first year of life [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"     77",
"    </a>",
"    ]. Proximal contractures may also occur, especially within the popliteal and antecubital fossae and axillary vaults. Scarring alopecia is common.",
"   </p>",
"   <p>",
"    Oral, esophageal, anal, and ocular mucosae are also affected with erosions and scarring (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ). Dystrophic teeth, restricted mouth opening and tongue mobility due to scarring promote severe caries, and, together with esophageal strictures, lead to reduced food intake and nutritional deficiencies. Severe generalized RDEB patients have an extremely high risk of developing squamous cell carcinomas, which is the leading cause of death in this group [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/78\">",
"     78",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H61550613\">",
"     'Skin cancer'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476115\">",
"    <span class=\"h3\">",
"     Recessive DEB, other",
"    </span>",
"    &nbsp;&mdash;&nbsp;In recessive DEB, other, blistering is less severe and mutilating deformities do not develop. The clinical picture is variable. Some patients have widespread disease whereas others present with blistering limited to the extremities. Skin lesions heal invariably with scars and milia. Oral, dental, nail, and hair manifestations are similar to those seen in recessive DEB, severe generalized, but are less extensive. Localized forms tend to improve over time and overlap with dominant DEB. The risk of squamous cell carcinomas is elevated [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476124\">",
"    <span class=\"h3\">",
"     Rare subtypes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare, localized subtypes of both dominant and recessive DEB include inverse, pretibial, pruriginous, and nail-only forms (",
"    <a class=\"graphic graphic_table graphicRef55262 \" href=\"UTD.htm?21/9/21662\">",
"     table 3",
"    </a>",
"    ). Pretibial DEB presents in adolescence or adulthood with fragile blisters and erosions that are often overshadowed by pruritic, lichenified plaques [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/79\">",
"     79",
"    </a>",
"    ]. DEB pruriginosa is also a late-onset variant of dominant, or occasionally recessive, dystrophic EB. Intense pruritus on a background of inherited skin fragility leads to skin signs resembling hypertrophic lichen planus or prurigo nodularis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900764\">",
"    <span class=\"h1\">",
"     KINDLER SYNDROME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476454\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kindler syndrome (KS) is a distinct type of autosomal recessive epidermolysis bullosa characterized by skin blistering, photosensitivity, progressive poikiloderma (a combination of skin atrophy, telangiectasia, and dyspigmentation), and extensive skin atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/1,81\">",
"     1,81",
"    </a>",
"    ]. KS is caused by loss-of-function mutations in the",
"    <em>",
"     FERMT1",
"    </em>",
"    gene, encoding the focal adhesion protein fermitin, also called kindlin-1.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900771\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;KS is caused by mutations in the",
"    <em>",
"     FERMT1",
"    </em>",
"    gene, encoding the fermitin family homolog 1 protein (FFH1), also referred to as kindlin-1, a focal adhesion protein predominantly expressed in skin basal keratinocytes, periodontal tissues, and colon. Kindlin-1 has a critical regulatory role in linking the actin cytoskeleton with the underlying extracellular matrix anchorage network and is implicated in the control of integrin activation (",
"    <a class=\"graphic graphic_figure graphicRef52111 \" href=\"UTD.htm?7/20/7493\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/82-85\">",
"     82-85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    About 40 different pathogenic mutations have been identified in KS, including frameshift, splice site, large deletion mutations, and gene rearrangements following homologous unequal crossing over [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/86-89\">",
"     86-89",
"    </a>",
"    ]. Loss-of-function mutations in",
"    <em>",
"     FERMT1",
"    </em>",
"    lead to the disruption of the attachment of the actin cytoskeleton to focal adhesion junctions at the dermoepidermal junction and impaired epithelial-mesenchymal signaling via these complexes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/81,90-94\">",
"     81,90-94",
"    </a>",
"    ]. KS ultrastructural key features of thickening and reduplication of lamina densa may be related to repeated episodes of keratinocyte disadhesion and overcompensation by excessive matrix production and remodelling beneath the basement membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. Long-term FFH1 deficiency is also associated with an increased cancer risk, suggesting that focal adhesions may have an important role in cell cycle control and cell and survival, growth, signalling, and invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/93,97,98\">",
"     93,97,98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H476412\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kindler syndrome (KS) presents at birth or in early infancy with trauma-induced skin blistering that predominantly involves the acral sites and heals with atrophic changes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/81\">",
"     81",
"    </a>",
"    ]. In late childhood, blistering generally subsides and gives way to progressive poikiloderma and skin atrophy localized to sun exposed areas such as the dorsal aspect of the hands and feet. Most patients with KS develop variable degrees of photosensitivity.",
"   </p>",
"   <p>",
"    Mucosal involvement tends to increase with age. Gingivitis and periodontitis are common findings. Esophageal or genitourinary stenoses, gastrointestinal symptoms, including constipation and colitis, have also been reported. Patients with KS have an increased risk of nonmelanoma skin cancer during adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55888270\">",
"    <span class=\"h1\">",
"     EXTRACUTANEOUS MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In severe forms of epidermolysis bullosa (EB), blistering, chronic nonhealing wounds, and scarring can occur in epithelial tissues other than skin, resulting in significant morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/53\">",
"     53",
"    </a>",
"    ]. Complications also may involve other organs and systems, such as the heart and musculoskeletal system [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"     77",
"    </a>",
"    ]. The extracutaneous manifestations and complications of EB are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H594268293\">",
"    <span class=\"h2\">",
"     Nails and hair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nail abnormalities are a feature of most epidermolysis bullosa (EB) subtypes (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ), since antigenic expression of basement membrane zone (BMZ) components in the normal matrix, nail bed, proximal nail fold, and hyponychium is similar to that of normal skin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/100\">",
"     100",
"    </a>",
"    ]. Nail involvement ranges from a mild cosmetic problem to a disabling condition.",
"   </p>",
"   <p>",
"    Early nail dystrophy and loss correlate with disease severity and progression, particularly in junctional epidermolysis bullosa (JEB) and recessive dystrophic epidermolysis bullosa (RDEB) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/101\">",
"     101",
"    </a>",
"    ]. Nail abnormalities may precede skin blistering as in late-onset JEB and pretibial DEB, or be an isolated finding as in &ldquo;nails-only&rdquo; dominant dystrophic epidermolysis bullosa (DDEB) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/102\">",
"     102",
"    </a>",
"    ]. In the nails-only DDEB variant, the involvement is often limited to the toenails and can be mild and easily overlooked. Moreover, nail involvement without blistering may be present for generations before a DEB family member develops blisters in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/102-105\">",
"     102-105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The expression of BMZ components in the anagen hair follicles of the human scalp is similar to that of the interfollicular epidermis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/106\">",
"     106",
"    </a>",
"    ]. Blistering of the scalp involving the lamina lucida and below, as in JEB and DEB, usually leads to cicatricial alopecia secondary to inflammation of the interfollicular epidermis and upper portion of the hair follicle. In addition, absence of or abnormal BMZ proteins in the hair follicle may increase hair fragility. The hair abnormalities and alopecia patterns associated with EB subtypes are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61550917\">",
"    <span class=\"h2\">",
"     Eye",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ocular involvement is frequent in patients with JEB or recessive DEB [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/107,108\">",
"     107,108",
"    </a>",
"    ]. Symptoms range from mild conjunctival irritation to severe cicatrization of eyelids, cornea, or conjunctiva and progressive visual impairment (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ). Corneal blisters and erosions are the most common ocular findings and have been reported in approximately 50 percent of patients with JEB Herlitz and 70 percent of patients with severe generalized DEB [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/108\">",
"     108",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55888322\">",
"    <span class=\"h2\">",
"     Oral cavity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The oral manifestations of EB include soft tissue and dental abnormalities (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"     77",
"    </a>",
"    ]. Intraoral blisters and superficial erosions are common in all EB patients, although they are usually minimal and clinically silent in those with EBS. Scarring and loss of normal architecture of intraoral soft tissues occur in most patients with JEB or DEB. Enamel hypoplasia with pitting and furrowing is a pathognomonic feature of all subtypes of JEB and predisposes to dental caries and tooth loss. Additional factors contributing to dental caries and premature tooth loss include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poor oral hygiene due to painful peri- and intraoral blisters or erosions and impaired manual dexterity",
"     </li>",
"     <li>",
"      Altered soft tissue architecture with contractures (microstomia, ankyloglossia), abnormal tongue mobility and obliteration of oral vestibules resulting in decreased food clearance",
"     </li>",
"     <li>",
"      Frequent feeding with high-calorie, cariogenic soft diets",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55888384\">",
"    <span class=\"h2\">",
"     Gastrointestinal tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with JEB or recessive DEB, any portion of the gastrointestinal tract may be injured [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/53\">",
"     53",
"    </a>",
"    ]. Gastrointestinal manifestations include esophageal strictures, gastroesophageal reflux, rectal tears, anal fissures and stenosis, and constipation (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ). Esophageal strictures, resulting from recurrent mucosal blistering and scarring, are the most frequent and often the most disabling complication. The majority of strictures occurs in the upper third of the esophagus, but they may arise anywhere, leading to progressive dysphagia initially with hard or bulky foods, then with softer foods, and eventually with liquids. In recessive DEB, esophageal strictures develop in early childhood and more than 50 percent of patients report symptoms by the age of 10.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61551144\">",
"    <span class=\"h2\">",
"     Genitourinary tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of the genitourinary tract are reported in approximately 30 percent of patients with JEB or recessive DEB (",
"    <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/109\">",
"     109",
"    </a>",
"    ]. Urethral meatal stenosis and recurrent vesiculation within the mucosa of the urethra, ureterovesical junction and ureters may cause dysuria and urinary retention. Subsequently, bladder distention and hypertrophy, vesicoureteral reflux, hydroureter and hydronephrosis may develop and ultimately lead to chronic renal failure, if not treated [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61550788\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900843\">",
"    <span class=\"h2\">",
"     Malnutrition and anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with EB, several factors contribute to severe nutritional compromise, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Feeding difficulties due to oropharyngeal involvement, esophageal narrowing, dysphagia, and poor swallowing coordination",
"     </li>",
"     <li>",
"      Moderate to severe malabsorption due to recurrent mucosal lesions of the small intestine",
"     </li>",
"     <li>",
"      High energy consumption from accelerated skin turnover, wound healing, and natural growth",
"     </li>",
"     <li>",
"      Hypercatabolic state from chronic inflammation and infection",
"     </li>",
"     <li>",
"      Transcutaneous loss of nutrients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Malnutrition may result in refractory anemia, hypoalbuminemia, failure to thrive, and delayed puberty with secondary hypogonadism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/111\">",
"     111",
"    </a>",
"    ]. Anemia is largely caused by iron deficiency resulting from reduced intake and absorption, blood loss from chronic skin and mucosal wounds, and loss of skin cells. Anemia has a significant impact on the general well being, causing fatigue, breathlessness, reduced exercise tolerance, poor wound healing, and anorexia. Many patients with severe forms of EB maintain hemoglobin levels of &lt;8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    despite therapy with iron supplements [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"     77",
"    </a>",
"    ]. Blood transfusion may be necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61550606\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin infection is common in all subtypes of epidermolysis bullosa (EB) and may have an exacerbating role in patients with severe generalized subtypes, such as recessive dystrophic EB and junctional EB Herlitz [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/112\">",
"     112",
"    </a>",
"    ].",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    and",
"    <em>",
"     Streptococcus pyogenes",
"    </em>",
"    are common infectious agents. Gram-negative infections with",
"    <em>",
"     Pseudomonas aeruginosa",
"    </em>",
"    ,",
"    <em>",
"     Escherichia coli",
"    </em>",
"    or",
"    <em>",
"     Proteus",
"    </em>",
"    also occur. Methicillin resistant",
"    <em>",
"     S. aureus",
"    </em>",
"    and ciprofloxacin-resistant",
"    <em>",
"     Pseudomonas",
"    </em>",
"    are frequently isolated from EB wounds.",
"   </p>",
"   <p>",
"    Sepsis, in most cases arising from cutaneous infection, is a frequent cause of morbidity in children with junctional and recessive dystrophic EB. The use of intravenous lines and indwelling ports are also a significant source of septicemia in EB patients, due to chronically colonized or infected surrounding or overlying skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61550613\">",
"    <span class=\"h2\">",
"     Skin cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Squamous cell carcinoma (SCC) of the skin is a frequent complication and the leading cause of death of several subtypes of EB. The risk is highest for recessive dystrophic epidermolysis bullosa (RDEB) (",
"    <a class=\"graphic graphic_picture graphicRef86599 graphicRef86600 \" href=\"UTD.htm?16/26/16808\">",
"     picture 9A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"     77",
"    </a>",
"    ]. Data from the US National EB Registry (NEBR) indicate that in patients with severe generalized RDEB the risk of developing SCC by age 55 is greater than 90 percent and the risk of death from metastatic disease by the same age is approximately 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    SCC generally develops in early adulthood at sites of chronic wounds, regeneration, or scarring, and shows an aggressive course with high rates of recurrence and metastasis after surgical excision. Suggested pathogenetic mechanisms include repetitive tissue stress and remodelling, growth activation of keratinocytes, polymorphisms of matrix metalloproteinases, or reduced activity of natural killer cells [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/113\">",
"     113",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21226?source=see_link\">",
"     \"Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Basal cell carcinoma (BCC) occurs with increased frequency in patients with epidermolysis bullosa simplex (EBS) Dowling-Meara, with estimated cumulative risks of 8 percent, 25 percent, and 44 percent by ages 40, 50, and 55, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/78\">",
"     78",
"    </a>",
"    ]. Patients with severe generalized RDEB may be at increased risk of melanoma during childhood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\", section on 'Epidermolysis bullosa'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H61550620\">",
"    <span class=\"h2\">",
"     Epidermolysis bullosa nevi",
"    </span>",
"    &nbsp;&mdash;&nbsp;EB nevi are large, eruptive, asymmetrical, often irregularly pigmented and highly dynamic melanocytic lesions that develop in patients with all EB variants [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/114,115\">",
"     114,115",
"    </a>",
"    ]. EB nevi appear gradually in infancy or adolescence as black to brown stippled maculae (",
"    <a class=\"graphic graphic_picture graphicRef86604 \" href=\"UTD.htm?8/58/9123\">",
"     picture 10",
"    </a>",
"    ); sometimes, they display explosive growth over months, with frequent appearance of small satellite lesions (",
"    <a class=\"graphic graphic_picture graphicRef86601 \" href=\"UTD.htm?42/28/43456\">",
"     picture 11",
"    </a>",
"    ). EB nevi undergo maturation like most common acquired melanocytic nevi; they begin as flat, black to brown pigmented lesions and subsequently become intradermal and lose their pigment, presenting as papillomatous (&ldquo;shagreen&rdquo;) nevi (",
"    <a class=\"graphic graphic_picture graphicRef86607 graphicRef86608 \" href=\"UTD.htm?6/63/7159\">",
"     picture 12A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EB nevi typically arise in sites of previous bullae or erosions, often with a darker rim at the confines of the preceding vesiculation (",
"    <a class=\"graphic graphic_picture graphicRef86603 \" href=\"UTD.htm?7/47/7924\">",
"     picture 13",
"    </a>",
"    ), suggesting that repetitive disruption of the basement membrane primes local nevus cell nests or single melanocytes to break senescence and undergo proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/115,117,118\">",
"     115,117,118",
"    </a>",
"    ]. An alternative pathogenetic hypothesis is that EB nevi originate from melanocytes or nevus cells, probably derived from incipient nevi or nests of nevus cells, that free-float in the fluid-filled cavity of an EB blister (&ldquo;flocking-bird melanocytes&rdquo;), set down at random, often at the edge of the blister, and proliferate excessively in the microenvironment of epidermal regeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/115,119\">",
"     115,119",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The random arrangement of proliferating melanocytic clones and secondary changes due to wound healing, scar formation, disruption of rete ridges, and neovascularization may account for the irregular appearance of EB nevi. EB nevi frequently manifest clinical, histological, and dermoscopic features suggestive of melanoma (",
"    <a class=\"graphic graphic_picture graphicRef86605 \" href=\"UTD.htm?21/15/21750\">",
"     picture 14",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/120\">",
"     120",
"    </a>",
"    ]. Although the state of chronic skin wounding and regeneration seems to promote carcinogenesis (see",
"    <a class=\"local\" href=\"#H61550613\">",
"     'Skin cancer'",
"    </a>",
"    above), malignant transformation of these nevi has not been reported. In contrast, spontaneous disappearance of EB nevi may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?27/28/28106/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2900857\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epidermolysis bullosa (EB) comprises group of rare inherited disorders characterized by marked mechanical fragility of epithelial tissues, with blistering and erosions following minor trauma. (See",
"      <a class=\"local\" href=\"#H2900679\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Four major types of EB are recognized, based upon the ultrastructural level of blister formation within the epidermal basal membrane zone (BMZ): simplex, junctional, dystrophic, and Kindler syndrome (",
"      <a class=\"graphic graphic_figure graphicRef52111 \" href=\"UTD.htm?7/20/7493\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2900693\">",
"       'Classification of EB'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Epidermolysis bullosa simplex (EBS) (",
"      <a class=\"graphic graphic_table graphicRef77709 \" href=\"UTD.htm?6/16/6415\">",
"       table 1",
"      </a>",
"      ) is the most common type of EB and is characterized by localized or generalized trauma-induced skin blistering that heals without scarring. In most cases, EBS is caused by autosomal dominant mutations in the",
"      <em>",
"       KRT5",
"      </em>",
"      and",
"      <em>",
"       KRT14",
"      </em>",
"      genes encoding keratins, resulting in tissue cleavage at the level of the basal keratinocytes. (See",
"      <a class=\"local\" href=\"#H5626143\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H68965254\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Junctional epidermolysis bullosa (JEB) (",
"      <a class=\"graphic graphic_table graphicRef67202 \" href=\"UTD.htm?9/28/9678\">",
"       table 2",
"      </a>",
"      ) is characterized by blistering of the skin and mucosae that heal with scarring. Most cases of JEB-Herlitz are caused by autosomal recessive mutations in the",
"      <em>",
"       LAMA3",
"      </em>",
"      ,",
"      <em>",
"       LAMB3",
"      </em>",
"      , and",
"      <em>",
"       LAMC2",
"      </em>",
"      genes encoding laminin-332, resulting in tissue cleavage in the lamina lucida of the BMZ. JEB-Herlitz presents with extensive mucocutaneous blistering at birth and is associated with early lethality (",
"      <a class=\"graphic graphic_picture graphicRef86264 graphicRef86267 graphicRef86269 graphicRef86270 graphicRef86271 \" href=\"UTD.htm?39/28/40394\">",
"       picture 2A-E",
"      </a>",
"      ). JEB-non Herlitz underlies mutations predominantly affecting COL17A1 (encoding type XVII collagen) and shows a generally milder course. (See",
"      <a class=\"local\" href=\"#H5626455\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H382308\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dystrophic epidermolysis bullosa (DEB) (",
"      <a class=\"graphic graphic_table graphicRef55262 \" href=\"UTD.htm?21/9/21662\">",
"       table 3",
"      </a>",
"      ) is characterized by blistering of the skin and mucosae that heal with scarring and milia (",
"      <a class=\"graphic graphic_picture graphicRef87097 \" href=\"UTD.htm?11/33/11795\">",
"       picture 7E",
"      </a>",
"      ). DEB is caused by autosomal dominant or recessive mutations in the",
"      <em>",
"       COL7A1",
"      </em>",
"      gene encoding the alpha-1 chain of type VII collagen resulting in tissue cleavage below the lamina densa of the BMZ. In severe recessive DEB, blistering starts at birth. Pseudosyndactyly, mitten deformity, esophageal strictures, oral and ocular involvement, and squamous cell carcinoma are frequent and early complications. (See",
"      <a class=\"local\" href=\"#H381977\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H382171\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Kindler syndrome (KS) is an autosomal recessive EB type characterized by skin blistering, photosensitivity, progressive poikiloderma, and extensive skin atrophy (",
"      <a class=\"graphic graphic_table graphicRef81536 \" href=\"UTD.htm?14/53/15195\">",
"       table 4",
"      </a>",
"      ). KS is caused by mutations in the",
"      <em>",
"       FERMT1",
"      </em>",
"      gene, encoding the focal adhesion protein fermitin, also called kindlin-1, resulting in tissue cleavage at variable levels in the BMZ zone. KS presents at birth or in early infancy with trauma-induced skin blistering that predominantly involves the acral sites and heals with atrophic changes. (See",
"      <a class=\"local\" href=\"#H2900771\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H476412\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Extracutaneous manifestations common to all severe subtypes of EB include (",
"      <a class=\"graphic graphic_table graphicRef86396 \" href=\"UTD.htm?10/29/10719\">",
"       table 5",
"      </a>",
"      ): hair and nail abnormalities; intraoral blistering and scarring and dental abnormalities; esophageal strictures; and genitourinary abnormalities. Skin infections, sepsis, malnutrition, anemia, and squamous cell carcinoma are frequent complications and are associated with significant morbidity and mortality. (See",
"      <a class=\"local\" href=\"#H55888270\">",
"       'Extracutaneous manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H61550788\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/1\">",
"      Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008; 58:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/2\">",
"      Uitto J, Richard G. Progress in epidermolysis bullosa: genetic classification and clinical implications. Am J Med Genet C Semin Med Genet 2004; 131C:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/3\">",
"      Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis 2010; 5:12.",
"     </a>",
"    </li>",
"    <li>",
"     Fine JD, Johnson LB, Suchindran C, et al. The National Epidermolysis bullosa registry. In: Epidermolysis bullosa: Clinical, epidemiologic, and laboratory findings of the National Epidermolysis Bullosa Registry, Fine JD, Bauer EA, McGuire J, Moshell A (Eds), The Johns Hopkins University Press, Baltimore 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/5\">",
"      Kho YC, Rhodes LM, Robertson SJ, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol 2010; 146:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/6\">",
"      McKenna KE, Walsh MY, Bingham EA. Epidermolysis bullosa in Northern Ireland. Br J Dermatol 1992; 127:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/7\">",
"      Browne F, Heagerty AHM, Martinez A, et al. The epidemiology of epidermolysis bullosa in the U.K.: A 9-year study. Br J Dermatol 2011; 165 (Suppl 1):8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/8\">",
"      Horn HM, Priestley GC, Eady RA, Tidman MJ. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol 1997; 136:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/9\">",
"      Abu Sa'd J, Indelman M, Pfendner E, et al. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol 2006; 126:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/10\">",
"      Has C, Spart&agrave; G, Kiritsi D, et al. Integrin &alpha;3 mutations with kidney, lung, and skin disease. N Engl J Med 2012; 366:1508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/11\">",
"      Ciubotaru D, Bergman R, Baty D, et al. Epidermolysis bullosa simplex in Israel: clinical and genetic features. Arch Dermatol 2003; 139:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/12\">",
"      Groves RW, Liu L, Dopping-Hepenstal PJ, et al. A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 2010; 130:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/13\">",
"      Garc&iacute;a M, Santiago JL, Terr&oacute;n A, et al. Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex. Br J Dermatol 2011; 165:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/14\">",
"      Pigors M, Kiritsi D, Kr&uuml;mpelmann S, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet 2011; 20:1811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/15\">",
"      Lane EB, McLean WH. Keratins and skin disorders. J Pathol 2004; 204:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/16\">",
"      S&oslash;rensen CB, Ladekjaer-Mikkelsen AS, Andresen BS, et al. Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. J Invest Dermatol 1999; 112:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/17\">",
"      Kang TW, Lee JS, Kim SE, et al. Novel and recurrent mutations in Keratin 5 and 14 in Korean patients with Epidermolysis bullosa simplex. J Dermatol Sci 2010; 57:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/18\">",
"      Rugg EL, Horn HM, Smith FJ, et al. Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol 2007; 127:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/19\">",
"      M&uuml;ller FB, K&uuml;ster W, Wodecki K, et al. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly. Hum Mutat 2006; 27:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/20\">",
"      Werner NS, Windoffer R, Strnad P, et al. Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. Mol Biol Cell 2004; 15:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/21\">",
"      Bauer JW, Rouan F, Kofler B, et al. A compound heterozygous one amino-acid insertion/nonsense mutation in the plectin gene causes epidermolysis bullosa simplex with plectin deficiency. Am J Pathol 2001; 158:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/22\">",
"      Cummins RE, Klingberg S, Wesley J, et al. Keratin 14 point mutations at codon 119 of helix 1A resulting in different epidermolysis bullosa simplex phenotypes. J Invest Dermatol 2001; 117:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/23\">",
"      McMillan JR, Akiyama M, Rouan F, et al. Plectin defects in epidermolysis bullosa simplex with muscular dystrophy. Muscle Nerve 2007; 35:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/24\">",
"      Schara U, T&uuml;cke J, Mortier W, et al. Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation. Eur J Pediatr 2004; 163:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/25\">",
"      Koss-Harnes D, H&oslash;yheim B, Anton-Lamprecht I, et al. A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J Invest Dermatol 2002; 118:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/26\">",
"      Charlesworth A, Gagnoux-Palacios L, Bonduelle M, et al. Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin. J Invest Dermatol 2003; 121:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/27\">",
"      Jonkman MF, Pasmooij AM, Pasmans SG, et al. Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am J Hum Genet 2005; 77:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/28\">",
"      South AP. Plakophilin 1: an important stabilizer of desmosomes. Clin Exp Dermatol 2004; 29:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/29\">",
"      Sprecher E, Molho-Pessach V, Ingber A, et al. Homozygous splice site mutations in PKP1 result in loss of epidermal plakophilin 1 expression and underlie ectodermal dysplasia/skin fragility syndrome in two consanguineous families. J Invest Dermatol 2004; 122:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/30\">",
"      Whittock NV, Haftek M, Angoulvant N, et al. Genomic amplification of the human plakophilin 1 gene and detection of a new mutation in ectodermal dysplasia/skin fragility syndrome. J Invest Dermatol 2000; 115:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/31\">",
"      McGrath JA, McMillan JR, Shemanko CS, et al. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet 1997; 17:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/32\">",
"      Sprecher E. Epidermolysis bullosa simplex. Dermatol Clin 2010; 28:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/33\">",
"      Lu W, Miyazaki K, Mizushima H, Nemoto N. Immunohistochemical distribution of laminin-5 gamma2 chain and its developmental change in human embryonic and foetal tissues. Histochem J 2001; 33:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/34\">",
"      Miosge N, Kluge JG, Studzinski A, et al. In situ-RT-PCR and immunohistochemistry for the localisation of the mRNA of the alpha 3 chain of laminin and laminin-5 during human organogenesis. Anat Embryol (Berl) 2002; 205:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/35\">",
"      Tuori A, Uusitalo H, Burgeson RE, et al. The immunohistochemical composition of the human corneal basement membrane. Cornea 1996; 15:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/36\">",
"      Hamill KJ, Paller AS, Jones JC. Adhesion and migration, the diverse functions of the laminin alpha3 subunit. Dermatol Clin 2010; 28:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/37\">",
"      Varki R, Sadowski S, Pfendner E, Uitto J. Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants. J Med Genet 2006; 43:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/38\">",
"      Kiritsi D, Kern JS, Schumann H, et al. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa. J Med Genet 2011; 48:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/39\">",
"      Jonkman MF, Pasmooij AM. Revertant mosaicism--patchwork in the skin. N Engl J Med 2009; 360:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/40\">",
"      Pasmooij AM, Nijenhuis M, Brander R, Jonkman MF. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol 2012; 132:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/41\">",
"      Jonkman MF, Scheffer H, Stulp R, et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997; 88:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/42\">",
"      Pasmooij AM, Pas HH, Deviaene FC, et al. Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet 2005; 77:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/43\">",
"      Pulkkinen L, Rouan F, Bruckner-Tuderman L, et al. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet 1998; 63:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/44\">",
"      DiPersio CM, Hodivala-Dilke KM, Jaenisch R, et al. alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol 1997; 137:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/45\">",
"      McLean WH, Irvine AD, Hamill KJ, et al. An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Genet 2003; 12:2395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/46\">",
"      Figueira EC, Crotty A, Challinor CJ, et al. Granulation tissue in the eyelid margin and conjunctiva in junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome. Clin Experiment Ophthalmol 2007; 35:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/47\">",
"      Fassihi H, Wessagowit V, Ashton GH, et al. Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa. Clin Exp Dermatol 2005; 30:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/48\">",
"      Natsuga K, Nishie W, Arita K, et al. Complete paternal isodisomy of chromosome 17 in junctional epidermolysis bullosa with pyloric atresia. J Invest Dermatol 2010; 130:2671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/49\">",
"      Castori M, Floriddia G, Pisaneschi E, et al. Complete maternal isodisomy causing reduction to homozygosity for a novel LAMB3 mutation in Herlitz junctional epidermolysis bullosa. J Dermatol Sci 2008; 51:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/50\">",
"      Stoevesandt J, Borozdin W, Girschick G, et al. Lethal junctional epidermolysis bullosa with pyloric atresia due to compound heterozygosity for two novel mutations in the integrin &beta;4 gene. Klin Padiatr 2012; 224:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/51\">",
"      Laimer M, Lanschuetzer CM, Diem A, Bauer JW. Herlitz junctional epidermolysis bullosa. Dermatol Clin 2010; 28:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/52\">",
"      Wright JT. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin 2010; 28:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/53\">",
"      Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 2009; 61:367.",
"     </a>",
"    </li>",
"    <li>",
"     Laimer M. Ear, nose and throat complications. In: Life with Epidermolysis Bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy, Fine JD, Hintner H (Eds), Springer Wien, New York 2008.",
"    </li>",
"    <li>",
"     Fine JD. Other internal complications. In: Life with Epidermolysis Bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy, Fine JD, Hintner H (Eds), Springer Wien, New York 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/56\">",
"      Fine JD, Johnson LB, Weiner M, Suchindran C. Cause-specific risks of childhood death in inherited epidermolysis bullosa. J Pediatr 2008; 152:276.",
"     </a>",
"    </li>",
"    <li>",
"     Fine JD. Premature death in EB. In: Life with Epidermolysis Bullosa (EB): Etiology, Diagnosis, Multidisciplinary Care and Therapy, Fine JD, Hintner H.  (Eds), Springer, New York 2008. p.197.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/58\">",
"      Fine JD. Squamous cell carcinoma and junctional epidermolysis bullosa. J Am Acad Dermatol 2012; 66:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/59\">",
"      Hashimoto I, Schnyder UW, Anton-Lamprecht I. Epidermolysis bullosa hereditaria with junctional blistering in an adult. Dermatologica 1976; 152:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/60\">",
"      Hintner H, Wolff K. Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 1982; 118:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/61\">",
"      Darling TN, Bauer JW, Hintner H, Yancey KB. Generalized atrophic benign epidermolysis bullosa. Adv Dermatol 1997; 13:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/62\">",
"      Jonkman MF, de Jong MC, Heeres K, et al. Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency. Arch Dermatol 1996; 132:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/63\">",
"      Yancey KB, Hintner H. Non-herlitz junctional epidermolysis bullosa. Dermatol Clin 2010; 28:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/64\">",
"      Fine JD, Johnson LB, Weiner M, Suchindran C. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope 2007; 117:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/65\">",
"      Yamada Y, Dekio S, Jidoi J, et al. Epidermolysis bullosa atrophicans generalisata mitis--report of a case with renal dysfunction. J Dermatol 1990; 17:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/66\">",
"      Varki R, Sadowski S, Uitto J, Pfendner E. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 2007; 44:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/67\">",
"      Bruckner-Tuderman L. Dystrophic epidermolysis bullosa: pathogenesis and clinical features. Dermatol Clin 2010; 28:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/68\">",
"      Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 2008; 17:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/69\">",
"      van den Akker PC, Jonkman MF, Rengaw T, et al. The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat 2011; 32:1100.",
"     </a>",
"    </li>",
"    <li>",
"     COL7A1 homepage.Leiden Open Variation Database (LOVD). grenada.lumc.nl/LOVD2/mendelian_genes/home.php?select_db=COL7A1 (Accessed on November 28, 2012).",
"    </li>",
"    <li>",
"     COL7A1 gene variants database www.col7.info (Accessed on November 28, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/72\">",
"      Christiano AM, Anhalt G, Gibbons S, et al. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics 1994; 21:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/73\">",
"      Christiano AM, Greenspan DS, Hoffman GG, et al. A missense mutation in type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet 1993; 4:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/74\">",
"      van den Akker PC, Mellerio JE, Martinez AE, et al. The inversa type of recessive dystrophic epidermolysis bullosa is caused by specific arginine and glycine substitutions in type VII collagen. J Med Genet 2011; 48:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/75\">",
"      Chiaverini C, Charlesworth AV, Youssef M, et al. Inversa dystrophic epidermolysis bullosa is caused by missense mutations at specific positions of the collagenic domain of collagen type VII. J Invest Dermatol 2010; 130:2508.",
"     </a>",
"    </li>",
"    <li>",
"     Fine JD. Musculoskeletal deformities. In: Life with Epidermolysis Bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy, Fine JD, Hintner H (Eds), Springer Wien, New York 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/77\">",
"      Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 2009; 61:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/78\">",
"      Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009; 60:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/79\">",
"      Rizzo C, Anandasabapathy N, Walters RF, et al. Pretibial epidermolysis bullosa. Dermatol Online J 2008; 14:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/80\">",
"      Brick K, Hand JL, Frankel AS, et al. Epidermolysis Bullosa Pruriginosa: Further Clarification of the Phenotype. Pediatr Dermatol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/81\">",
"      Lai-Cheong JE, McGrath JA. Kindler syndrome. Dermatol Clin 2010; 28:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/82\">",
"      D'Souza MA, Kimble RM, McMillan JR. Kindler syndrome pathogenesis and fermitin family homologue 1 (kindlin-1) function. Dermatol Clin 2010; 28:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/83\">",
"      Siegel DH, Ashton GH, Penagos HG, et al. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet 2003; 73:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/84\">",
"      Meves A, Stremmel C, Gottschalk K, F&auml;ssler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol 2009; 19:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/85\">",
"      Lai-Cheong JE, Parsons M, McGrath JA. The role of kindlins in cell biology and relevance to human disease. Int J Biochem Cell Biol 2010; 42:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/86\">",
"      Has C, Wessagowit V, Pascucci M, et al. Molecular basis of Kindler syndrome in Italy: novel and recurrent Alu/Alu recombination, splice site, nonsense, and frameshift mutations in the KIND1 gene. J Invest Dermatol 2006; 126:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/87\">",
"      Lai-Cheong JE, Tanaka A, Hawche G, et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol 2009; 160:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/88\">",
"      Zhou C, Song S, Zhang J. A novel 3017-bp deletion mutation in the FERMT1 (KIND1) gene in a Chinese family with Kindler syndrome. Br J Dermatol 2009; 160:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/89\">",
"      Has C, Yordanova I, Balabanova M, et al. A novel large FERMT1 (KIND1) gene deletion in Kindler syndrome. J Dermatol Sci 2008; 52:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/90\">",
"      Lai-Cheong JE, Ussar S, Arita K, et al. Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome. J Invest Dermatol 2008; 128:2156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/91\">",
"      Larjava H, Plow EF, Wu C. Kindlins: essential regulators of integrin signalling and cell-matrix adhesion. EMBO Rep 2008; 9:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/92\">",
"      Calderwood DA. Talin controls integrin activation. Biochem Soc Trans 2004; 32:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/93\">",
"      Kloeker S, Major MB, Calderwood DA, et al. The Kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion. J Biol Chem 2004; 279:6824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/94\">",
"      Ussar S, Moser M, Widmaier M, et al. Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 2008; 4:e1000289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/95\">",
"      Lanschuetzer CM, Muss WH, Emberger M, et al. Characteristic immunohistochemical and ultrastructural findings indicate that Kindler's syndrome is an apoptotic skin disorder. J Cutan Pathol 2003; 30:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/96\">",
"      Nofal E, Assaf M, Elmosalamy K. Kindler syndrome: a study of five Egyptian cases with evaluation of severity. Int J Dermatol 2008; 47:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/97\">",
"      Lahn M, Kloeker S, Berry BS. TGF-beta inhibitors for the treatment of cancer. Expert Opin Investig Drugs 2005; 14:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/98\">",
"      Yasukawa K, Sato-Matsumura KC, McMillan J, et al. Exclusion of COL7A1 mutation in Kindler syndrome. J Am Acad Dermatol 2002; 46:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/99\">",
"      Has C, Castiglia D, del Rio M, et al. Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum Mutat 2011; 32:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/100\">",
"      Cameli N, Picardo M, Pisani A, et al. Characterization of the nail matrix basement membrane zone: an immunohistochemical study of normal nails and of the nails in Herlitz junctional epidemolysis bullosa. Br J Dermatol 1996; 134:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/101\">",
"      Moss C, Wong A, Davies P. The Birmingham Epidermolysis Bullosa Severity score: development and validation. Br J Dermatol 2009; 160:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/102\">",
"      Tosti A, de Farias DC, Murrell DF. Nail involvement in epidermolysis bullosa. Dermatol Clin 2010; 28:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/103\">",
"      Dharma B, Moss C, McGrath JA, et al. Dominant dystrophic epidermolysis bullosa presenting as familial nail dystrophy. Clin Exp Dermatol 2001; 26:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/104\">",
"      Sato-Matsumura KC, Yasukawa K, Tomita Y, Shimizu H. Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in 2 families with dystrophic epidermolysis bullosa. Arch Dermatol 2002; 138:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/105\">",
"      Tosti A, Piraccini BM, Scher RK. Isolated nail dystrophy suggestive of dominant dystrophic epidermolysis bullosa. Pediatr Dermatol 2003; 20:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/106\">",
"      Tosti A, Duque-Estrada B, Murrell DF. Alopecia in epidermolysis bullosa. Dermatol Clin 2010; 28:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/107\">",
"      Tong L, Hodgkins PR, Denyer J, et al. The eye in epidermolysis bullosa. Br J Ophthalmol 1999; 83:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/108\">",
"      Fine JD, Johnson LB, Weiner M, et al. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry. Am J Ophthalmol 2004; 138:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/109\">",
"      Fine JD, Johnson LB, Weiner M, et al. Genitourinary complications of inherited epidermolysis bullosa: experience of the national epidermylosis bullosa registry and review of the literature. J Urol 2004; 172:2040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/110\">",
"      Almaani N, Mellerio JE. Genitourinary tract involvement in epidermolysis bullosa. Dermatol Clin 2010; 28:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/111\">",
"      Martinez AE, Allgrove J, Brain C. Growth and pubertal delay in patients with epidermolysis bullosa. Dermatol Clin 2010; 28:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/112\">",
"      Mellerio JE. Infection and colonization in epidermolysis bullosa. Dermatol Clin 2010; 28:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/113\">",
"      South AP, O'Toole EA. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Dermatol Clin 2010; 28:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/114\">",
"      Lanschuetzer CM, Laimer M, Nischler E, Hintner H. Epidermolysis bullosa nevi. Dermatol Clin 2010; 28:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/115\">",
"      Bauer JW, Schaeppi H, Kaserer C, et al. Large melanocytic nevi in hereditary epidermolysis bullosa. J Am Acad Dermatol 2001; 44:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/116\">",
"      Grubauer G, Hintner H, Klein G, Fritsch P. [Acquired, surface giant nevus cell nevi in generalized, atrophic, benign epidermolysis bullosa]. Hautarzt 1989; 40:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/117\">",
"      Gallardo F, Toll A, Malvehy J, et al. Large atypical melanocytic nevi in recessive dystrophic epidermolysis bullosa: clinicopathological, ultrastructural, and dermoscopic study. Pediatr Dermatol 2005; 22:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/118\">",
"      Cash SH, Dever TT, Hyde P, Lee JB. Epidermolysis bullosa nevus: an exception to the clinical and dermoscopic criteria for melanoma. Arch Dermatol 2007; 143:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/119\">",
"      Lanschuetzer CM, Emberger M, Hametner R, et al. Pathogenic mechanisms in epidermolysis bullosa naevi. Acta Derm Venereol 2003; 83:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/28/28106/abstract/120\">",
"      Lanschuetzer CM, Emberger M, Laimer M, et al. Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern. Br J Dermatol 2005; 153:97.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15449 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-E0FBF310BF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28106=[""].join("\n");
var outline_f27_28_28106=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2900857\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900679\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4215666\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900693\">",
"      CLASSIFICATION OF EB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900707\">",
"      EPIDERMOLYSIS BULLOSA SIMPLEX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2900714\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5626143\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H68965254\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H576858238\">",
"      - EBS, localized",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H576858308\">",
"      - EBS, Dowling-Meara",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H576858354\">",
"      - EBS, other generalized",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H576858380\">",
"      - Unusual variants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900721\">",
"      JUNCTIONAL EPIDERMOLYSIS BULLOSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H381880\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5626455\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H382308\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2900729\">",
"      - JEB, Herlitz",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2900736\">",
"      - JEB, non-Herlitz",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900750\">",
"      DYSTROPHIC EPIDERMOLYSIS BULLOSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H382238\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H381977\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H382171\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H476057\">",
"      - Dominant DEB, generalized",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H476064\">",
"      - Recessive DEB, severe generalized",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H476115\">",
"      - Recessive DEB, other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H476124\">",
"      - Rare subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900764\">",
"      KINDLER SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H476454\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2900771\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H476412\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H55888270\">",
"      EXTRACUTANEOUS MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H594268293\">",
"      Nails and hair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61550917\">",
"      Eye",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55888322\">",
"      Oral cavity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H55888384\">",
"      Gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61551144\">",
"      Genitourinary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H61550788\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2900843\">",
"      Malnutrition and anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61550606\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61550613\">",
"      Skin cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H61550620\">",
"      Epidermolysis bullosa nevi",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2900857\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/15449\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15449|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/20/7493\" title=\"figure 1\">",
"      Basement membrane zone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15449|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/4/40002\" title=\"picture 1A\">",
"      EB simplex localized 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/41/34449\" title=\"picture 1B\">",
"      EB simplex localized 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/20/37185\" title=\"picture 1C\">",
"      EB simplex Dowling-Meara 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/39/27252\" title=\"picture 1D\">",
"      EB simplex Dowling-Meara 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/13/15568\" title=\"picture 2A\">",
"      Junctional EB Herlitz 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/5/24659\" title=\"picture 2B\">",
"      Junctional EB Herlitz 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/12/7363\" title=\"picture 2C\">",
"      Junctional EB Herlitz 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/8/18565\" title=\"picture 2D\">",
"      Junctional EB Herlitz 4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/40/34432\" title=\"picture 2E\">",
"      Junctional EB Herlitz 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/7/26738\" title=\"picture 3\">",
"      Junctional EB Herlitz 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/37/31313\" title=\"picture 4\">",
"      Junctional EB non-Herlitz",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/34/43552\" title=\"picture 5A\">",
"      JEB non-Herlitz adults 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/38/30304\" title=\"picture 5B\">",
"      JEB non-Herlitz adults 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/58/17314\" title=\"picture 6\">",
"      JEB non-Herlitz adult nails",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/59/42930\" title=\"picture 7A\">",
"      DEB1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/56/42882\" title=\"picture 7B\">",
"      DEB2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/40/6790\" title=\"picture 7C\">",
"      DEB3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/54/36708\" title=\"picture 7D\">",
"      DEB4",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/33/11795\" title=\"picture 7E\">",
"      DEB milia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/15/13554\" title=\"picture 8\">",
"      Mitten deformity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/15/15603\" title=\"picture 9A\">",
"      DEB squamous cell carcinoma 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/34/9763\" title=\"picture 9B\">",
"      DEB squamous cell carcinoma 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/58/9123\" title=\"picture 10\">",
"      EB nevi 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/28/43456\" title=\"picture 11\">",
"      EB nevi 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/51/21298\" title=\"picture 12A\">",
"      EB nevi 5",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/45/9937\" title=\"picture 12B\">",
"      EB nevi 6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/47/7924\" title=\"picture 13\">",
"      EB nevi 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/15/21750\" title=\"picture 14\">",
"      EB nevi dermoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/15449|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/16/6415\" title=\"table 1\">",
"      EB simplex variants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/28/9678\" title=\"table 2\">",
"      JEB variants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?21/9/21662\" title=\"table 3\">",
"      DEB variants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/53/15195\" title=\"table 4\">",
"      Kindler syndrome 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/29/10719\" title=\"table 5\">",
"      EB extracutaneous complications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39255?source=related_link\">",
"      Diagnosis of epidermolysis bullosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=related_link\">",
"      Glossary of genetic terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/63/3066?source=related_link\">",
"      Overview of the management of epidermolysis bullosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/46/21226?source=related_link\">",
"      Recognition and management of high-risk (aggressive) cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_28_28107="AJCC criteria for histologic grade of neuroendocrine tumors";
var content_f27_28_28107=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    AJCC criteria for histologic grade of neuroendocrine tumors of the gastrointestinal tract",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Mitotic count (per 10 HPF)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ki-67 index (percent)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        G1",
"       </td>",
"       <td>",
"        &lt;2",
"       </td>",
"       <td>",
"        &le;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        G2",
"       </td>",
"       <td>",
"        2-20",
"       </td>",
"       <td>",
"        3-20",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        G3",
"       </td>",
"       <td>",
"        &gt;20",
"       </td>",
"       <td>",
"        &gt;20",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Cellular pleomorphism is not a useful feature for grading carcinoid tumors. High proliferative index has been linked with more aggressive behavior. The above grading scheme has been proposed for neuroendocrine tumors of the gastrointestinal tract.",
"    <div class=\"footnotes\">",
"     * HPF: high power field; 10 HPF = 2 mm",
"     <sup>",
"      2",
"     </sup>",
"     , at least 40 fields (at 400x magnification) evaluated in areas of highest mitotic density.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      MIB1 antibody; percent of 2000 tumor cells in areas of highest nuclear labeling.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28107=[""].join("\n");
var outline_f27_28_28107=null;
var title_f27_28_28108="Cervical cancer survival";
var content_f27_28_28108=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Survival by FIGO stage for patients with cervical cancer: 1999 to 2001 FIGO statistics",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        FIGO stage",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\">",
"        Overall survival, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        One&nbsp;year",
"       </td>",
"       <td class=\"subtitle2\">",
"        Two&nbsp;years",
"       </td>",
"       <td class=\"subtitle2\">",
"        Five&nbsp;years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IA1",
"       </td>",
"       <td>",
"        829",
"       </td>",
"       <td>",
"        99.8",
"       </td>",
"       <td>",
"        99.5",
"       </td>",
"       <td>",
"        97.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IA2",
"       </td>",
"       <td>",
"        275",
"       </td>",
"       <td>",
"        98.5",
"       </td>",
"       <td>",
"        96.9",
"       </td>",
"       <td>",
"        94.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IB1",
"       </td>",
"       <td>",
"        3020",
"       </td>",
"       <td>",
"        98.2",
"       </td>",
"       <td>",
"        95.0",
"       </td>",
"       <td>",
"        89.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IB2",
"       </td>",
"       <td>",
"        1090",
"       </td>",
"       <td>",
"        95.8",
"       </td>",
"       <td>",
"        88.3",
"       </td>",
"       <td>",
"        75.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIA",
"       </td>",
"       <td>",
"        1007",
"       </td>",
"       <td>",
"        96.1",
"       </td>",
"       <td>",
"        88.3",
"       </td>",
"       <td>",
"        73.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIB",
"       </td>",
"       <td>",
"        2510",
"       </td>",
"       <td>",
"        91.7",
"       </td>",
"       <td>",
"        79.8",
"       </td>",
"       <td>",
"        65.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIA",
"       </td>",
"       <td>",
"        211",
"       </td>",
"       <td>",
"        76.7",
"       </td>",
"       <td>",
"        59.8",
"       </td>",
"       <td>",
"        39.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIB",
"       </td>",
"       <td>",
"        2028",
"       </td>",
"       <td>",
"        77.9",
"       </td>",
"       <td>",
"        59.5",
"       </td>",
"       <td>",
"        41.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVA",
"       </td>",
"       <td>",
"        326",
"       </td>",
"       <td>",
"        51.9",
"       </td>",
"       <td>",
"        35.1",
"       </td>",
"       <td>",
"        22.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IVB",
"       </td>",
"       <td>",
"        343",
"       </td>",
"       <td>",
"        42.2",
"       </td>",
"       <td>",
"        22.7",
"       </td>",
"       <td>",
"        9.3",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FIGO: International Federation of Gynecology and Obstetrics.",
"    </div>",
"    <div class=\"reference\">",
"     Original table modified for this publication.&nbsp;From: Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet 2006; 95:S43. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28108=[""].join("\n");
var outline_f27_28_28108=null;
var title_f27_28_28109="Tests to diagnose UTI in children";
var content_f27_28_28109=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Test characteristics of tests used to diagnose urinary tract infections in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sensitivity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Specificity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Positive likelihood ratio*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Negative likelihood ratio",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Ref",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Dipstick",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Leukocyte esterase (LE)",
"       </td>",
"       <td>",
"        84 percent",
"       </td>",
"       <td>",
"        78 percent",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitrite",
"       </td>",
"       <td>",
"        50 percent",
"       </td>",
"       <td>",
"        98 percent",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        0.5",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitrite or LE",
"       </td>",
"       <td>",
"        88 percent",
"       </td>",
"       <td>",
"        93 percent",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nitrite and LE",
"       </td>",
"       <td>",
"        72 percent",
"       </td>",
"       <td>",
"        96 percent",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Microscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"6\">",
"        Uncentrifuged",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Pyuria (&gt;10/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) (all ages)",
"       </td>",
"       <td>",
"        77 percent",
"       </td>",
"       <td>",
"        89 percent",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Pyuria (&gt;10/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) (&lt;2 years)",
"       </td>",
"       <td>",
"        90 percent",
"       </td>",
"       <td>",
"        95 percent",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        [1,2]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bacteriuria (gram stained)",
"       </td>",
"       <td>",
"        93 percent",
"       </td>",
"       <td>",
"        95 percent",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Overall (P+B) = enhanced",
"       </td>",
"       <td>",
"        85 percent",
"       </td>",
"       <td>",
"        99.9 percent",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Overall (P or B)",
"       </td>",
"       <td>",
"        95 percent",
"       </td>",
"       <td>",
"        89 percent",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        0.1",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"6\">",
"        Centrifuged",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Pyuria (&gt;5/hpf)",
"       </td>",
"       <td>",
"        67 percent",
"       </td>",
"       <td>",
"        79 percent",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        [1]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bacteriuria",
"       </td>",
"       <td>",
"        81 percent",
"       </td>",
"       <td>",
"        83 percent",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        [3]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Overall (P+B)",
"       </td>",
"       <td>",
"        66 percent",
"       </td>",
"       <td>",
"        99 percent",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        [2]",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Positive likelihood ratio: The positive likelihood ratio is the probability that a child with a UTI will have a positive test divided by the probability that a child without a UTI will have a positive test (eg, true positive rate/false positive rate). The higher the positive likelihood ratio, the better the test.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Negative likelihood ratio: The negative likelihood ratio is the probability that a child with a UTI will have a negative test divided by the probability that a child without a UTI will have a negative test (eg, false negative rate/true negative rate). The lower the negative likelihood ratio, the better the test (a perfect test has a negative likelihood ratio of zero).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Gorelick MH, Shaw KN. Screening tests for urinary tract infection in children: A meta-analysis. Pediatrics 1999; 104:e54.",
"       </li>",
"       <li>",
"        Huicho L, Campos-Sanchez M, Alamo C. Metaanalysis of urine screening tests for determining the risk of urinary tract infection in children. Pediatr Infect Dis J 2002; 21:1.",
"       </li>",
"       <li>",
"        Finnell SM, Carroll AE, Downs SM, the Subcommittee on Urinary Tract Infection. Technical Report--Diagnosis and Management of an Initial UTI in Febrile Infants and Young Children. Pediatrics 2011.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28109=[""].join("\n");
var outline_f27_28_28109=null;
var title_f27_28_28110="Contents: Interactive diabetes cases";
var content_f27_28_28110=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Interactive diabetes cases",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Interactive diabetes cases",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Interactive diabetes case 01",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/48/5889\">",
"           Interactive diabetes case 1: Inpatient management in type 1 diabetes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 02",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/10/2210\">",
"           Interactive diabetes case 2: Switching from oral agents to insulin in type 2 diabetes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 03",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/20/9538\">",
"           Interactive diabetes case 3: Hypoglycemia in a patient with type 1 diabetes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 04",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/21/12626\">",
"           Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 05",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/17/13586\">",
"           Interactive diabetes case 5: Insulin management in a 73-year-old diabetic woman admitted to the hospital",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 06",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/27/30129\">",
"           Interactive diabetes case 6: Uncontrolled diabetes in a 64-year-old woman treated with insulin",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 07",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/4/2114\">",
"           Interactive diabetes case 7: Management of diabetes in a 72-year-old man with type 2 diabetes, GI bleeding and multiple other medical problems",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 08",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/13/4306\">",
"           Interactive diabetes case 8: Discordant values for A1C and home blood glucose values",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 09",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/60/15299\">",
"           Interactive diabetes case 9: Management of type 1 diabetes in a patient on glucocorticoid therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 10",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/1/10259\">",
"           Interactive diabetes case 10: A 45-year old woman with variable glucose values and hypoglycemia unawareness on insulin therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 11",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/4/8258\">",
"           Interactive diabetes case 11: A 34-year old pregnant woman with type 2 diabetes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 12",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/22/13666\">",
"           Interactive diabetes case 12: Perioperative management of a 67-year-old man with type 2 diabetes who undergoes coronary artery bypass surgery",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 13",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/16/32002\">",
"           Interactive diabetes case 13: Deterioration of metabolic control in a 59-year-old man with type 2 diabetes complicated by retinopathy, nephropathy, and neuropathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 14",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/12/6339\">",
"           Interactive diabetes case 14: A 41-year-old man with type 2 diabetes and hypertriglyceridemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 15",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/46/37602\">",
"           Interactive diabetes case 15: A 74-year-old woman with type 2 diabetes and recurrent hyperkalemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 16",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/48/39682\">",
"           Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 17",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/54/9058\">",
"           Interactive diabetes case 17: A 57-year-old woman with newly discovered type 2 diabetes",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 18",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/48/18178\">",
"           Interactive diabetes case 18: A 61-year-old man with type 2 diabetes and a recent change in diet (Medical Nutrition Therapy)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 19",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/2/38946\">",
"           Interactive diabetes case 19: Pain and dysesthesias of the lower extremities in a 29-year-old woman with type 1 diabetes (distal sensory neuropathy)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Interactive diabetes case 20",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/15/25842\">",
"           Interactive diabetes case 20: A 76-year-old man with long-standing type 2 diabetes, orthostatic hypotension, and recurrent syncope",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-F5E8C4E60E-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f27_28_28110=[""].join("\n");
var outline_f27_28_28110=null;
var title_f27_28_28111="Bicipital tendon rupture";
var content_f27_28_28111=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bicipital tendon rupture: Photo one",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 220px; height: 361px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 64-year-old man on coumadin had a \"spontaneous\" rupture of the right long head of the biceps. Bicipital tendon ruptures are dramatic; most develop some degree of ecchymosis, although bruising here is accentuated by his anticoagulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_28_28111=[""].join("\n");
var outline_f27_28_28111=null;
